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The aim of this doctoral thesis was to study the incidence, risk factors and outcomes of type 
1 diabetes for children in South Australia, born from 1999-2013. The incidence of type 1 
diabetes has doubled in the last four decades in many countries including Australia, and has 
substantial individual and economic consequences. Evidence from studies on type 1 diabetes 
aetiology and its implications is mixed. In this thesis, the linkage of multiple population-wide 
administrative data over 15 years, and use of rigorous epidemiological approaches has 
resulted in a better understanding of the risk factors and implications of type 1 diabetes.    
 There are four studies in this doctoral thesis. In the first descriptive study, the incidence of 
type 1 diabetes was estimated by individual and area-level socioeconomic characteristics 
among children (aged ≤11 years) in South Australia, born from 2002-2013. Findings of the 
study showed that type 1 diabetes incidence rates differed depending on the measures of 
socioeconomic characteristics. Individual-level indicators showed higher type 1 diabetes 
incidence among more advantaged children, however, there was no clear area-level 
socioeconomic patterning of type 1 diabetes. Area-level measures of socioeconomic position 
are likely to have a greater risk of misclassification from true socioeconomic position, which 
suggests that the use of area-level measures may be misleading. Socioeconomic position is a 
major determinant of health and can modify the risk factors of type 1 diabetes. For example, 
as per hygiene hypothesis, the socioeconomically dis-advantaged children are less likely to 
have type 1 diabetes, which is supported by the findings of individual-level socioeconomic 
patterning of type1 diabetes in the first study.  In addition, socioeconomically disadvantaged 
xxvi 
 
women are less likely to have a caesarean birth and more likely to smoke in pregnancy. I 
chose to study these two risk factors of type 1 diabetes because the evidence was inconsistent, 
and some studies had methodical limitations.   
 Evidence about the effect of caesarean section on childhood type 1 diabetes is mixed; ranging 
from very small or no risk to 20-30% increased risk. A prevailing theory is that exposure to 
the gut and vaginal microbiota during a vaginal birth protects against type 1 diabetes. 
Therefore, in the second study, the impact of caesarean birth on childhood type 1 diabetes 
(aged ≤15 years) was estimated. This involved linking multiple administrative datasets of 
children in South Australia, born from 1999-2013. The question was extended to whether 
type 1 diabetes risk differed for children born by prelabour or intrapartum caesarean to further 
test the idea of microbiota exposure on type 1 diabetes. That is because children born by 
prelabour caesarean do not get exposure to maternal vaginal microbiota, and intrapartum 
caesarean births may have some exposure. Findings of the study obtained from Cox 
proportional hazard regression analysis showed a negligible 5% higher incidence (HR = 1.05, 
95% CI 0.86-1.28) for caesarean births compared with normal vaginal delivery, with wide 
confidence intervals including the null. Contrary to the hypothesis of a higher type 1 diabetes 
risk for prelabor caesarean (because of non-exposure to maternal vaginal microbiota) type 1 
diabetes risk for intrapartum caesarean was slightly higher (HR = 1.08, 95% CI 0.82-1.41) 
than prelabor caesarean (HR = 1.02, 95% CI 0.79-1.32). This negligible risk of type 1 
diabetes for children who had caesarean birth, either prelabor or intrapartum, and the 
potential for unmeasured confounding suggested that birth method induced variation in 
neonatal microbiota might not be involved in modifying type 1 diabetes risk.  
xxvii 
 
 Like caesarean section, maternal smoking in pregnancy is also a debated risk factor for 
childhood type 1 diabetes. Evidence about maternal smoking on childhood type 1 diabetes is 
inconsistent; studies have been small, and many did not adjust for important confounders or 
address missing data. In the third study of this doctoral thesis, the effect of maternal smoking 
in pregnancy on childhood type 1 diabetes was estimated using Cox proportional hazard 
regression analysis, once again by linking multiple administrative datasets of children in 
South Australia, born from 1999-2013. The analytical approach for this study ranged; from 
Cox proportional hazard analysis with adjustment for wide range of confounders using the 
SA ECDP linked data, involving multiple imputation for missing data; to conducting meta-
analysis in order to get more precise estimate. But smoking is notoriously residually 
confounded, therefore, I made special efforts to investigate the possibility of residual 
confounding by using a negative control and E-value. The findings demonstrated that 
maternal smoking in pregnancy was associated with a 16% (HR 0.84, 95% CI 0.67, 1.08) 
lower childhood type 1 diabetes incidence, compared with unexposed children, which was 
also supported by the meta-analytic estimates of population-based cohort studies (HR 0.72, 
95% CI 0.62, 0.82) and case-control studies (OR 0.71, 95% CI 0.55, 0.86). The negative 
control outcome and E-value analyses indicated the potential for residual confounding in the 
effect of maternal smoking on childhood type 1 diabetes. Triangulation of evidence from this 
study along with the results of similar population-based studies, suggested a small reduced 
risk of childhood type 1 diabetes for children exposed to maternal smoking in pregnancy. 
However, the mechanisms linking maternal smoking in pregnancy with childhood type 1 
diabetes require further investigation. 
xxviii 
 
In the fourth study of this thesis, the impact of childhood type 1 diabetes on children’s 
educational outcomes in year/grade 5 at age ~10 were estimated, linking population-wide 
data of children in South Australia, born from 1999-2005. In this study, a doubly-robust 
analytical method called augmented inverse probability weighting (AIPW) was used to 
compute the average treatment effect of type 1 diabetes on children’s educational outcomes. 
AIPW gives an unbiased estimate if either the outcome model or the treatment model is 
correctly specified. The findings of this study demonstrated that children with type 1 diabetes 
are not disadvantaged in terms of educational outcomes in year 5, potentially reflecting 
improvement in type 1 diabetes management in Australia.  
In summary, the work in this doctoral thesis has demonstrated that type 1 diabetes incidence 
differed depending on the measure of socioeconomic position. The hygiene hypothesis was 
only supported by the individual-level socioeconomic pattering of type 1 diabetes incidence 
in South Australia. The involvement of birth method induced variation in neonatal microbiota 
in type 1 diabetes was not supported by the caesarean and childhood type 1 diabetes study. 
Despite the evidence of residual confounding in the estimate of maternal smoking in 
pregnancy on childhood type 1 diabetes, triangulation of the evidence suggested small 
reduced risk for children exposed to maternal smoking in pregnancy, but further research will 
be needed to understand the mechanism. The findings of similar educational outcomes for 
children with and without type 1 diabetes, highlighted the importance of improvements in 





CHAPTER 1 INTRODUCTION  
  
Type 1 diabetes is a chronic childhood disease of an autoimmune origin, caused by the 
destruction of insulin producing pancreatic β-cells.1 The resulting severe insulin deficiency 
impairs the cellular uptake and utilization of glucose, and leads to an increased blood glucose 
concentration and hyperglycaemia. Uncontrolled hyperglycaemia increases the risk of 
microvascular (diabetic retinopathy, renal disease, peripheral neuropathy and amputation) and 
macrovascular complications (stroke, myocardial infarction, cardiac failure and peripheral 
vascular diseases).2, 3 4 When the body is unable to metabolize glucose for energy, lipolysis 
occurs, leading to the production and accumulation of ketone bodies in the blood, a condition 
called ketoacidosis.5 Both hyperglycaemia and ketoacidosis have consequences for children’s 
health and development.  
In the last four decades the incidence of type 1 diabetes has doubled in many countries in the 
world including Australia. Genetics alone cannot explain the increasing incidence. The role of 
the environment in type 1 diabetes pathogenesis is suggested by rising type 1 diabetes 
incidence6, 7 and  global variation in type 1 diabetes incidence (1.01-60.9 per 100,000 person-
years).3, 6-9  In addition, the disparity in type 1 diabetes incidence in genetically similar European 
populations with different socio-economic characteristics,10 and discordance in type 1 diabetes 
incidence among monozygotic twins,11 also support the involvement of environmental in type 





 Evidence suggests the environment is playing an important role in driving the increasing type 
1 diabetes incidence. However, identifying the exact cause(s) that initiate the autoimmune 
process leading to type 1 diabetes remains elusive. 
 
1.1 Why study the risk factors and implications of type 1 diabetes? 
 
In my doctoral thesis, I studied the incidence, selected risk factors (caesarean birth and maternal 
smoking in pregnancy) and implications of type 1 diabetes for children’s educational outcomes 
in South Australia.  There were four reasons to study these risk factors and implication of type 
1 diabetes; firstly the increasing incidence of type 1 diabetes and its impact for children’s health 
and development, the psychosocial burden and economic implications associated with type 1 
diabetes care and management.  Children with type 1 diabetes are three times more likely to be 
hospitalized per person-year,12 have 3% lower school attendance per-year,13 and 19% higher 
mental health referral rates than children without type 1 diabetes.14 People with type 1 diabetes 
have an average of 12 years lower life expectancy than the general population.15  The annual 
estimated health care cost of type 1 diabetes in Australia was $570 million for 2008 and 
hospitalization accounted for 47% of this cost.16, 17  
Secondly at population level apart from rising type 1 diabetes incidence,6 caesareans birth rates 
are also on the rise,18  while smoking rates are declining.19  However, the evidence about the 
effect of caesarean birth20-25 and maternal smoking in pregnancy on childhood type 1 diabetes,26-





not clear if either of these are causal.  Women cannot be randomised to have caesarean birth or 
to smoke in pregnancy; these are such confounded variables, that it is difficult to study these 
risk factors as causes. Therefore, there is a very opportunity to apply some innovative causal 
methods to try to understand these risk factors and implications of type 1 diabetes on educational 
outcomes. In addition, large studies are needed for power since type 1 diabetes is rare disease.  
Thirdly; most of the findings came from case-control studies, expect few population-based 
cohort studies, and the whole-of-population linked data platform granted the opportunity to look 
at these risk factors in a whole-of-population sample rather than a case-control study. Lastly; 
there were methodological limitations in most previous studies; there is inconsistency in 
evidence about these risk factors and the implication of type 1 diabetes, due to variability in 
study designs, small numbers, and unavailability of individual level-socioeconomic information 
or not adjusting for important confounders putting some estimates at risk of confounding bias.  
In the South Australian Early Childhood Data Project (SA ECDP) that I have used in my 
doctoral dissertation, information on individual and areal-level socioeconomic factors, 
caesarean birth and maternal smoking in pregnancy along with a wide range of other variables 
(potential confounders) has been collected using validated forms as part of the perinatal statistics 
(detail in chapter 3). Multiple population-wide datasets (hospitalization, perinatal and births, 
and school assessment) have been linked in the SA ECDP database, making it feasible to study 
the risk factors and implications of type 1 diabetes, in an efficient way using cutting-edge 






1.2 Thesis aim and research questions 
 
The overarching aim of my doctoral project was to study the incidence, risk factors and 
implications of type 1 diabetes. The four specific question addressed in this thesis included; 
1. What are the socioeconomic characteristics of children with type 1 diabetes in South 
Australia born from 2002-2013?  
2. What is the effect of caesarean birth on childhood type 1 diabetes? Does the risk of 
type 1 diabetes differ by prelabour and intrapartum caesarean? 
3. What is the effect of maternal smoking in pregnancy on the risk of childhood type 1 
diabetes? What is the risk of bias due to residual confounding in the effect estimate? 
4. What is the impact of type 1 diabetes on children’s educational outcomes?  
 
1.3 Thesis outline 
 
This doctoral dissertation is organized as follows.  
In Chapter 2 I reviewed the existing literature about the incidence, genetic and environmental 
risk factors and the hypothesized mechanisms, and burden of type 1 diabetes. The focus then 
moved to the specific research areas to be explored in my thesis; the socioeconomic patterning 
of type 1 diabetes; caesarean birth, maternal smoking in pregnancy, and type 1 diabetes; and 





review was to find the gaps in the existing literature about the risk factors and implication of 
type 1 diabetes, and to be able to identify potential confounders for the above mentioned 
research questions.  
In Chapter 3 I have described; the study population and design, the multiple population-wide 
administrative datasets used in my doctoral research; including birth registration data, perinatal 
statistics, hospitalisation data, school enrolment census and school assessment data. It also 
describes the data linkage process; the epidemiological methods used, which includes directed 
acyclic graphs (DAGs) for identifying confounding; augmented inverse probability weighting; 
methods to estimate unmeasured confounding such as negative control outcome analysis and E-
value; and the technique used to deal with missing data (multiple imputation). The analytical 
approaches used in each of the four research questions are also discussed in greater depth than 
able to be included in each of the papers.    
 Chapter 4 is a submitted paper in the Journal of Paediatrics and Child Health (accepted for 
publication during examination) and addressed the first research question of this doctoral 
dissertation. In this descriptive paper, I estimated the incidence rate of type 1 diabetes by area-
level and individual-level socioeconomic characteristics, for children in South Australia born 
from 2002-2013. I used linked hospitalization, birth registration and perinatal statistics datasets 
to explore the association between socioeconomic position and the type 1 diabetes incidence in 
childhood.  
Chapter 5 is a published academic paper in Diabetic Medicine. In this study I explored the 





extending the question to whether type 1 diabetes risk differed by prelabour or intrapartum 
caesarean. Multiple linked population-wide datasets (hospital, births, and perinatal 
characteristics) of children in South Australia, born from 1999-2013 were used for this study.  
Chapter 6 is an academic paper, accepted for publication in Diabetologia (published during 
examination). This was the most extensive work from my doctoral dissertation. Firstly, I 
estimated the association between maternal smoking in pregnancy and childhood type 1 diabetes 
using Cox proportional hazard regression using multiple linked population-wide datasets of 
children in South Australia, born from 1999-2013. Secondly, I assessed the risk of bias due to 
residual confounding with a negative-control outcome design and an E-value analysis; and 
finally in order to get more precise estimate of the association between maternal smoking in 
pregnancy and type 1 diabetes, I conducted a meta-analysis of published population-based and 
case-control studies, along with my own findings. 
Chapter 7 is an academic paper published in Pediatric Diabetes during examination. In this 
paper I estimated the effect of type 1 diabetes on children’s educational outcomes, compared to 
children without type 1 diabetes, using multiple population-wide administrative datasets of 
children in South Australia. Here I apply the potential outcomes approach to compute the 
average treatment effect of type 1 diabetes on children’s educational outcomes in year/grade 5 
(age ~ 10 years), by using augmented inverse probability weighting.   
Chapter 8 summarizes the key findings; and discusses the contribution of this doctoral research, 





CHAPTER 2 BACKGROUND 
 
2.1 Preface  
 
In this chapter I have reviewed the concepts of type 1 diabetes prevalence and incidence; the 
genetics and common environmental risk factors; the proposed hypotheses for the increasing 
type 1 diabetes incidence; and the burden of type 1 diabetes. In addition, I also reviewed the 
existing literature around the main areas I have explored in my doctoral dissertation, including 
the risk factors (socioeconomic position, caesarean birth, maternal smoking in pregnancy) and 
implications of type 1 diabetes for children’s educational outcomes.   
  
2.2 What is type 1 diabetes?  
 
The autoimmune-mediated destruction of pancreatic beta (β) cells in type 1 diabetes results in 
impaired insulin production. The progressive loss of β-cell function causes absolute insulin 
deficiency, making people dependent on the administration of exogenous insulin for survival.2, 
3 Insulin is an essential hormone for the human body to regulate cellular uptake and utilization 
of glucose.2, 38 Without insulin to allow glucose to enter cells, blood glucose builds up in 
circulation resulting in hyperglycaemia. Due to severe insulin deficiency the body is unable to 
metabolize glucose for energy and consequently the breakdown of fatty acids (lipolysis) occurs, 





bodies results in ketoacidosis.5 Persistent hyperglycaemia can cause microvascular (affecting 
capillaries and small blood vessels) and macrovascular (affecting large arteries) complications. 
Microvascular complications include diabetic retinopathy, renal disease, peripheral neuropathy 
and amputation. Macrovascular complications are stroke, myocardial infarction, cardiac failure 
and peripheral vascular diseases.2, 3 4 
The risk of type 1 diabetes can be identified in the asymptomatic stage by genetic susceptibility, 
appearance of autoantibodies, and dysglycemia.38, 39 While clinically asymptomatic (stage 0 to 
stage 2) type 1 diabetes autoantibodies start appearing,40 but the β-cell mass remains intact.1, 41 
Long-term risks associated with type 1 diabetes are higher for children who are positive for one 
autoantibody than people without autoantibodies, however less than 10% of people who are 
positive for a single autoantibody develop clinical type 1 diabetes over 10 years.1, 42 The risk of 
type 1 diabetes is over 90% in first-degree relatives of patients who are positive for at least two 
autoantibodies, whereas risk is less than 20% in relatives who are positive for one autoantibody.2  
The rate of progression from autoantibody seroconversion to overt type 1 diabetes varies from 
a few months to many years.40, 43 Islet autoimmunity starts many months and years before type 
1 diabetes diagnosis, and 90% of children who are diagnosed with type 1 diabetes before puberty 
have islet autoantibodies by age 5 years.41 Longitudinal follow-up studies among genetically at 
risk children have shown that islet autoantibodies appear in the second half of infancy43 peaking 
at around 9-24 months,43, 44 45 but are rarely detected before the age of 6 months.45 Remittance 





accelerated progression from islet autoimmunity to clinical diabetes is proposed to have caused 
the escalation in type 1 diabetes incidence among children.46  
There are three stages in the development of type 1 diabetes. Appearance of at least two islet 
autoantibodies marks stage 1 of type 1 diabetes.1, 41, 42 Stage 2 is characterized by two positive 
autoantibodies, dysglycaemia, the start of decline in pancreatic β-cell mass, and this is 
accompanied by a five year risk of 75% for developing type 1 diabetes.1, 42 Stage 3 is the 
clinically symptomatic phase of type 1 diabetes and is characterized by the presence of at least 
two autoantibodies, hyperglycaemia, and 10-20% loss of the pancreatic β-cell mass.1, 42 In 
addition to the appearance of autoantibodies, widely accepted criteria for diagnosis of clinical 
type 1 diabetes is fasting blood glucose levels ≥126 mg/dl or ≥7 mmol/L and oral glucose 
tolerance test  ≥200 mg/dl or ≥11.1 mmol/L.38, 47 Type 1 diabetes stages are important for 
screening and identifying at risk individuals for potential interventions in order to delay the 
onset of clinical type 1 diabetes. Most importantly, identification of individuals, particularly 
children, at the asymptomatic stage, will help prevent severe hyperglycaemia and diabetic 
ketoacidosis and the long-term consequences for children’s health and development.   
 Type 1 diabetes can be diagnosed at any age, however, most people with type 1 diabetes are 
diagnosed in childhood.48, 49 Type 1 diabetes accounts for ≥85% of all diabetes in children aged 
<20 years in the world.50 In Australia, 61% of newly diagnosed type 1 diabetes cases were made 






2.3  Prevalence of type 1 diabetes  
 
According to the 2017 International Diabetes Federation report, globally around 1.1 million 
children aged <19 years have type 1 diabetes and 132,600 new cases are diagnosed every year.52 
In developed countries approximately 7-9% of all diabetes cases are type 1 diabetes, and 87-
91% are type 2 diabetes cases.52 The proportion of diabetes cases that are type 1 and type 2 is 
not clear in middle and low income countries, due to a lack of data. In Australia, the National 
Diabetes Register data demonstrated that 6,091 children aged 0-14 had type 1 diabetes in 2013, 
equating to a prevalence of 139 cases per 100,000.53 Within Australian jurisdictions, South 
Australia had the second highest prevalence of type 1 diabetes (159 per 100,000), with the 
highest being in Tasmania (166 per 100,000) and the lowest in the Northern Territory (50 per 
100,000).53  
 
2.4  Incidence of type 1 diabetes  
 
2.4.1 Trends and variation in global type 1 diabetes incidence 
 
There are regional and country-level variations in type 1 diabetes incidence.3 Current evidence 
suggests that type 1 diabetes incidence ranges from 1.01 per 100,000 person-years in China8 to 





diabetes incidence, and the Western Pacific region and Africa have the lowest incidence.54 Type 
1 diabetes incidence has almost doubled in most European countries in the last three decades.7 
For example, in Finland, type 1 diabetes incidence was 38.2 per 100,000 person-years from 
1989-1993, and has reached 60.9 per 100,000 person-years in 2009-2013.7 The regional and 
country-level variations in type 1 diabetes incidence depict the wide distribution of type 1 
diabetes related genes, and different environmental factors in each country that could be playing 
a vital role in influencing type 1 diabetes pathogenesis.  
There is consensus in evidence that childhood type 1 diabetes incidence has been rising over the 
last four decades in many countries.3, 6, 7, 55 However, some recent studies have reported 
stabilization in type 1 diabetes incidence,9, 49, 56 while others depicted a sinusoidal pattern in type 
1 diabetes incidence rates.57 Until now the most comprehensive global evidence (data from 112 
centres around the world) of type 1 diabetes incidence comes from the World Health 
Organization’s DIAMOND study that demonstrated a 2.8% average annual increase in type 1 
diabetes incidence from 1990-1999, among children aged ≤14 years.6 More recent evidence 
from 26 European centres demonstrated a 3.4% average annual increase in type 1 diabetes 
incidence from 1989-2013, with a range of 0.5% in Spain−Catalonia to 6.6% average annual 
increase in Poland-Katowice, among 0-14 year olds.7  Some studies suggest that previously type 
1 diabetes incidence was rising rapidly among younger children (0-4, 5-9 years),58 although this 
has recently shifted to older age groups (10-14 years).9, 59 
Most type 1 diabetes incidence data comes from industrialized countries with a high Human 





increasing in high income countries, due to the lack of population-based data from middle- and 
low-income countries.  
 
2.4.2  Type 1 diabetes incidence in Australia  
 
According to the Australian Institute of Health and Welfare, in 2017 about 2,742 people were 
diagnosed with type 1 diabetes (all age groups), which equates to an incidence of 12 cases per 
100,000 population, and 9% of all diabetes cases.51 About 1,114 or 41% of new type 1 diabetes 
cases diagnosed in 2017 were amongst children 0-14 years old, equating to an incidence of 24 
per 100,000 population for this age group.51 Australia ranks ninth in the world for published 
type 1 diabetes incidence among children aged under 15 years (Figure 2-1).54   
 
 
Figure 2-1: Top 10 countries with published type 1 diabetes incidence 





Australia experienced increasing trends in type 1 diabetes incidence a decade ago, but more 
recent evidence has depicted some stabilization in type 1 diabetes incidence. A population-based 
register study reported that type 1 diabetes incidence was 13.6 per 100,000 population per year, 
among 0-14 year olds in 1984, in Sydney.60 Similar type 1 diabetes incidence (13.2 per 100,000 
person-year) was observed in Western Australia from 1985-1989.61 Since then type 1 diabetes 
incidence has almost doubled among 0-14 year olds in Australia (24 per 100,000 population, 
2000-2013).57, 62 Further evidence of increasing incidence is seen in jurisdiction specific studies. 
An average 3.3% annual increase in type 1 diabetes incidence was observed from 1985-2003 in 
Western Australia (WA),63 and a 2.8% average annual increase was reported in New South 
Wales from 1990-2002.64   
As mentioned following the increase in incidence, a plateauing trend in type 1 diabetes incidence 
has been observed over the last decade in many countries7 including Norway,56 Finland,9  
Sweden59 and Australia.63 A study in Western Australia (WA) showed an average 3.3% per year 
increase in type 1 diabetes incidence from 1985 to 2003, however, no significant change in the 
temporal trend were observed (−0.6% per year) from 2003 to 2016.63 At a national level, the 
Australian National Diabetes Register data showed a sinusoidal cyclic pattern (five-year cyclic 
variation) in childhood type 1 diabetes incidence from 2000-2011, and an average annual 
increase of 1.2% was observed only among 10-14 year old children.57, 65 Thus, the increasing 
trend in type 1 diabetes incidence is showing signs of slowing down, or plateauing in many 






2.4.3 Ethnic variation in type 1 diabetes incidence 
 
Variation in childhood type 1 diabetes incidence has been observed across different ethnic 
groups within Australia,62 Norway,66 Sweden,67 and the US.32 In Australia type 1 diabetes 
incidence is lower among Aboriginal and Torres Strait Islander people than non-Indigenous 
Australians.62 In Norway, lower type 1 diabetes incidence was observed among children from 
other backgrounds (based on mother’s country of birth) than the Norwegian children.66 Similar 
ethnic differences in type 1 diabetes incidence were observed in the US (higher type 1 diabetes 
incidence in white Americans than other ethnicities),32 and Sweden (higher type 1 diabetes 
incidence in native Swedes than second-generation immigrants, except Finnish immigrants).67 
These findings suggest that Caucasians have higher type 1 diabetes incidence than other ethnic 
groups in Europe, US and Australia. Potential reasons for these ethnic differences in type 1 
diabetes incidence could be genetic variation, differences in socioeconomic conditions, lifestyle, 
eating and dietary behaviours among these groups. 
 
2.4.4 Type 1 diabetes incidence by gender and age  
 
There is some suggestion of disparities in type 1 diabetes incidence by gender and age-group, 
however the evidence is mixed. In most countries, including Italy,68 Finland,9 and Sweden,59 the 





been reported in Australia63 and Poland.69 For example, in Finland from 2006 to 2011, the 
incidence of type 1 diabetes was 68 per 100,000 person-years for boys and 55 per 100,000 
person-years for girls.9 Countries appear to differ at the age when the type 1 diabetes incidence 
peaks. In most countries, including Sweden,59 Norway,66 US,70 Northern Ireland,71 and 
Australia,57, 63, 64 the highest type 1 diabetes incidence has been observed among 10-14 year 
olds. Gender differences in peak age of diagnosis have also been reported. For example, in 
Sweden72 and Australia63 type 1 diabetes incidence rate has been observed to be highest for 
males aged 10-14 years and females aged 5-9 years. This suggest that peak age of diagnosis 
happens earlier for girls than boys, at least in some countries.  
 
2.4.5 Urban-rural variation in type 1 diabetes incidence  
 
Urban-rural disparities have also been observed in type 1 diabetes incidence. Based on the 
remoteness index in Australia, high type 1 diabetes incidence was observed in more accessible 
areas53 or urban73 areas than remote and very remote areas, but no urban-rural difference was 
found in Poland.69 On the contrary, a higher type 1 diabetes incidence was observed in remote 
areas in Northern Ireland,71 and rural areas in Finland74 compared to more accessible and urban 
areas. The differences in individual socioeconomic conditions, ethnicity of the residents, and 
household conditions in remote and accessible areas could play a role in the variation in type 1 





2.5 Genetic and familial risk of type 1 diabetes 
 
In terms of genetic susceptibility, more than 61 gene variants have been linked with the risk of 
type 1 diabetes.75 In particular, the human leukocyte antigen (HLA) class II genes are the most 
important loci 76-80 and account for up to 50% of genetic risk of type 1 diabetes.77, 80 HLA genes 
have many different alleles that modify the adaptive immune system, and help the body in 
distinguishing between the body’s own protein and foreign proteins or pathogens. HLA genes 
are categorized into class I, class II, and class III.  The HLA class II genes are the most important 
alleles for type 1 diabetes pathogenesis, and has three major (HLA-DP, HLA-DQ and HLA-DR) 
and two minor histocompatibility complex proteins (MHC class II DM and DO).80, 81 The HLA 
DR-DQ haplotypes confer the highest risk for type 1 diabetes and are known as DR3 and DR4.80, 
81 82, 83 Some haplotypes such as DR2 confer protection for diabetes.81  In addition, some HLA 
class 1 and class III haplotypes are also reported to be involved in type 1 diabetes pathogenesis.81 
The frequencies of HLA allele and haplotype differs across populations in different countries 
and this may partly explain the variation in type 1 diabetes incidence globally. Only less than 
10% of people with HLA-conferred susceptibility develop type 1 diabetes. Non-HLA genetic 
variants also contribute to type 1 diabetes risk.75, 77, 80, 84 For example, the insulin gene on 
chromosome 11p15 has shown to confer about 10% of the genetic susceptibility to type 1 
diabetes.84 The combination of more than two different haplotypes further escalates the risk.85 
Genetic risk scores consisting of multiple loci can predict more than 10% risk of pre-
symptomatic type 1 diabetes for children without family history.86 Some environmental factors 





epigenetic modification or DNA methylation,87 and might have a role in type 1 diabetes 
pathogenesis. However, this is a very new area of investigation and further work is needed to 
understand the epigenetic processes. 
Having a first degree relative with type 1 diabetes is linked with 10-15 fold increased lifetime 
risk of type 1 diabetes than general population.28, 41, 88, 89 However, about 78-85% of new cases 
are being diagnosed without having any family history of type 1 diabetes,77, 90 suggesting an 
influence of environment in the pathogenesis of  type 1 diabetes. The type 1 diabetes prevalence 
is ~0.3% in the general population by age 20 years, and ~5% among those who have a first-
degree relative with type 1 diabetes.41 A study using Finnish Diabetes Register data (type 1 
diabetes n = 1,488), established to characterize the familial and sporadic cases of newly 
diagnosed type 1 diabetes, demonstrated that 21.8% of newly diagnosed cases had a first and 
second degree relative affected with type 1 diabetes, and 78.2%  were sporadic cases.90 About 
12.2% of the newly diagnosed cases had a first degree relative with type 1 diabetes, out of which 
6.2% had an affected father, 3.2% had an affected mother, and 4.8% cases had a sibling with 
type 1 diabetes.90 Among first-degree relatives, siblings of children with type 1 diabetes have a 
higher risk of type 1 diabetes than parents.89 Compared with mothers, a father having type 1 
diabetes is a stronger predictor of a child having type 1 diabetes.21, 28, 89 The very high proportion 
of sporadic cases without having any first-and-second degree relatives with type 1 diabetes or 
family history points to the environment as playing an important role in increasing the type 1 
diabetes incidence. A study that analysed HLA class II genotype frequencies over time (1965-
2006) in two large populations with type 1 diabetes (diagnosed at aged ≤18 years) demonstrated 





type 1 diabetes cases (Figure 2-2).91 This reduction in high risk genotypes over four decades 
suggests an increasing influence of environmental factors in type 1 diabetes pathogenesis.  
 
 
Figure 2-2: Percent HLA-DR3/4-DQB1*0302 in new onsets type 1 diabetes over time  
(A stepwise decrease in the highest risk HLA genotypes frequencies in new onset type 1 
diabetes cases over time from 1965-2006) 






2.6 Potential mechanisms explaining environmental determinants 
 
Although research suggests that environmental factors might be interacting with genetic 
predisposition in altering type 1 diabetes risk, the cause of the initiation of the autoimmune 
process of type 1 diabetes remains unknown. Many hypotheses have been proposed as potential 
explanations for the rising type 1 diabetes incidence. I will discuss the most commonly proposed 
hypotheses here; the hygiene hypothesis and β-cell stress hypothesis and microbiota 
composition.  
 
2.6.1 Hygiene hypothesis and type 1 diabetes  
 
The hygiene hypothesis92-94 evolved from epidemiological observations that reported low type 
1 diabetes incidence in areas with overcrowded households95, 96 and high population density;97 
although the evidence about area-level variation in type 1 diabetes incidence is inconsistent.98, 
99 In the early 20th century type 1 diabetes was a rare but fatal disease, particularly in the pre-
insulin era, and insulin discovery (1922) made prolonged survival possible for people with type 
1 diabetes.55 Studies from different European countries (Denmark, Sardinia area of Italy, and 
Norway) reported increasing trends in type 1 diabetes incidence from the mid-20th century.55, 
100-102 The ‘Epidemiological transition’ is a well-known phenomenon, one aspect of which is a 
decline in infectious diseases in the last century (as a cause of mortality) and a substantial 





in part to improvements in living standards, socioeconomic conditions, sanitation, and hygiene. 
With the decline in infectious diseases over time there has been a concomitant rise in the 
incidence of immune-mediated diseases such as type 1 diabetes,105 theorized to be due to under-
stimulation of the immune system.94, 106 David P. Strachan, a professor of epidemiology, is 
known as one of the early researchers to point to the hygiene concept as an explanation for 
increasing incidence in hay fever,107 and he wrote that, “over the past century declining family 
size, improvements in household amenities, and higher standards of personal cleanliness have 
reduced the opportunity for cross infection in young families.”107 Researchers in type 1 diabetes 
epidemiology have been suggesting similar concepts termed as the hygiene hypothesis as one 
of the potential explanations for the rise in type 1 diabetes incidence.32, 92, 93 The hygiene 
hypothesis proposes that the increasing type 1 diabetes incidence is attributed to reduced 
stimulation of the immune system by lack of exposure to microbial antigens postnatally and in 
early childhood and decreased frequency of childhood infections,  perhaps due to improved 
living conditions and change in human environment and hygienic measures.92, 108 Gale writes 
“something protective might have been lost from the childhood environment over recent decades, 
a concept known as the hygiene hypothesis.”93  
In line with the hygiene hypothesis, regions with the lowest frequency of tuberculosis and 
diarrhoeal diseases, such as Northern Europe, North America and Australia, have the highest 
incidence rates of type 1 diabetes.92 Improved sanitation and hygiene may also have caused a 
reduction in herd immunity for enterovirus infection in pregnancy,109 thus increasing the risk of 
prenatal enterovirus infections. For example, over 20 years in Finland and Sweden the 





incidence has substantially increased.109 Most studies suggest that maternal enterovirus 
infections are linked with higher risk of childhood type 1 diabetes, but the evidence is 
inconsistent.94, 110, 111 The Environmental Determinants of Diabetes in the Young (TEDDY) 
study reported that other gestational infections were not linked with islet autoimmunity but 
maternal respiratory infections were associated with reduced islet autoimmunity in genetically 
at risk children.112  
Epidemiological evidence for the hygiene hypothesis of type 1 diabetes is inconsistent. For 
example, a large population-based study from Germany showed that recurrent viral respiratory 
tract infections in the first six months of life were associated with 17% increased risk of type 1 
diabetes at the age of 8 years, compared with  unexposed children.113 On the other hand, a 
matched case-control study from the UK reported no association between early life infections 
and risk of childhood type 1 diabetes, hence not supporting the hygiene hypothesis.114 Most 
studies that reported increased risk of type 1 diabetes for children exposed to respiratory 
infections were based on parental reporting about the frequency of childhood respiratory 
infections.82, 115 There is lack of consensus about the link between early life infections and 
childhood type 1 diabetes.113, 114, 116 It is hard to determine whether the associations between 
early infections and type 1 diabetes were due to increased exposure to viruses or underlying 
susceptibility to viral infections due to immune response dysregulation.82 Despite the mixed 
evidence, the hygiene hypothesis continues to be discussed as an environmental cause and 






2.6.2  Accelerator and β-cell stress hypothesis  
 
Another potential explanation for increasing type 1 diabetes incidence is the accelerator and β-
cell stress hypothesis. This hypothesis suggests that many environmental factors leading to fast 
growth and overweight in early life could cause insulin resistance and consequently damage 
pancreatic β-cells.117 When insulin resistance is present, blood glucose rises leading to 
glucotoxic effects, which in turn may impact insulin producing pancreatic β-cells (β-cell 
apoptosis),118 or may induce neo-autoantigens and initiate autoimmune-mediated destruction of 
the pancreatic β-cells. According to the accelerator hypothesis three processes accelerate the 
loss of pancreatic β-cell through apoptosis; 1) constitution (intrinsic), 2) insulin resistance, and 
3) autoimmunity.119 The first accelerator is the intrinsically high rate of apoptosis of the 
pancreatic β-cells, this step is necessary for developing diabetes, however is not sufficient to 
cause diabetes alone. The second accelerator is insulin resistance, which results from lack of 
physical activity and weight gain, and it further escalates the β-cell apoptosis. This second 
accelerator is driven by environmental factors and thought to be involved in the increasing 
diabetes incidence. In the last process a small proportion of people with genetic component, 
with an intrinsically high β-cell apoptosis rate and insulin resistance, develop islet 
autoimmunity.119  
According to the accelerator and β-cell stress hypothesis visceral fat gain is as crucial for 
developing type 1 as it is for type 2 diabetes.119 Supporting this hypothesis, many studies of 





studies, and population-based linked data studies have demonstrated that higher weight gain in 
infancy is positively associated with type 1 diabetes risk.120-123 For example, a population-based 
study that used Norwegian and Danish cohorts showed that  higher weight gain from birth to six 
months was associated with 21% increased risk of childhood type 1 diabetes.121 Similarly, the 
Australian BABY DIAB study demonstrated that weight gain in early infancy was associated 
with an increased risk of islet autoimmunity.122    
Higher birthweight,24, 124, 125 and gestational age (both preterm and post-term births)124 have also 
been linked with higher childhood type 1 diabetes risk, although the evidence is divergent.125, 
126 For example, a meta-analysis of 12 studies showed that heavier birthweight (>4000 g) was 
associated with 17% increased risk of childhood type 1 diabetes, and lower birthweight 
(<2500g) was associated with 18% reduced type 1 diabetes risk.127 The small increased risk of 
type 1 diabetes for children born with a higher birthweight is supported by a large meta-analysis 
consisting of  30 studies by Cardwell et al.128 On the contrary, a large population-based study 
from Sweden that used a sibling design depicted no excess type 1 diabetes risk for children who 
were large-for-gestational-age, and similar to the meta-analysis depicted low risk of type 1 
diabetes for extremely low birthweight children (<1500g).126  It is difficult to tease apart why 
studies arrive at different conclusions, however, in this case the null effect from the sibling study 
points to the potential for residual confounding to have biased results in some of the 
observational studies. In addition, most previous studies have only used birthweight as a 
measure of growth, the sibling study used birthweight-for-gestational age, which extricates birth 





2.6.3 Microbiota composition and type 1 diabetes 
 
Microbiota composition is one of the hypothesized mechanisms linking various environmental 
factors with type 1 diabetes. Studies have reported the link between microbiota and type 1 
diabetes pathogenesis.129-132A child’s intestinal microbiota goes through changes during the first 
three years of life, and by age three it transitions in to an adult like composition.131 133 Numerous 
factors can modify a child’s intestinal microbiota composition; such as birth method,134 
exposure to antibiotics,135, 136 microbial exposure, hygiene level in the immediate environment,  
feeding and dietary practices.133, 137-139 During early life the immune system also develops, and 
intestinal microbiota can influence immune maturation.140, 141 Studies have shown differences 
in microbiota composition of children with and without type 1 diabetes.131, 142 In addition, 
alterations in microbiota have been shown to occur before the onset of islet autoimmunity among 
children who develop type 1 diabetes.131, 143 The Diabetes Prediction and Prevention study 
(DIPP) study observed reduced diversity of the gut microbial composition in children who later 
develop type 1 diabetes, compared to healthy children.144 This suggests an important role of 
microbiota composition in type 1 diabetes pathogenies.  
 
2.7  Environmental determinants  
 
Studies have suggested that environmental factors are interacting with genetic predisposition 





increasingly important role of the changing environment in type 1 diabetes pathogenesis.82 
There could be factors changing in the environment that are potentially driving the increase in 
type 1 diabetes incidence. The role of the environment is supported by a study that followed 
type 1 diabetes progression rate in monozygotic twins in Britain and the US.11 It demonstrated 
that the probability of concordance for type 1 diabetes was 39% at 40 years of follow-up from 
type 1 diabetes diagnosis of the index twin.11 Most of the twins in that study remained discordant 
for type 1 diabetes at the end of follow-up, highlighting the role of non-genetic factors in the 
disease development. The role of environment in type 1 diabetes pathogenesis is supported by 
further evidence of a large disparity in type 1 diabetes incidence between the adjacent regions 
of Karelia, Russia (7.4 per 100,000) and Finland (41.4 per 100,000) from 1990-1999, although 
HLA DQ genotypes for type 1 diabetes were similarly prevalent in these areas.146 In addition, 
migrants have been shown to acquire the same risk of type 1 diabetes as the population in the 
newly adopted country of residence.147, 148 For example, a Swedish study (n = 1.9 million) 
demonstrated that residents born in Sweden with foreign-born parents had 60–70% higher type 
1 diabetes prevalence compared with new immigrants and adoptees with the same origin.147 
In the following sections I will describe the existing literature revolving around my doctoral 
project including; socioeconomic position and type 1 diabetes incidence; caesarean birth and 
maternal smoking in pregnancy and risk of type 1 diabetes; and implications of type 1 diabetes 
for children’s educational outcome. I will also briefly mention the potential mechanisms 
(discussed above) linking each specific exposure with the outcome, and also how my research 





2.7.1 Socioeconomic patterning of type 1 diabetes incidence  
 
Socioeconomic circumstances are a major determinant of health, and can influence the living 
environment, household crowding, and health behaviours (smoking, nutritional intake etc) and 
hence can play role in altering the risk of type 1 diabetes. The hygiene hypothesis is one of the 
hypothesized link between socioeconomic conditions and type 1 diabetes incidence; potentially 
through differential microbial exposures and immune stimulation in low and high 
socioeconomic groups.32 For example people from low socioeconomic conditions are more 
likely to live in crowded households and use public transport leading to more immune 
stimulation; and household crowding has been linked with low type 1 diabetes incidence.95 
There is mixed evidence about socioeconomic patterning of type 1 diabetes. However, most 
studies have relied on area-level measures, which don’t account for individual variability in 
environments, which may expose children to more or less immune stimulants. Most previous 
studies that looked at the broader ecological picture, reported a positive association between 
country-level socioeconomic determinants and type 1 diabetes incidence.105, 149 For example a 
Polish study reported a positive association between increasing life expectancy, and gross 
domestic product (GDP) and type 1 diabetes incidence.105 The lack of data from low income 
countries on type 1 diabetes incidence makes it harder to draw firm conclusions as to whether 
socioeconomic circumstances are associated with type 1 diabetes or not. However, the countries 
ranked in the top 10 for type 1 diabetes incidence are mostly high income countries, such as 
Finland, Sweden, Norway, UK, Canada, Denmark, USA and Australia.54 This suggests the 





environments and lifestyles may play an important role in altering type 1 diabetes risk. Studies 
from middle income countries reported low type 1 diabetes incidence, such as 1.01 per 100,000 
person-years in China (2010-2013),8 and 12.8/100,000 in Brazil (1986 to 2015).150    
Most studies have looked at the country-level, or small area level socioeconomic position and 
type 1 diabetes incidence using different measures. For example, studies from the UK have 
reported mixed evidence about the association between Townsend deprivation index (area-level 
measure of disadvantage) and type 1 diabetes incidence.98, 99, 151  Two studies from Australia 
reported inconsistent evidence of association between the Index of Relative Socio-economic 
Disadvantage (IRSD) and type 1 diabetes incidence.73, 152 Others have reported an association 
between neighbourhood level measures of affluence such as the proportion of people with higher 
education, higher income, and car ownership and type 1 diabetes incidence.96 The indices 
(Townsend deprivation index and IRSD) used to measure area-level disadvantage, have been 
created by combining information on the prevalence of different characteristics of individuals 
within a particular area. For example, the IRSD combines information on the prevalence of  
people with low income, unemployed, with no internet, people classified as labours and machine 
operators, one parent families, overcrowded household, families with no cars and with poor 
English speaking skills,153 to generate an area-level score of relative disadvantage. It is possible 
the different types and numbers of variables used to create these various indices may explain 
variability in the evidence of the association between area-level socioeconomic indicators and 
type 1 diabetes incidence. However, even when multiple studies used the same index, mixed 
findings of the association between small area-level socioeconomic conditions and type 1 





population-based study that used IRSD as a measure of area-level socioeconomic disadvantage 
based on maternal residence at the time of child birth during 1980-2002, demonstrated no 
difference in type 1 diabetes incidence between people living in the least and most 
disadvantaged areas.152 Yet another Western Australia study (1985 to 2002) reported a higher 
type 1 diabetes incidence in the least disadvantaged groups;73  when used  IRSAD based on the 
maternal residence at the time of type 1 diabetes diagnosis. This may point to that area-level 
socioeconomic indices are not reliable measures that can be used for studying health disparities 
because they do not capture individual variation and are prone to ecological fallacy. Work 
undertaken by the Australia Bureau of Statistics demonstrated individual variation within each 
area that in the area-level index would all be represented as having the same socioeconomic 
conditions. This adds to the evidence suggesting that area-level measures are not reflective of 
individual-level socioeconomic conditions.154  
As can be seen from the above evidence, that most studies have used area-level measures of 
socioeconomic position that is probably because individual level-data is not easily available in 
most studies. Only two studies (Italy, US) have used individual-level socioeconomic 
information to study the incidence of type 1 diabetes, and both reported higher type 1 diabetes 
incidence in socioeconomically advantaged children.32, 155 I took advantage of the linked data to 
look at type 1 diabetes incidence with both individual and area-level indicators of 
socioeconomic circumstances, which was an opportunity to understand if previous studies may 
be subject to the ecological fallacy, and to also explore the hygiene hypothesis. To my 
knowledge, all previous Australian studies on socioeconomic conditions and type 1 diabetes 





descriptive study, I compared the area-level and individual-level socioeconomic disparity in 
type 1 diabetes incidence, using South Australian population-wide linked data. Due to the data-
linkage, I had access to individual-level socioeconomic information to be able to study the 
Question-1 of my doctoral thesis (Chapter 4). The individual-level indicators of socioeconomic 
condition in my study include parent’s employment, private or public healthcare, and whether 
the child was born in a public or private hospital. The area-level socioeconomic position used 
in my dissertation has been measured by The Index of Relative Socio-economic Advantage and 
Disadvantage (IRSAD). More detail about this index is given in Chapter 3.    
  
2.7.2 Caesarean birth and risk of childhood type 1 diabetes  
 
A hypothesized link between caesarean birth and type 1 diabetes is thought to be birth mode- 
induced variation in neonatal microbiota composition,156 which could impact immune 
development.140 Gut bacterial colonisation patterns differ among neonates born by emergency 
caesarean, elective caesarean and natural birth.156 For example, children born by emergency and 
elective caesarean have different profiles than those born by normal vaginal delivery in 
colonization of E coli, K oxytoca, and K pneumoniae.156 Gut microbial community composition 
and the products of bacterial metabolism may influence the education and maturation of the 
immune system in early life that is required for self/non-self regulation and thereby 
susceptibility to immune-mediated diseases.140 Indeed, studies have shown differences in the 





previously - changes in microbiota composition have been observed before the onset of islet 
autoimmunity among children who developed type 1 diabetes.143 131 A recent TEDDY study 
comparing the composition and functional capacity of the microbiome of children followed 
from three months up to age 5 years found that, compared with controls, the microbiome of 
children that developed type 1 diabetes had fewer genes related to fermentation and short-chain 
fatty acid synthesis.158 
A further phenomenon that may link caesarean birth with type 1 diabetes is that in the last three 
decades both caesarean rates and type 1 diabetes incidence have increased in parallel, and this 
has occurred in many countries. Most of the countries ranked in the top ten for published type 
1 diabetes incidence, such as Australia, the UK, Canada, the USA, Saudi Arabia and Denmark 
also have much higher caesarean rates than the WHO recommendation of 10-15% of all births.18, 
159, 160 However, not all countries with higher caesarean rates have high type 1 diabetes 
incidence. For example, Brazil150, 161 and China8, 162 have the highest rates of caesarean births in 
the world at 77% and 46% respectively, but have low type 1 diabetes incidence. However, 
studies that have tested the hypothesized link between the caesarean birth induced changes in 
neonatal microbiota and childhood type 1 diabetes have reported inconsistent evidence. Many 
case-control studies,28, 163 a linked data study,164 and a meta-analysis consisting of 20 studies 
(17 case-control)25 showed 23-39% higher type 1 diabetes risk for children born by caesarean 
section. In contrast, large population-based cohort studies with better adjustment for potential 
confounding depicted a very small effect or no association between caesarean and childhood 
type 1 diabetes.20-24 For example, a large population-based cohort study of 2.6 million Swedish 





attenuated closer to the null.20 This suggests previously reported higher effects of caesarean on 
childhood type 1 diabetes might be due to residual confounding.  
Of the studies on caesarean birth and risk of type 1 diabetes, 20-24 28, 163, 164 only one20 focused 
on caesarean type (emergency and elective caesarean) and risk of type 1 diabetes. However, 
emergency and elective caesarean birth do not distinguish whether birth occurred before or after 
the onset of labour. Therefore, given the proposed mechanism is through microbiome exposure 
I was able to take advantage of the whole-of-population administrative data in the SA ECDP 
and I explored the association between prelabour and intrapartum caesarean and risk of 
childhood type 1 diabetes in study 2.  That’s because children born by caesarean before labour 
(prelabour) have no exposure to maternal vaginal microbiota, and they might have high risk of 
type 1 diabetes compared with children born after the onset of labour (intrapartum caesarean). 
Therefore, in study 2, I estimated the risk of type 1 diabetes for children born by caesarean; 
extending the question to whether the risk differs by prelabour or intrapartum caesarean (detail 
in Chapter 5) to better understand the role of exposure to the vaginal microbiome. 
 
2.7.3 Maternal smoking during pregnancy and risk of childhood type 1 
diabetes 
 
The mechanism linking maternal smoking during pregnancy and childhood type 1 diabetes is 
not fully understood, although it has been hypothesized to be through multiple pathways such 





suppression.87, 165-169 A genome-wide meta-analysis of 13 birth cohort studies reported 
differential DNA methylation CpG sites among children born to mothers who smoked during 
pregnancy, compared to unexposed children.87 Similarly, another study found differences in 
mean DNA methylation level between children with type 1 diabetes and their healthy co-twin.170 
There is also evidence about transfer of nicotine from mother to the foetus,168, 171 and nicotine 
may impact both innate and adaptive immunity.169, 172   
In many countries, the incidence of childhood type 1 diabetes has been increasing.3, 54, 173At the 
same time maternal smoking in pregnancy rates have been declining,19, 174 raising a question 
about the causal effect of maternal smoking on childhood type 1 diabetes.  For example, in 
Australia, type 1 diabetes incidence has increased from 21.5 per 100,000 population in 2000, to 
24.7 per 100,000 population in 2015; 175  while prevalence of smoking during late pregnancy 
reduced from 17.3% in 2006 176 to  9.9% in 2016.177 The link between maternal smoking in 
pregnancy and childhood type 1 diabetes has been investigated using various study design (high 
risk population cohort studies, case-control studies, population-based studies); however the 
evidence is mixed; ranging from increased, 26, 27 decreased 28-33 to no risk.34  Studies that showed 
higher risk of childhood type 1 diabetes for children exposed to maternal smoking were 
generally smaller studies conducted in populations at risk of developing type 1 diabetes.26, 27 
Studies that have shown decreased risk of childhood type 1 diabetes following exposure to 
maternal smoking in pregnancy have effect estimates that vary from 13%-60% reduced risk in 
case-control studies,28, 32, 33 and 25%-35% lower risk in population-based cohort studies.29, 30 
The varying estimates could be due to small numbers of children exposed to maternal smoking, 





led me to extensively explore the effect of maternal smoking in pregnancy on childhood type 1 
diabetes in study 3. To study the effect of maternal smoking in pregnancy on childhood type 1 
diabetes, I used multiple population-wide administrative linked datasets. I deployed advanced 
analytical methods to assess the risk of bias due to unmeasured confounding such as negative-
control outcome analysis and E-value. I had the problem of having a large study with an 
imprecise effect estimate, so did all the others studies, rather than simply adding another study 
to the mix, combining relevant studies in a meta-analysis would bring new knowledge.  
Therefore, I summarized the adjusted effect estimates from previous case-control and 
population-based cohort studies, along with my own study in meta-analyses in study 3 (detail in 
Chapter 6).   
In the following section, I will focus on some other perinatal factors relevant to the studies 
undertaken in my doctoral thesis. Some of the factors I am going to discuss are potential 
confounders in my studies; including birthweight and gestational age, parental age, and maternal 
obesity. Some of the factors discussed below are the antecedents of the confounders, and are 
associated with the discussed hypothesized mechanisms of type 1 diabetes. For example pre-
natal nutrition affects maternal pregnancy weight and child’s weight , which are linked with the 
β-cell stress and accelerators hypothesis, and also influences microbiota composition impacting 
children’s immune development. Although there are plethora of other risk factors that have been 






2.7.4 Other Parental characteristics and risk of childhood type 1 diabetes 
 
As mentioned, parental characteristics such as age, obesity, and diabetes are important 
confounders in my studies (Chapter 5, 6, and 7).  Parental diabetes and child risk of type 1 
diabetes has previously been discussed (section 2.5). Thus, here I briefly explore existing 
research on the effect of parental age, obesity, and some dietary factors on type 1 diabetes.  
2.7.4.1 Parental age and childhood type 1 diabetes 
Whether parental characteristics such as age at child birth are associated with childhood type 1 
diabetes is uncertain.24, 31, 163 Mostly older parental age (both mother’s and father’s) has been 
associated with a small increased risk of childhood type 1 diabetes.31, 163, 178, 179 However, large 
population-based cohort studies with more comprehensive adjustment for confounding did not 
find clear parental age patterning for childhood type 1 diabetes.21, 24, 163 For example, a meta-
analysis of 30 observational studies, 25 of which were case-control studies, demonstrated that a 
five-year increase in maternal age was associated with a 5% increased risk of childhood type 1 
diabetes.180 In contrast, a large Swedish study consisting of 14,949 children with type 1 diabetes 
with individual level socioeconomic information of over 36 years, demonstrated no effect of 
mother’s age.24 It is possible the small observed effect of maternal age in previous case-control 
studies could be due to unmeasured confounding, as matching in case-control studies does not 





2.7.4.2 Maternal obesity and childhood type 1 diabetes 
Most studies support the idea that maternal obesity is associated with increased risk of type 1 
diabetes. Multiple case-control studies, population-based cohort studies and a meta-analysis 
showed that maternal obesity is associated with 18%-41% higher risk of childhood type 1 
diabetes,24, 31, 183-186 except a Finnish birth cohort study.187 For example, a prospective 
population-based Finnish birth cohort study (type 1 diabetes n = 175) that monitored children 
with increased HLA-conferred susceptibility for 3-12 months from birth (1997-2002) showed 
no association between maternal BMI measured at the beginning of pregnancy and β-cell 
autoimmunity.187 However, the largest population-based studies have shown positive 
associations between high maternal BMI and type 1 diabetes. Data from the Danish National 
Birth Cohort (children’s mean age 15.5 years) and the Norwegian Mother and Child Cohort 
(children’s mean age 11 years) showed that obesity was associated with a 41% higher incidence 
of  type 1 diabetes (HR =1.41, 95% CI 1.06-1.89).185 The balance of evidence suggests there is 
some increased risk of type 1 diabetes as a result of higher maternal BMI. 
2.7.4.3 Maternal nutrition and childhood type diabetes 
The mechanisms that potentially link maternal diet in pregnancy to children’s risk of type 1 
diabetes could be through the impact of diet on maternal weight, nutritional deficiencies, DNA 
methylation and the gut microbiota that children acquire at birth. There is divergent evidence 
about the effect of maternal nutrition in pregnancy such as gluten,188-190 and vitamin D,82 191-194 
on childhood type 1 diabetes. Although there are not many studies that have explored the effect 





(based on HLA genotype and family history) showed a negligible protective effect;189 whereas 
large population-based cohort studies demonstrated increased type 1 diabetes risk.188 A small 
protective effect of higher prenatal vitamin D concentration on childhood type 1 diabetes is 
reported by many small studies.82 191-194  However, a recent large population-based Scandinavian 
cohort study that estimated the effect of average maternal vitamin D concentration during 
pregnancy on type 1 diabetes risk and showed no effect.195 No clear pattern has been observed 
between maternal polyunsaturated fatty acid intake or serum concentration during pregnancy196, 
197 or lactation198 and risk of childhood type 1 diabetes. Maternal iron supplement intake during 
pregnancy has been associated with 5% to 33% higher type 1 diabetes risk.199-201 However 
maternal iron intake from food, and anaemia or low haemoglobin levels has not been linked 
with high risk for childhood type 1 diabetes.200 Some possibilities for these inconsistencies in 
evidence about the findings about maternal nutritional intake and type 1 diabetes incidence 
could be due to differences in study samples (high risk populations vs population-based), short 
duration of follow-up time and small number of children with type 1 diabetes which affected 
the power and precision, and perhaps measuring the blood concentration of nutrients at different 
points in pregnancy.  
 






2.7.5.1 Breastfeeding and childhood type 1 diabetes 
Breastfeeding could be linked with type 1 diabetes through its potential impact on gut 
microbiota composition137 and immune development.202, 203 There is consensus in evidence 
about a small protective effect of breastfeeding for childhood type 1 diabetes, however, there is 
heterogeneity in the evidence about the effect of exclusive breastfeeding duration.27, 204-208 For 
example, a 2019 systematic review concluded there was little to moderate evidence that never 
feeding human milk compared with ever feeding human milk (both breastfed or human milk fed 
by other methods), and shorter duration of exclusive human milk feeding were associated with 
higher type 1 diabetes risk.205 Similarly a large population-based study that used data from two 
large Scandinavian birth cohorts showed twofold increased risk of type 1 diabetes for children 
who were never breastfed (HR = 2.29, 95% CI 1.14-4.61) compared with breastfed children.204  
2.7.5.2   Infant feeding, weaning age and childhood type 1 diabetes 
Early feeding practices induce changes in children’s gut microbiota,138, 209 and thus may 
influence their immune maturation. Infant feeding also influences children’s body weight,210 
and weight gain in early infancy has been linked with increased risk of type 1 diabetes (has been 
discussed above).119-123 Many studies have highlighted age at cereal or gluten introduction (both 
early and delayed gluten introduction) as a potential risk factor for type 1 diabetes, however, the 
evidence is mixed.189, 207, 208, 211-214 For example, an American prospective birth cohort study 
(DAISY) conducted in a high risk population either HLA genotype or have a first-degree relative 
with type 1 diabetes (n=1183, 1994-2002) demonstrated that both early (0 to 3 months, HR = 





containing cereals, compared to 4-6 months were associated with an increased incidence of islet 
autoimmunity in children.211 Early gluten introduction and high type 1 diabetes risk is supported 
by other studies.208 27 In contrast, the TEDDY212 study that prospectively followed genetically 
at risk children (n = 8,676)  in the US, Finland, Germany and Sweden reported that late (>9 
months) introduction of gluten increased the rate of islet autoantibody appearance (HR = 1.57, 
95% CI 1.07-2.31), compared to introduction between 4-9 months of age, and demonstrated 
lower incidence of insulin autoantibody appearance (HR = 0.68, 95% CI 0.47- 0.99) for early 
introduction of gluten (<4 months). A Finnish prospective birth cohort study in a high genetic 
risk group (n = 5,915) demonstrated that early (<3 months) introduction of solid food was 
associated with higher type 1 diabetes risk only in short term follow-up (up to age 3 years), but 
not at longer term follow up (15 years).207 There is also discrepancy in evidence about weaning 
age for other solid foods and type 1 diabetes risk.27, 82, 208 The reasons for variability in the 
findings about gluten introduction and type 1 diabetes incidence in these cohort studies could 
be due to; differences in the timings and type of first complementary food; variation in length 
of follow up; differences in types of infant formulas, and perhaps changing infant feeding habits 
or use of probiotics overtime in different populations.  
2.7.5.3   Other early-life characteristics and type 1 diabetes 
Looking broadly across the literature, other child related factors associated with an increased 
risk of childhood type 1 diabetes include higher neonatal blood iron content,201 high iron intake 
in first four months of life,215 hospitalization for gastroenteritis,216 exposure to broad spectrum 





analyses by Cardwell et al. (2011, 2012)219, 220 have demonstrated that a birth interval of ≤3 
years219 and increasing birth order220 are associated with a small lower childhood type 1 diabetes 
risk, which could be linked with the hygiene hypothesis. Childhood vaccinations221 have also 
been investigated and found to not be linked to type 1 diabetes.  
 
2.8 Burden of type 1 diabetes 
 
In recent decades the reduction in incidence rates of severe complications of type 1 diabetes 
such as diabetic retinopathy, nephropathy, and cardiovascular diseases has been possible 
through technological advances in glucose monitoring and insulin delivery, and improved 
management of type 1 diabetes.3, 222-225 In the pre-insulin era (prior to 1922) type 1 diabetes was 
a fatal disease, and 50% patients would die within the first 20 months of diagnosis with less than 
10% survival over 5 years.226 Type 1 diabetes-specific mortality was 824 deaths/1,000 person-
years in 1898-1914 among ≤10 year old children in the US.227 After insulin discovery and use 
for treatment, type 1 diabetes-specific mortality declined sharply to 61 deaths per 1,000 person-
years in 1922-1926, to less than 1 death per 1,000 in 1950-1961.227Although the type 1 diabetes-
specific mortality rate has declined, however,  a gap in life expectancy of people with and with 
and without type 1 diabetes persists.226 228 Achieving glycaemic control remains challenging for 
people with type 1 diabetes, and some acute and chronic complications contribute to lower life 
expectancy.229 In Australia, people with type 1 diabetes have a life expectancy of 68.6 years, 





Poor glycaemic control leading to diabetic ketoacidosis and severe hyper-and-hypoglycaemia 
are major causes of morbidity, hospitalization,12 mortality15  and high health-related costs.17 
Children with type 1 diabetes have been reported to have three times more hospital days per 
person-year than children without type 1 diabetes.12  Children with type 1 diabetes may be prone 
to other illnesses and experience more hospitalizations, which is one of the reasons for the high 
costs to the health system. For example, in a European survey study, people with type 1 diabetes 
reported poorer health and poor health related quality of life;230 and reported much higher 
prevalence of chronic comorbidities including pain (37.8% vs 22.2%), hypertension (28.1% vs 
16.3%), and depression (16.9% vs 10.5%) than the general population.230 Managing a complex 
medical condition requiring daily adherence to multiple self-care behaviours is challenging and 
stressful for children with type 1 diabetes. Over 50% of adolescent with type 1 diabetes reported 
general and diabetes-specific stress, and high level of stress was negatively associated with poor 
quality of life and fewer self-management activities.231 In addition, children’s diagnosis with 
type 1 diabetes leads to higher levels of paediatric parenting stress.232 It suggests that type 1 
diabetes not just effects the individual diagnosed with this illness; but has substantial 
psychological consequences for the family, because of the complex nature of the disease that 
requires vigilance with glycaemic control for survival and to avoid debilitating complications 
like stroke, vision loss, and amputations.  
For the individual, type 1 diabetes has an impact on patients’ quality of life and their life 
expectancy, and for a country, type 1 diabetes is linked to high costs of health care and increased 
hospitalisations. The annual estimated health care cost of type 1 diabetes for Australia in 2008 





government started subsidising insulin pumps in 2008 for low income families with children 
≤18 years old, with full subsidization of continuous glucose monitoring systems for all children 
aged <21 in 2017,233-235 which is an additional cost to the health system.  Although  type 1 
diabetes only affects ~0.3% of the general population, its complications account for 5% of all 
hospital bed days, and 4% of all ambulatory care or hospital admissions, which is more than 
angina or asthma.236 
 
2.8.1 Type 1 diabetes and children’s academic achievement  
 
Children with type 1 diabetes may potentially be at risk of poor cognitive function and 
educational outcomes, due to poor glycaemic control,237, 238 illness-related hospitalization,12 
absences from school,13 239 and psychological challenges.14 As glucose is a major fuel source 
for the brain, both hyperglycemic240-242 and hypoglycemic243 episodes have the potential to 
impact brain functioning.238 Diabetic ketoacidosis (DKA) at type 1 diabetes presentation has 
both short and long term consequences for glycaemic control (through exacerbation of β-cell 
loss),240 and memory function.241, 242 For example, a cohort study reported morphological and 
functional brain changes among children with DKA at initial type 1 diabetes diagnosis, 
demonstrating that while most of the changes resolved, brain changes during DKA were 
associated with alterations in attention and memory at six months follow-up.238 The 
psychosocial challenges14 that children with type 1 diabetes face could also impact their quality 





after initial recruitment into a longitudinal study reported that mental health referral rates were 
19% higher among children with type 1 diabetes compared with healthy controls.14  
Despite the multiple potential mechanisms linking type 1 diabetes with children’s educational 
outcomes, there is uncertainty around the effect of childhood type 1 diabetes on children’s 
educational outcome. Small cross sectional studies have demonstrated poor cognitive functions 
among children with type 1 diabetes.244, 245 Large population-based studies that use data from 
three decades ago demonstrated negative effects,35, 36 and two recent studies showed no effect 
of type 1 diabetes on educational outcomes.13, 37 Recently, a large Swedish population-based 
study showed a negative effect of type 1 diabetes on children’s educational outcomes.246 This 
study showed that children with type 1 diabetes are still disadvantaged in educational outcome 
in some developed countries, even in an era of improved type 1 diabetes management. Similarly, 
a nationwide Swedish population-based study that used data from two decades ago (births 1973-
1986, school data from 1988-2003) reported poor school outcomes in mathematics, English, 
Swedish and sports for children with type 1 diabetes at the end of compulsory schooling (<16 
years of age) compared to children without type 1 diabetes.35 A recent Western Australian study 
that linked state-wide diabetes register data with school assessment data (2008-2011) 
demonstrated that type 1 diabetes was not associated with a decrement in school performance.13 
These divergent findings could be due to variability in adjustment for confounders, and due to 
advances in management of type 1 diabetes. For example, most previous studies did not adjust 
for father’s age, pre-pregnancy hypertension and diabetes, ethnicity and other socioeconomic 
indicators, and were at risk of bias due to unmeasured confounding.26, 30, 31 In addition, mostly 





functions of children using cognitive tests.  In my fourth study,  I used academic test scores as 
an outcome from national school assessment program, which measures the real-life educational 
experiences of children, and important for moving ahead in school, and for future 
employment.247-249 In the last decade there has been substantial improvement in type 1 diabetes 
management, I wanted to explore the extend to which these improvement have benefited 
children in South Australia in reaching optimum learning capabilities at schools. I used the 
potential outcome approach to compute the average treatment effect of type 1 diabetes on 
children’s educational outcome, using AIPW. The results obtained from a potential outcome 
approach (the outcome which would have been observed if the exposed person had not been 
exposed) such has AIPW may be interpreted as the outcome as though the entire population 
were exposed or unexposed to type 1 diabetes. AIPW procedure can have a similar interpretation 
to a randomized control trial (RCT) in the absence of unmeasured confounding250 (more detail 







CHAPTER 3 METHODS 
 
In this chapter, I describe; 1) the study population and design, 2) the multiple administrative 
datasets used for my doctoral research; 3) the data linkage process; 4) the epidemiological 
concepts including methods to deal with confounding; and 5) the analytical approaches used in 
each of the four research questions.    
My doctoral research includes studies of the incidence, risk factors and outcomes of type 1 
diabetes for children in South Australia, born from 1999-2013. South Australia is a southern 
State in Australia with a population of 1.677 million, and accounts for 7% of the total Australian 
population.251South Australia’s population is representative of Australia in terms of 
socioeconomic characterises and heath indicators such as life expectancy,252 and maternal and 
child health characteristics.253, 254  
Most of the data used in my doctoral thesis was sourced from the South Australian heath 
system’s hospitalization and perinatal statistics. In Australia, mostly the first contact an 
individual has with the health system is often with primary health care (delivered by general 
practitioners, dentists, nurses, allied health professionals etc), which broadly encompasses care 
unrelated to a hospital visit.  Sometimes individuals may also be admitted to hospital following 
presentation at an emergency department. When there is need, individuals are referred by 
primary health care providers to the secondary care services provided in both private and public 





private hospitals are licensed and regulated by governments, but owned and operated by the 
private sector.  In Australia, of births that occur in hospital, most births occur in public hospitals 
(74% in 2017), and 26% of children are born in private hospitals.253 The Australian Government 
has funded a universal public health insurance scheme called Medicare since 1984.255 Medicare 
covers hospital, medical and pharmaceutical expenses, and is funded through general taxation 
revenue and a specific 2% Medicare levy. Ambulance services, dental treatment, physiotherapy 
and other allied health services, glasses and contact lenses are not subsidized through Medicare. 
Medicare is only available to Australian and New Zealand citizens, Australian permanent 
residents, and people from countries with health insurance agreements.255 Other people outside 
these categories must take out private health insurance, or pay full fees for health services.  
 
3.1  Study population 
 
To investigate the four research questions in my dissertation, I used multiple administrative, 
whole-of-population linked data sources as part of the South Australian Early Childhood Data 
Project (SA ECDP), which are routinely collected by various government departments in South 
Australia. Whole-of-population here means that every South Australian child, born from 1999-
2013 who has a birth, perinatal or hospitalisation record is included in my studies. A range of 
information on births, perinatal characteristics, hospitalizations, and school assessments were 





286,058 South Australian children born from 1999-2013. Of these, n =285,871 with a South 
Australian birth or perinatal record, and 87 had a hospitalisation record (but no birth or perinatal 
record). Of the total children, 557 children or 0.2% were identified as having type 1 diabetes 
from all South Australian public hospital admission data from the calendar years 2001-2014.  
Children entered the SA ECDP at birth, in each successive birth years from 1999-2013, therefore 
each birth cohort consist of different age groups of children. For example birth cohort of 1999-
2013 consist of children aged ≤15 years. And birth cohort 1999-2001 only consist of ≤ 2 years 
old children. Children were followed from birth until the diagnosis of type 1 diabetes, or 
censored at the end of follow up in June 2014.  The study population size, the birth years 
included and length of follow-up differed in each study depending on the administrative datasets 
required to answer each research question (Table 3.1, details are in section 3.6).   
 
3.2 Data sources 
 
In this thesis, I used data from the South Australian Early Childhood Data Project (SA ECDP 
Figure 3-1), 256-258 which has been created by linking multiple government administrative 
datasets. The SA ECDP, since its inception in 2008 has been led by Professor John Lynch, and 
been sustained by continuous project grants and government partnerships secured by the SA 
ECDP lead researchers. New data is added to the existing SA ECDP database,256-258 in an 
ongoing process of grant applications, ethics approvals, and data linkage. The de-identified data 





in the SA ECDP have information on pregnancy and birth, maternal and child heath, child 
development, child protection, education, and hospitalizations (Figure 3-1). The datasets from 
the SA ECDP used in my doctoral project included birth registration data, perinatal statistics, 
hospitalization data, school enrolment and school assessment data. A summary of the data 
sources used in each study is given in Table 3-1 with a detailed description in the following 







Figure 3-1: Data Sources held in the South Australia Early Childhood Data Project (SA ECDP) 






3.2.1  Birth Registration data 
 
The first source of data is birth registrations on South Australian children born from 1999-
2013, collected by the South Australian government’s office of Births, Deaths and Marriages. 
In South Australia, all babies born >20 weeks gestation and >400 grams are legally required 
to be registered within 60 days after birth.256, 259 This important source of information is used 
by the government for counting citizens, and identification for issuing driver’s licences and 
passports, and for government services such as schools, Medicare and Centrelink (social 
security support) enrolment.  The data collected through the birth registry includes mother’s 
and father’s age, ethnicity, child demographics, and basic clinical information such as 
birthweight and plurality. In this doctoral thesis, I used this dataset as a supplement and cross 
check for the more comprehensive perinatal statistics data.  
 
3.2.2  Perinatal Statistics Collection 
 
According to South Australian law enacted in the Health Care Regulations 2008260, it is 
mandatory to report perinatal information for every birth (>20 weeks gestation and >400 g) 
occurring in South Australia to the Minister for Health and Wellbeing within ~30 days after 





Australia. The South Australian Ministry of Health and Wellbeing has been collecting this 
information since 1981, and has been using the data for producing annual pregnancy reports 
to track maternal and child health indicators.259 All Australian jurisdictions report perinatal 
data to the federal government, which is used to monitor maternal and child health indicators 
at a national level.253 Perinatal data is collected by midwives or neonatal nurses usually at the 
time of birth either at home or at hospital using a validated form called the Supplementary 
Birth Record. In Australia in 2017, 97% of births occurred in hospitals, 2.4% of births 
occurred in birth centres, 0.3% were home births, and 0.7% occurred before arriving at 
hospital.253 Irrespective of location, the Supplementary Birth Record is mandated to be filled 
out for all births. 
The information collected by nurses and midwives using the Supplementary Birth Record 
was validated in 1991 (records of 1986) and 2001 (records of 1994) against medical records 
collected by South Australian hospitals.261 The validations were performed by the South 
Australian Pregnancy Outcome Unit, Department of Human Services, to check the accuracy 
of the perinatal data collection process. Perinatal information is important for identifying 
population groups at risk of poor pregnancy outcomes, for preventive interventions, and for 
monitoring maternal and child health indicators. In the second validation using records from 
1994, 121 variables in the Supplementary Birth Record form (including all perinatal variables 
used in my doctoral thesis) were examined against the hospital records, and found to be valid 
in capturing the perinatal information.261 The maternal smoking and caesarean section 





5 and 6).  Data on caesarean birth and onset of labour was part of the 1994 Supplementary 
Birth Record form, which was validated. Collection of information on maternal smoking (as 
used in study 3 in this doctoral dissertation) in the first and second half of pregnancy has 
been included in the Supplementary Birth Record since 1998 (Figure 3-2).262 Therefore, 
maternal smoking information was not part of the 1994 Supplementary Birth Record form 
that was validated. However, other studies have demonstrated that maternal smoking 
reported in pregnancy is reflective of actual tobacco exposure in pregnancy.171  
The perinatal statistics data used in this project consists of all children born in South Australia 
from 1999-2013. Perinatal statistics includes basic demographic, pregnancy and birth 
information about the mother; e.g. age, employment, ethnicity, smoking status, maternal BMI 
(body mass index), postcode, parity, and any medical condition or complications of 
pregnancy, labour or delivery.259 It also includes neonatal information, such as infant 
gestation, birthweight, sex and birth outcomes. The perinatal statistics data provided 
information about the exposures in study 1 (socioeconomic variables), 2 (caesarean section), 






Figure 3-2: Supplementary Birth Records form 2001 







3.2.3  Hospital Admissions data 
 
Children with type 1 diabetes were identified from the Integrated South Australian Activity 
Collection (ISAAC), which contains admissions to all public hospitals in South Australia.263 
I used admission data from July 2001 to June 2014  in this thesis as hospital data prior to July 
2001 was not available for linkage.256 The hospital admission data consists information on 
date of birth, sex, date of admission and discharge, age at admission, ethnicity, postcode, and 
up to 26 different diagnoses codes (depending on number of illnesses diagnosed in each 
hospital admission episode). The diagnose-1 is the primary diagnosis, and the remaining 25 
diagnoses are additional or secondary diagnoses on each admission episode.  
I used the International Classification of Disease, Tenth revision, Australian Modification 
(ICD-10-AM) codes E10, E101-E109 to identify children with type 1 diabetes from all public 
hospitals data in South Australia. The ICD-10-AM codes are assigned to each patient by the 
trained hospital staff, following discharge after each hospital admission episode.264 In South 
Australia there is only one hospital with a specialized paediatric endocrinology unit, where 
children are admitted for stabilization after type 1 diabetes diagnoses, and that is a public 
hospital so was included in this study along with all other public hospitals data.265   
 Children appearing in the public hospital system may have multiple admission episodes from 
2001-2014 and each hospitalisation may have up to 26 different ICD-10-AM diagnosis 





after experiencing an injury, the injury is recorded as the primary diagnosis, and other health 
conditions (asthma, type 1 diabetes etc.) are recorded as additional diagnoses. I used the 
primary and the 25 additional ICD-10-AM diagnosis codes to identify children with type 1 
diabetes.  For children with multiple hospitalisations for type 1 diabetes, I extracted the first 
hospital admission with type 1 diabetes to identify the number of individuals with type 1 
diabetes. The date of admission with first type 1 diabetes hospitalization was used as age of 
the first type 1 diabetes diagnosis.  
From 2001-2014, 557 children aged ≤15 years were identified as having type 1 diabetes from 
the hospitalization data. This equates to an incidence rate of 25.3 per 100,000 person-years, 
which is consistent with the incidence of 24.4 per 100,000 population (from 2000-2016) 
estimated using Australian national diabetes register data.175 The consistency of type 1 
diabetes incidence in my thesis with the Australian national diabetes register supports the 
high case ascertainment in this study.175 The National Diabetes Register is a database of 
Australians who use insulin for treating diabetes. The National Diabetes Register consists of 
multiple data sources; including National Diabetes Services Scheme (NDSS); the NDSS 
Sales data, which records the start of first insulin use based on purchase of insulin and 
injections; and the Australasian Paediatric Endocrine Groups (APEG) state-based registers. 
NDSS is how people access subsidised insulin related products, and the reason why the 






In my thesis, children with type 1 diabetes were identified from all public hospital 
admissions. There are no private paediatric hospitals in South Australia, where these kids 
could be hsopitalised. The National Diabetes Register data is not linked to the SA ECDP as 
was not ethically approved and had no funding. To confirm whether numbers were right, I 
compared the annual incidence in the SA ECDP with published NDR data and it was found 
to be consistent. Others have also shown that similar public hospital data are suitable for 
identifying cases of  type 1 diabetes with 99.8% case ascertainment, and this is also likely to 
be the case for the SA ECDP.267 The inclusion of both primary and additional/secondary 
ICD-10-AM diagnoses codes to identify children with type 1 diabetes helped ensure high 
case ascertainment.  
 
3.2.4 Education data 
 
3.2.4.1  School assessment data 
The South Australian Department for Education provided all the public schools data on 
children’s educational outcomes used for this doctoral research.268 The school data is 
collected under a national program called “The National Assessment Program—Literacy and 
Numeracy – NAPLAN”. The NAPLAN assessments used from 2008-2015 are a paper and 





the NAPLAN assessments on the same day in grade/years 3, 5, 7 and 9. NAPLAN assesses 
children’s understanding of the Australian curriculum for literacy and numeracy skills.268 
NAPLAN scores are important to determine children’s progress through school.247-249  
NAPLAN results are reported using five scales; one for each domain of writing, reading, 
spelling, grammar and numeracy (Figure 3-3). Raw NAPLAN scores are converted to scaled 
scores, ranging from 0-1000. I used year 5, age ~10 NAPLAN data in study 4 (explained in 
section 3.6.4). In 2017, the average year 5 NAPLAN scale scores for South Australian 
children ranged from 455 to 494, and the Australian national average ranged from 472 to 505 
(Figure 3-3);  South Australian children scored lower across all NAPLAN domains compared 
with the Australian national average.268   
NAPLAN assessment data from 2008-2015 were used in this project because NAPLAN 
assessments commenced in 2008, and the latest available data were from 2015. Available 
information in the school assessment dataset includes the test scores undertaken by students, 
achievement against proficiency bands, and student demographics.   
3.2.4.2  South Australian School Enrolment Census  
The School Enrolment Census is collected each year in term 1 and term 3 of the school year 
(there are four 10-week terms in a school year) by the Government of South Australia, 
Department for Education. The School Enrolment Census contains important information on 
parental education, and country of birth that were used as confounders in this research. There 





census record for each child was used as country of birth and parental education were not 
likely to change between school enrolment and the NAPLAN assessment. If parents’ 
education data was missing, then parental education data was extracted using their sibling’s 
school enrolment information. Parent’s education information from this dataset was used as 
a confounder in study 4 (Chapter 7), to estimate the effect of type 1 diabetes on educational 
outcomes.  Parents’ education data is therefore only available for children who have entered 
















Figure 3-3: Average NAPLAN scales scores of year 5 children in the five domains of 
literacy and numeracy in Australia, 2017 






3.3  Data linkage 
 
Data linkage brings together multiple sources of previously unconnected information on the 
same individuals. The data were de-identified to protect privacy, that’s how the SA ECDP 
was granted ethics approval for data linkage. The multiple administrative datasets included 
in the SA ECDP256 were linked by an independent data linkage agency - SA NT DataLink.256, 
269 After all the relevant ethics and custodian approvals are obtained, data custodians send 
the requested dataset to the data linkage agency with key identifying information including 
name, gender, date of birth, and address. This demographic information is used by the data 
linkage agency to probabilistically match children across different datasets and, after 
matching children, create an anonymising project linkage key. The data custodian then 
attaches the anonymising project specific key to their original detailed dataset and then 
remove all identifying information.256 The de-identified datasets can then be provided to the 
researchers for analysis. During the data linkage process, the separation of the identifying 
data (name, gender, date of birth, and address), from the clinical or services data protects 
individual’s privacy, while making population level data accessible for researchers.270 Unlike 
many Scandinavian countries, in Australia there is no unique individual citizen identifier 
number that could be used for data-linkage. In Australia, information on the same individuals 
from multiple data sources are probabilistically matched and linked using basic demographic 
information, and it is possible that a small degree of incorrect linkage may happen. No studies 





South Wales and Western Australia have reported about 0.1-0.5% false linkage rate in 
Australian data linkage systems.269, 271   
In the following sections (3.4, 3.5 and 3.6) I will describe the epidemiological concepts 
such as confounding, and the methods used to deal with confounding, and missing data; 
and the analytical methods used to answer each research question.  
 
3.4  Confounding  
 
Confounding is a source of bias in the effect estimate of the exposure on outcome, and 
corresponds to lack of comparability between the exposed and unexposed groups.272-274  Due 
to confounding, the effect of the exposure of interest on the outcome is distorted because the 
effect of extraneous factors (called confounders) is mixed with any actual exposure effect.272 
In modern formal definitions, a confounder is a common cause of both the exposure and 
outcome.272, 273 In observational studies treatment assignment is not randomized, therefore 
the observed effect estimates could be due to differences and imbalances in variables other 
than the exposure of interest being investigated.272 Therefore, adjusting for confounders helps 
achieve conditional exchangeability, and gives an effect estimate which is due to the 
exposure of interest272, 273, 275 276 However, adjustment for confounding is unlikely to ever 





In the following section I will discuss the different analytical approaches used in this doctoral 
thesis to deal with the issue of confounding including; the use of DAGs to identify 
confounders (in study 2, 3 and 4); and use of AIPW- a potential outcome approach as a 
different method to dealing with confounding (in study 4).  I adjusted for a wide range of 
relevant confounders in each study in an attempt to reduce bias by confounding (discussed 
in chapters 4, 5, 6, and 7).  I will also discuss the methods used in this thesis to assess the risk 
of bias due to unmeasured confounding including negative control outcome analysis and E-
value.  
 
3.4.1 Directed acyclic graphs (DAGs) 
 
DAGs are an approach to constructing models to assess what should be adjusted for to 
achieve conditional exchangeability. Before carrying out any analyses in this doctoral thesis, 
a DAG was drawn to identify possible confounding pathways. (A simplified examples of a 
DAGs is given in Figure 3-4 below, with actual DAGs used in studies 2 and 3 are given in 
chapter 5,  and 6 respectively).277 DAGs are a simple, flexible tools for demonstrating the 
statistical associations between variables given a set of assumptions about the causal 
structure.278-280 Depending on the research question and a priori subject matter knowledge, 
the causal relationship between exposures, outcomes and confounders, are shown in DAGS 





variable to the other, either harmful or protective.281 In Figure 3-4 below, the confounder is 
a cause of the exposure and the outcome, and this is why confounders are frequently referred 
to as ‘common causes’. Variables that are in the causal pathway from the exposure to the 
outcome are called mediators; for example, birth weight is a mediator between maternal 
smoking and childhood type 1 diabetes.  Adjusting for mediators can attenuate the total effect 
of the exposure on the outcome and considered over-adjustment bias in epidemiology282, 







3.4.2  Augmented inverse probability weighting  
Conceptually the AIPW method fits under the potential outcomes theory, where the results 
may be interpreted as the education outcome as though the entire population were exposed 
to type 1 diabetes, versus their education outcome as though they did not have type 1 diabetes. 
The doubly robust AIPW procedure can have a similar interpretation to a randomised control 









untreated are exchangeable because both the treated and untreated groups are similar across 
all measured and unmeasured characteristics due to the randomization. Therefore the 
difference between the treated and untreated in the outcome is considered to be due to the 
exposure.276 Hence a causal effect of the treatment on the outcome could be estimated in a 
perfectly randomized RCT, given no loss to follow up and full compliance.276 However, in 
observational studies, since treatment is not randomly assigned, the exposed and unexposed 
may differ on many characteristics and hence they may not be exchangeable, leading to 
confounding bias in the effect estimates. In conventional regression, adjustment for 
confounders is an attempt to obtain conditional exchangeability. Only in potential outcome 
approach and AIPW a hypothetical population is created called the pseudo population, where 
every child appears both as exposed (type 1 diabetes) and unexposed (no type 1 diabetes). It 
can’t happen in real life, that is why it is called the potential outcome – the outcome that child 
would have had, had the child been assigned to the alternative exposure (or treatment if it 
was a RCT). The pseudo population is created by weighting each child in the study by the 
inverse of the conditional probability of receiving the exposure given covariates.250, 283, 284 In 
other words, inverse probability weighting removes confounding by comparing the same 
child under two different exposure conditions.250, 283, 284  
AIPW is a potential outcome approach to deal with confounding beyond traditional 
regression adjustment. Augmented Inverse Probability Weighting (AIPW) is also known as 
a doubly robust method250 because it allows the specification of a treatment model for 





a robust estimate if one of those models is correctly specified. In study 4 of this thesis, to 
computed the average treatment effect (ATE) of type 1 diabetes on educational outcomes of 
children in year 5, two models were specified; the treatment model (logit) for computing 
probability of type 1 diabetes  given observed covariates; and the outcome model (linear). A 
priori identified confounders (socioeconomic and perinatal characteristics mentioned in 
Table 7.1 of chapter 7) were included in both the outcome and treatment model, based on 
DAGs.  
 
3.4.3  Negative control outcome analysis 
 
Negative control outcome analysis is a tool used in epidemiology to detect the risk of bias in 
the effect estimate due to unmeasured confounding and other threats to the validity of causal 
inference.285 Negative controls in epidemiological studies are similar to those in experimental 
studies conducted in laboratories, where researchers leave out an essential ingredient or 
inactivate the active ingredient, to test an effect that would be implausible by the 
hypothesized mechanism.286 In the third study of this thesis, I was particularly concerned 
about the potential for residual confounding. A negative control outcome analysis285 offered 





Most previous studies had reported a protective effect of maternal smoking for childhood 
type 1 diabetes but many of these did not adjust for some important confounders. I also 
acknowledge that I did not have information on father’s type 1 diabetes, which is potentially 
an important confounder of the maternal smoking and childhood type 1 diabetes association. 
Therefore, I estimated the risk of bias due to unmeasured confounding in the effect of 
maternal smoking on childhood type 1 diabetes using a negative control analysis.  
One of the assumptions underlying choosing a negative control outcome is to select an 
outcome which is not directly caused by the exposure.285  Ideally, the association between 
the exposure and the−negative control outcome association should have similar set of 
measured and unmeasured confounders as the exposure and outcome of interest (Figure 3-
5). This condition is called perfect U-comparability.285 In routinely collected observational 
data finding a perfectly U-comparable negative control outcome is difficult, and the negative 
control outcome is more likely to only achieve approximate U-comparability with the 
primary outcome of interest.285 Looking across all available variables in the linked datasets, 
I decided to use a variable “children not having a school card” as the negative control 
outcome.  This information was obtained from school enrolment census. A school card is 
given to socioeconomically disadvantaged Australian children for financial assistance with 






As shown in Figure 3-5, socioeconomic position is a potential confounder (C) of the maternal 
smoking (X) and childhood type 1 diabetes (Y) association. This is because socioeconomic 
position causes both maternal smoking and childhood type 1 diabetes.  Socioeconomically 
disadvantaged mothers are more likely to smoke in pregnancy.253 And socioeconomically 
advantaged children are more likely to have childhood type 1 diabetes. Socioeconomic 
position also acts as a confounder in the negative control outcome. Similarly, 
socioeconomically advantaged children are more likely to “not have a school card”.  
However, there is no plausible association between maternal smoking and “child not having 
a school card”, and as can be seen in Figure 3-5 there is no direct arrow leading from maternal 
smoking to “child not having a school card”. Therefore, if after adjusting for the measured 
confounders, any observed effect of maternal smoking on the negative control outcome must 
be due to back door paths or unmeasured confounding (U) (Figure 3-5).  In practice there 
would be many arrows relevant to each confounder, but for simplicity all of the measured 
confounders have been bundled up together in Figure 3-5. In Figure 3-5, the red and orange 
arrows from measured and unmeasured confounders going toward maternal smoking and 
type 1 diabetes are depicting backdoor or indirect path (confounding path).  A backdoor path 
is a non-causal path from the exposure to the outcome, and indicate common causes 










Figure 3-5: Directed acyclic graph (DAG) showing negative-control outcome analysis  
 
Measured confounders (C): Parents’ age, parents’ occupation, mother’s birth region, 
maternal ethnicity, remoteness, IRSAD (Index of Relative Socio-economic Advantage and 
Disadvantage), mother type of patient (health care), private or public hospital for child 






3.4.4  E-value  
 
The potential for bias from factors that were not measured (unmeasured confounding) is a 
common issue in observational studies. However, methods have been developed to perform 
sensitivity analyses to quantify this bias. One of the simplest approaches proposed by Ding 
and VanderWeele, is calculating the E-Value.287, 288 The E-value quantifies the minimum 
strength of association (on a risk ratio scale) that an unmeasured confounder needs to have 
with the exposure and the outcome to explain away the observed effect.287, 288 Haneuse, 
VanderWeele and David stated that “E-value analysis asks the question: how strong would 
the unmeasured confounding have to be to negate the observed results?”287, 288 The E-value 
also assesses the extent of unmeasured confounding that would be needed to shift the 
confidence intervals to include the null.288 E-value is another method for understanding 
confounders in causal analyses; and it assesses how much evidence there is for causality; the 
outcome is caused by the exposure of interest, and not attributed to other unmeasured 
confounders.  
In study 3 (section 3.6.4) I calculated E-value for the hazard ratio of maternal smoking in 
pregnancy on childhood type 1 diabetes following Ding and VanderWeele, in Stata287-289 
Although the E-value is on a risk ratio scale, I used hazard ratio scale because my effect 






3.5  Multiple imputation for missing data 
 
Missing data can result in biased estimates of the effect and can lead to loss of power and 
precision.290, 291 A number of techniques have previously been used to deal with missing data 
including; extreme case analysis (imputing values with best or worst possible values); overall 
mean imputation (replacing missing data with the mean values of the observed data); or last 
value forward method (where the last measured value is used for replacing the missing data). 
290 292-294 Other methods have been based on inverse probability weighting to make the 
complete case representative of all the cases; and approaches based on maximum likelihood 
have also been used to deal with missing data.290 292, 293 However, the single value imputation 
techniques have limitations and may generate biased estimates as they do not take into 
account any uncertainty around the imputed missing value.292, 294 Among the statistical 
approaches to analyse missing data, multiple imputation has been shown to be an efficient 
and least biased approach compared with complete-case and extreme-case analysis294-296 
First introduced by Rubin,297, 298 multiple imputation is a flexible way of dealing with missing 
data, and it creates multiple copies (each copy has a different estimated value for missing 
data) of the dataset to allow for the uncertainty about the missing value.290, 293 Multiple 
imputation has been used to improve the validity of the estimates, to increase precision and 
power, and to avoid bias due to the loss of information.290, 293, 299 However, it is  important to 
carefully think about the reasons of missing data before deploying any method to deal with 





completely at random (MCAR); 2) missing at random (MAR); and 3) missing not at random 
(MNAR).290, 293, 300 The data are said to be MCAR when the missing data is neither predicted 
by the observed data nor dependent on the missing data.300, 301 In case of MCAR, there are 
no systematic differences between the observed and missing data, hence complete case 
analysis does not give a biased estimate.300, 301 The MAR assumption implies that missing 
data can be predicted by the observed data.299 There might be systematic differences between 
the observed and missing values, but these differences can be explained by other observed 
variables, hence multiple imputation can be used under the MAR assumption.290, 301 The 
MNAR assumption implies that missingness depends on the missing data, and could not be 
predicted using the observed data.290  MNAR can not really be tested, although the MAR 
assumption holds if missingness is predicted by measured variables.  
Multiple imputation could be performed either by multiple imputation using multivariate 
normal distribution (MVN) or by multiple imputation by chained equation (MICE).292 MICE 
is a flexible approach to impute categorical variables.299 In MICE different regression models 
(logit, multinomial, linear) can be specified for each variable depending on the type of 
variables (binary, categorical, ordinal, continuous) included in the imputation model.292 299 
Whereas MVN assumes a joint multivariate normal distribution, and needs variables to be 
normally distributed or transformed to approximate normality.292 In this doctoral thesis, 
MICE was performed given the different types of variables included in the datasets.292, 299 
Multiple imputation was conducted in all four studies (Chapters 4-7) to deal with missing 





Analyses involving multiple imputation were conducted in three phases: an imputation phase, 
analysis phase, and pooling phase. In the imputation phase, twenty datasets were created, 
with fifty iterations each or fifty cycles of regressions before switching to create the next 
imputed dataset.293 At the end of 50 cycles of regression, one imputed dataset is created and 
saved, and this process is repeated for generating all twenty datasets. Enders (2017) writes 
about the reason for creating multiple iterations as “to avoid imputations based on a single 
set of regression parameters, an iterative algorithm uses Bayesian estimation to update the 
regression model parameters, and it uses new estimates to generate each set of 
imputations.293 Thus each of the twenty datasets contains a different set of imputed estimates 
for the missing values. The twenty datasets and the fifty cycles of regressions for each 
imputed dataset were generated to account for the uncertainty about the missing values.290, 
293 Then in the analysis phase, the twenty datasets were analysed separately using models 
appropriate for each question (question 1- 4). In the last pooling phase, the estimates and 
standard errors from the twenty datasets were combined using Rubin’s rules.298, 299 Rubin’s 
rules take in to account between and within imputation variance.293, 297, 298 For standard 
regression estimates statistical packages have written programs that combine the estimates 
across multiple imputed datasets. However, there were no packages available to pool 
incidence rates and average treatment effects from the AIPW results in paper 1 and paper 4. 
Therefore, I developed Stata syntax using Rubin’s formula, to pool the incidence rates from 





from the twenty datasets in study 4 (Chapter 7). All the analyses were conducted on 
complete-case and imputed data.  
 
3.6  Analytical approaches used in each research question 
 
In the following section I will describe the analytical methods deployed to answer each 
research question. As mentioned above, children identified with type 1 diabetes from 
hospital data were merged with perinatal and birth registration data, and other required 






Table 3-1: Summary of the datasets, year of data and analytical methods used in each study   
   
Chapter  Study  Exposure  Outcome  N Data Sources   Years  Statistical methods  
 4 Socioeconomic 
characteristics of 




Childhood type 1 
diabetes 
N = 231,685 








Incidence rates  
 5 Caesarean section 





Childhood type 1 
diabetes 
N = 286,058 









6 Maternal smoking in 
pregnancy and risk of 




Childhood type 1 
diabetes 
N = 286,058 

























outcomes in year 5 























3.6.1 Research question 1: What are the socioeconomic characteristics of 
children with type 1 diabetes?  
 
In the first descriptive study (Chapter 4), I calculated incidence rates of type 1 diabetes by 
individual and area-level socioeconomic indicators, among children in South Australia, born 
from 2002-2013. Although hospitalization data in the SA ECDP started July 2001, births 
registration and perinatal data started from 1999. In order to keep the same period of births 
and hospitalisation data and avoid misclassification of children with type 1 diabetes born 
before 2002, I used data for the 2002-2013 birth years and the 2002-2014 hospitalization 
calendar years for study 1. 
As mentioned in chapter 2 , socioeconomic position is one of the major determinants of health 
and a fundamental cause of health inequalities that exist between people with and without 
socioeconomic resources.302 Socioeconomic position can influence people’s lifestyle, health 
behaviours, healthcare and environmental exposure, which may have implications for type 1 
diabetes. Therefore, the purpose of this study was to describe socioeconomic patterning of 
childhood type 1 diabetes incidence in South Australia. South Australia is the most 
disadvantaged mainland state of Australia, and to date there has been no population-level 
study of type 1 diabetes among South Australian children. Mostly previous studies of type 1 
diabetes in childhood have used area-level or country-level measures of socioeconomic 





have been inconsistent.95, 98, 99, 105, 151, 303, 304 However, very few studies reported individual-
level socioeconomic indicators and type 1 diabetes incidence.32, 155 Therefore, in the first 
study I compared and described individual and area-level socioeconomic pattering of type 1 
diabetes incidence.  
For this study, children with type 1 diabetes were identified from hospital admissions data 
from July 2002 – June 2014 using ICD-10-AM diagnoses codes as described above. The 
hospital admissions data was merged with the perinatal statistics and births registration data 
of children. Birth registration data was used to supplement any missing information collected 
in the perinatal data. The follow-up time for each child started from birth and ended at 
diagnosis for children with type 1 diabetes or was censored at the end of follow-up (June 
2014) for children without type 1 diabetes. For example, children born in 2002 were followed 
for eleven years and children born in 2013 were followed for one year. The mean follow-up 
time was 6 years. All children (n = 231,685) born from 2002-2013, contributed to 1,443,756 
person-time at risk, and 333 children were diagnosed with type 1 diabetes during the follow-
up from 2002-2014.  
The age-specific incidence of type 1 diabetes (per 100,000 population) was calculated by 
using total number of children in each age-group as the denominator. Due to the differences 
in the follow up time for each child, incidence rate (per 100,000 person-years) by individual 
and area-level socioeconomic characteristics was calculated using total person-time at risk 





socioeconomic indicators such as parent’s employment, whether mother was a private or 
public patient (health insurance) at the time of childbirth, or whether the child was delivered 
in a private or public hospital. In addition, I also calculated type 1 diabetes incidence rate by 
area-level socioeconomic position, which was measured by the Index of Relative 
Socioeconomic Advantage and Disadvantage (IRSAD). The individual-level socioeconomic 
indicators considered here (parents’ employment, private or public healthcare, private or 
public hospital birth) are well known and widely used internationally. However, since the 
IRSAD measure is unique to Australia, I will describe it further in the following section.  
3.6.1.1  IRSAD:  An area-level measure of socioeconomic position 
The Index of Relative Socio-economic Advantage and Disadvantage  (IRSAD) was used  as 
an area-level measure of socioeconomic position in this study.305 IRSAD is developed by the 
Australian Bureau of Statistics using five-yearly census data, to assess people’s access to 
resources and their ability to participate in society.305 IRSAD ranks areas from most 
disadvantaged to most advantaged. As commonly practiced in Australia, I used the IRSAD 
quintiles; quintile 1 represented most disadvantaged, and quintile 5 depicted most advantaged 
areas. IRSAD is constructed based on a weighted combination of selected variables from the 
Census such as income, education, occupation, housing and others, using principal 
component analysis (detail of variables in Table 3-2).305 Each child born in South Australia 
included in the perinatal dataset was assigned an IRSAD score based on their mother’s 





Table 3-2: Census variables used by the Australian Bureau of Statistics for creating the 
Index of Relative Socio-economic Advantage and Disadvantage (IRSAD) 
Low income  % People with stated annual household equivalised income 
between $1 and $20,799 (approx. 1st and 2nd deciles) 
No internet  % Occupied private dwellings with no internet connection 
Education <year 11 % People aged 15 years and over whose highest level of 
education is Year 11 or lower. Includes Certificate I and II 
Child living with 
jobless parents 
% Families with children under 15 years of age who live with 
jobless parents 
Occupation (labour) % Employed people classified as 'labourers” 
One parent families % One parent families with dependent offspring only 
Unemployed  % People (in the labour force) unemployed 
Disability  
(age <70 years) 
% People aged under 70 who have a long-term health condition or 
disability and need assistance with core activities 
Low rent % Occupied private dwellings paying rent less than $166 per 
week (excluding $0 per week) 
Separated /divorced  % People aged 15 and over who are separated or divorced 
Occupation Employed people classified as Machinery Operators and Drivers 
Low skill workers % Employed people classified as Low Skill Community and 
Personal Service Workers 
No car % Occupied private dwellings with no cars 
Overcrowded 
households 
% Occupied private dwellings requiring one or more extra 
bedrooms (based on Canadian National Occupancy Standard) 
No education  % People aged 15 years and over who have no educational 
attainment 
3 or more cars % Occupied private dwellings with three or more cars 






Spare bedroom % Occupied private dwellings with one or more bedrooms spare 




% employed people classified as Managers 
4 or more bedrooms  % Occupied private dwellings with four or more bedrooms 
Occupation  
(Professionals) 
% Employed people classified as Professionals 
Diploma  % People aged 15 years and over whose highest level of 
education attainment 
is a diploma qualification 
High mortgage % Occupied private dwellings paying mortgage greater than 
$2,800 per month 
High income  % People with stated annual household equivalised income 
greater than $52,000 (approx. 9th and 10th deciles) 







3.6.2  Cox proportional hazard regression 
 
In study 2 and 3, Cox proportional hazard regression was used. Cox proportional hazard 
regression is used to estimate the effect of an exposure on the outcome; when the outcome is 
time to event or survival data. In the second and third study of this thesis, I used Cox 
proportional hazard regression to estimate the effect of caesarean birth and maternal smoking 
on childhood type 1 diabetes.  I used Cox regression to account for different time to diagnosis, 
and different length of follow-up for each birth cohorts. One of the assumptions of Cox 
proportional hazard regression is that the hazard ratio is constant over time, or the effect of 
given covariate does not change overtime.306 Therefore, before conducting Cox proportional 
hazard regression analyses in study 2 and 3, I tested the proportional hazard assumption by 
Schoenfled residual test,306, 307 which showed non-violation of the proportional hazard 
assumption. 
 
3.6.3 Research question 2: What is the effect of caesarean birth on 
childhood type 1 diabetes? Does the risk of type 1 diabetes differ by 






A range of perinatal factors have been linked with type 1 diabetes.  Caesareans that are not 
medically indicated are potentially preventable, therefore if caesareans increase the risk of 
type 1 diabetes they may represent a modifiable risk factor.308 However evidence about the 
impact of caesarean birth on childhood type 1 diabetes is mixed, 20-22, 25, 164 and less is known 
about whether type 1 diabetes risk differs between prelabour and intrapartum caesarean 
births.21 Therefore in the second study (Chapter 5) I estimated the effect of caesarean birth 
on childhood type 1 diabetes, extending the question to whether the risk of type 1 diabetes 
differed by caesarean type; intrapartum or pre-labour caesarean. As mentioned in chapter 2, 
birth method induced disparity in gut microbiota is a hypothesized link between caesarean 
birth and childhood type 1 diabetes.134 For this research question, it was hypothesized that 
type 1 diabetes risk would be higher among children born by prelabour caesarean than 
intrapartum caesarean births. That is because children born by prelabour caesarean do not get 
exposed to maternal vaginal microbiota, and intrapartum caesareans births presumably have 
some exposure.  
Children with type 1 diabetes identified from hospital data using ICD-10-AM codes (2001-
2014) were merged with perinatal statistics and birth registration data (1999-2013) for the 
analysis of this question (Table 3-1). Data on exposure (caesarean birth) and confounders 
were sourced from perinatal statistics. Information on birth method (normal spontaneous and 
instrumental vaginal deliveries, elective and emergency caesarean) and onset of labour 
(spontaneous, no labour and induction) were combined to classify prelabour or intrapartum 





spontaneous or induced labour, and intrapartum caesarean included all emergency and 
elective caesareans performed after the onset of labour (spontaneous or induced labour). 
For this study, children were followed from birth until type 1 diabetes diagnosis, or until 
censored at the end of follow up (June 2014). The follow up time ranged from one year (for 
2013 births) to 15 years (for 1999 births), with a mean follow up of eight years. Due to these 
differences in follow-up time, Cox proportional hazard regression was used to estimate the 
incidence of type 1 diabetes for children who had caesarean birth compared with normal 
vaginal delivery (primary analysis). In secondary analysis, the crude and adjusted effect of 
intrapartum and prelabour caesarean birth on childhood type 1 diabetes was estimated, 
compared with normal vaginal delivery, using Cox proportional hazards regression. Both 
primary and secondary analyses were adjusted for a wide range of a priori identified 
confounders, in order to reduce confounding bias. The confounders were identified based on 
subject matter knowledge and previous research, using a DAG (Figure 5-2). Detail about the 
confounders for this study is given in Chapter 5. 
In addition to the primary and secondary analyses, five different sensitivity analyses were 
performed, to investigate the robustness of the effect estimate, which are discussed in Chapter 
5. Multiple imputation by chained equation was used to impute the missing data (discussed 






3.6.4 Research question 3: What is the effect of maternal smoking in 
pregnancy on the risk of childhood type 1 diabetes? What is the 
risk of bias due to residual confounding in the effect estimate? 
 
Similar to caesarean birth, maternal smoking in pregnancy is a modifiable risk factor for 
childhood type 1 diabetes, however the evidence is mixed. Maternal smoking in pregnancy 
has been linked with both higher and lower risk of childhood type 1 diabetes.26, 29-31, 34  In the 
third study an extensive and rigorous epidemiological approach was deployed to understand 
the association between maternal smoking in pregnancy and childhood type 1 diabetes.  
Firstly, in the primary and secondary analyses, I estimated the effect of maternal smoking on 
childhood type 1 diabetes using whole-of-population South Australian linked data. Secondly, 
because of the small number of children exposed to maternal smoking in previous studies as 
well as in my dataset, in order to get a more precise estimate, I performed meta-analyses of 
the findings from published studies and my study. Thirdly, I assessed the risk of bias due to 
residual or unmeasured confounding in the estimate of maternal smoking on childhood type 
1 diabetes in my findings of the South Australian linked data study using negative control 
and E value approaches.   
3.6.4.1  Primary and secondary analyses 
Primary and secondary analyses involved use of multiple administrative datasets to estimate 





similar to study 2, children identified with type 1 diabetes from hospital data were merged 
with the perinatal statistics and birth registration data (1999-2013). Data on maternal 
smoking in pregnancy and confounders were sourced from perinatal statistics. Similar to 
question 2, children were followed from birth until type 1 diabetes diagnosis, or until the end 
of follow up in June 2014, with the mean follow up of eight years (follow up ranged 1-13 
years).  
In the primary analysis, crude and adjusted risk of childhood type 1 diabetes for children 
exposed to maternal smoking in pregnancy was estimated by Cox proportional hazard 
regression, compared with unexposed children. A priori identified confounders were 
included in the adjusted model, to reduce confounding bias (Figure 6-2). Detail about these 
confounders are discussed in Chapter 6. Information on maternal smoking collected in the 
first and second half of pregnancy were combined to create the maternal smoking during 
pregnancy exposure. For the primary analysis, maternal smoking was categorised as; 1) non-
smokers, 2) those who smoked only in the first or second half of pregnancy, 3) consistent 
smokers. In order to get a cleaner effect of consistent maternal smoking throughout 
pregnancy, the children who were only exposed to maternal smoking for short time (only in 
the first or the second half of pregnancy) were grouped separately. Those women who 
reported smoking in both the first and second half pregnancy of pregnancy were categorized 
as “consistent smokers”. I wanted to look at the impact of maternal smoking only in the first 





effect. Therefore, due to small numbers, smoking only in the first or second half of pregnancy 
category was created by combining the following four groups;  
1. women who quit smoking in the first half of pregnancy and never smoked again in 
pregnancy (n = 10,605, type 1 diabetes = 22), 
2. women who quit smoking at/before first antenatal visit but resumed smoking later in 
pregnancy  (n = 400, type 1 diabetes = 0), 
3. women who reported smoking only in the first half of pregnancy (total n = 3,869, 
type 1 diabetes = 8),  
4. Women who reported smoking only in the second half of pregnancy (n = 316, type 1 
diabetes = 1).   
A total of 316 women reported smoking only in the second half of pregnancy from 1999-
2013.  There were no reports of smoking only in the second half of pregnancy in 2008, 2009, 
2010, 2011, and 2013. As can be seen from the above-mentioned numbers in each group, the 
majority of women quit smoking in the first half of pregnancy and never smoked again in 
pregnancy. Therefore, exposure to maternal smoking was mostly limited to the first half of 
pregnancy, among those children whose mothers were categorized as “smokers only in the 
first and second half of pregnancy”. 
For the secondary analysis, the crude and adjusted effect of any smoking in pregnancy was 
estimated, compared with non-smokers, using Cox proportional hazard regression. Due to 





and second half of pregnancy, and consistent smokers were combined to create “any smoking 
in pregnancy” category.  
In addition to the primary and secondary analyses, five sensitivity analyses were performed, 
details are discussed in chapter 6. Multiple imputation was performed to impute the missing 
data (discussed in section 3.5)290, and analyses were conducted on both complete-case and 
imputed data.   
3.6.4.2 Meta-analyses 
It was evident from the published literature that even the large studies on maternal smoking 
and childhood type 1 diabetes have imprecise estimates, and this is also true for my study.  
Previously published population-based studies also had small numbers of children exposed 
to maternal smoking in pregnancy that impacted their precision.30 There was no published 
meta-analysis on maternal smoking and childhood type 1 diabetes when this study was 
conducted. Therefore, in order to get a more precise estimate of the effect of maternal 
smoking in pregnancy on childhood type 1 diabetes, findings from my study and previous 
case-control and population-based cohort studies were meta-analysed.26, 27, 29-31, 34 I searched 
Web of Science, PubMed, and EMBASE databases systematically using the terms type 1 
diabetes, insulin depended diabetes mellitus, childhood diabetes, maternal smoking in 
pregnancy, prenatal, environmental and perinatal factors. While studying the literature for 





papers to report the incidence and perinatal risk factors of type 1 diabetes. Therefore, these 
terms were chosen to search for studies on maternal smoking and childhood type 1 diabetes.  
Literature showed that most cohort studies are conducted in high risk population to explore 
the risk factors of type 1 diabetes and mostly reported multiple risk factors and preclinical 
type 1 diabetes as their outcome. None of those studies had specifically focused on maternal 
smoking as their main exposure of interest, and maternal smoking was only reported as one 
of the baseline characteristics. Therefore, I chose only those studies for meta-analysis that 
had reported clinical type 1 diabetes as their outcome and had adjusted for some confounders 
in their estimate of the effect of maternal smoking on childhood type 1 diabetes. Case-control 
studies reported odds ratios, and population-based cohort studies reported hazard ratios. 
Therefore, I performed meta-analyses separately for case-control,26, 31-33, 309, 310 and 
population-based cohort studies,27, 29, 30 using random effects models, assuming non-
homogeneity among studies.  
3.6.4.3  Assessing risk of bias due to unmeasured confounding 
As mentioned above, unmeasured confounding is a major issue threatening the validity of 
the effect estimate in observational studies. I assessed the risk of bias due to residual 
confounding in the effect estimate of maternal smoking on childhood type 1 diabetes (in my 
original findings obtained from SA ECDP data) using negative control outcome analysis 
(discussed above in section 3.4.3).285 I also estimated the risk of bias due to unmeasured 





original findings) using E-value (discussed above in section 3.4.4) following Ding and 
VanderWeele, in Stata287, 288 289 
 
3.6.5 Research question 4: What are the implications of type 1 diabetes 
for children’s educational outcomes?  
 
I estimated the average treatment effect (ATE) of type 1 diabetes on children’s educational 
outcomes in year 5, using augmented inverse probability weighting method (AIPW, 
discussed above in section 3.4.2).250 For this study, children identified with type 1 diabetes 
from hospital data (2001-2014) were merged with school enrolment, school assessment data 
(2008-2015), perinatal statistics and births registration data (1999-2005). Data on educational 
outcomes of children born 1999-2005 were sourced from the nationally administered school 
assessment data, called NAPLAN268 collected from 2008-2015. Although there were 557 
children identified with type 1 diabetes from 2001-2014 from hospitalisation data, only 162 
children identified with type 1 diabetes had taken year 5 NAPLAN assessment after their 
diagnosis and were thus included in this study. A large number of children with type 1 
diabetes had taken year 5 NAPLAN assessment, compared with NAPLAN assessments in 
other year levels (year 3, 7 and 9) in the SA ECDP dataset. Therefore, year 5 NAPLAN 





scores of children as an outcome, keeping in mind that fluctuations in children’s blood 







CHAPTER 4  INCIDENCE OF TYPE 1 DIABETES BY 
SOCIODEMOGRAPHIC CHARACTERISTICS AMONG 
SOUTH AUSTRALIAN CHILDREN: WHOLE-OF-
POPULATION STUDY 
 
4.1 Preface  
Chapter 4 contains the first epidemiological descriptive study contributing to this thesis.  
 (This paper was under review in the Journal of Paediatrics and Child Health, when the thesis 
was submitted for examination. It was accepted for publication while the thesis was under 
examination). 
 
This paper addresses the first question of my doctoral project.  
What are the socioeconomic characteristics of children with type 1 diabetes in 
South Australia born from 2002-2013?  
My doctoral studies began by examining the incidence and socioeconomic characteristics of 
South Australian children who developed type 1 diabetes. Understanding the basic 
epidemiological patterns of type 1 diabetes was the logical first step, before exploring in-
depth other risk factors and implications of type 1 diabetes. Patterns of incidence of type 1 






Most previous studies (including other Australian studies) have used area-level 
socioeconomic position to describe the socioeconomic patterning of type 1 diabetes 
incidence. Only two non-Australian studies have reported individual level socioeconomic 
patterning of type 1 diabetes in incidence. Area-level measures many not reflect individual-
level variation in socioeconomic condition, and are prone to ecological fallacy. Therefore, I 
took advantage of the linked SA ECDP data with information on individual level 
socioeconomic position, to estimate the incidence of type 1 diabetes by individual and area-








• In this study, individual-level socioeconomic factors supported the hygiene 
hypothesis, which links more advantaged socioeconomic circumstances to greater 
risk of type 1 diabetes.  
 
• No association was found between area level socioeconomic position measured using 
the Index of Relative Socioeconomic Advantage and Disadvantage (IRSAD). The 
IRSAD applies combinations of different socioeconomic measures from households 










4.2 PUBLICATION 1: Incidence of type 1 diabetes by sociodemographic 
characteristics among South Australian children: whole-of-
population study 


























What is already known? 
 
➢ Past studies have reported mixed evidence about the association between various 
area-level socioeconomic indicators and the incidence of T1D. 
➢ Previous studies reported higher type 1 diabetes incidence in affluent areas. However, 
much less is known about individual-level patterning of socioeconomic 
characteristics of children with T1D. 
What this study adds? 
➢ Area and individual-level measures of socioeconomic circumstances were not 
consistently associated with T1D incidence rates in South Australia.  
➢ Higher T1D incidence rates were observed in the most advantaged groups of 
individual-level socioeconomic indicators (both parents employed, mother 
Caucasian, mother had private healthcare).  






4.2.2 Abstract  
 
Objective 
To describe and compare the incidence of Type 1 diabetes (T1D) in South Australia by 
individual and area-level socioeconomic characteristics among children aged ≤11 years. 
Design 
Whole-of-population, data linkage study (n=231,685). 
Setting 
South Australia, children born from 2002-2013, hospitalization followed from 2002-2014. 
Data Source 
De-identified, linked administrative hospitalization, birth and perinatal data from the South 
Australian Early Childhood Data Project.  
Outcome Measure 
Incidence was calculated by identifying T1D cases from T1D-related hospitalizations using 






Overall, 333 children aged ≤11-years (173 boys) were identified as having T1D. The T1D 
incidence rate was 23.0 per 100,000 person-years (95% CI: 20.7-25.7), with no sex 
difference.  
T1D incidence was higher among children whose mothers were Caucasian, private patients, 
and whose parents were employed. For example, T1D incidence was 26.0 per 100,000 (95% 
CI: 22.8-29.5) among children with both parents employed, compared to 20.0 per 100,000 
(95% CI: 12.3- 30.6) among children with both parents unemployed.  
There was no clear gradient in the association between area-level socioeconomic position 
and T1D, with highest incidence for the fourth quintile (26.5 per 100,000 [95% CI: 20.9-
33.1]). The most advantaged area (19.4 per 100,000 [95% CI: 13.8-26.5]) had lower 
incidence than the most disadvantaged area (23.5 per 100,000 [95% CI: 18.9-28.9]).  
Conclusion 
T1D incidence rates differed depending on the measures of socioeconomic characteristics. 
Individual-level indicators showed higher incidence among more advantaged children, 
however, there was no clear area-level socioeconomic patterning of T1D. 
 







Type 1 diabetes (T1D) is a chronic childhood disease and incidence is increasing in many 
countries.54 In 2015, the International Diabetes Federation reported more than half a million 
children aged 0-14 years globally have T1D and 86,000 new cases were diagnosed 
annually.311 The World Health Organization’s DIAMOND project highlighted wide variation 
in age standardized incidence of T1D; from 0.1 per 100,000/year in China to 40.9 per 
100,000/year in Finland, with around 3% annual increase in incidence from 1990-1999.6 
Australia ranks ninth highest among countries with published T1D incidence (22.5 per 
100,000 population) and tenth highest for prevalence among OECD countries with 6,091 
children aged 0-14 years with T1D.54 Although T1D is characterized by autoimmune 
destruction of insulin producing pancreatic β-cells, the exact cause remains unknown. Studies 
attribute increasing incidence to environmental factors in early life interacting with genetic 
predisposition.106  Socioeconomic conditions influence the environment of an individual, and 
hence may alter susceptibility to T1D.   
There is mixed evidence regarding the association between national, regional and 
neighbourhood level socioeconomic indicators and T1D incidence. Studies using different 
socioeconomic measures from Poland (country-level gross domestic product, access to water 
supply and sewage system, and life expectancy)105, Northern Ireland (area’s population 
density and household crowding)95, and UK (area’s population density and Townsend 





based study demonstrated that neighbourhood-level affluence indicators (household income, 
vehicle ownership, high education) are linked with higher T1D risk.96 The hygiene 
hypothesis has been highlighted as one factor that drives higher T1D rates in advantaged 
areas106, but the evidence for higher T1D incidence in affluent areas is contentious. Evidence 
from Germany304 showed high T1D incidence in the most deprived areas. However, some 
studies demonstrated no socioeconomic patterning of T1D.  For example, a study in Western 
Australia (WA) based on diabetes-register data (aged <15 years) found no association 
between area-level socioeconomic disadvantage and T1D incidence.152 
All these studies have used different indicators to measure national, regional and 
neighbourhood socioeconomic conditions, and demonstrated inconsistent evidence. Area-
level studies may not represent individual-level risk factors. Therefore, individual-level 
studies are needed to see whether individual socioeconomic conditions have any role in 
influencing T1D risk. Only two studies in Italy155 and Washington32 focused on individual-
level socioeconomic characteristics and T1D incidence and reported lower T1D risk in 
disadvantaged children. No previous Australian study has focused on individual-level 
socioeconomic measures and T1D incidence. Therefore, this cohort study describes the 
incidence of T1D in South Australia (SA) by individual and area-level socioeconomic 







4.2.4 Methods  
4.2.4.1 Data source and participants 
This population-based study used linked, de-identified government administrative data from 
the South Australian Early Childhood Data Project (n~280,000).256 Children born from 2002 
to 2013 were followed for hospitalization from 2002 to 2014 (aged ≤11 years-old).  
Routinely collected birth registration, perinatal, and hospitalization data were 
probabilistically linked by an independent linkage agency (SA-NT DataLink; 
www.santdatalink.org.au, accessed 3rd December 2019) using demographic information 
including name, birth date, sex and address. Researchers receive de-identified data from 
custodians following the data linkage. Australian data linkage systems (SA-NT DataLink;  
www.santdatalink.org.au, accessed 3rd December 2019) typically estimate a false linkage rate 
of 0.1-0.5%. 
4.2.4.2 Type 1 diabetes 
Hospitalization data recording all admissions to public hospitals in SA was used to identify 
T1D incident cases. Children with their first T1D-related hospitalization were identified, 
based on the International Classification of Disease, Australian-modification (ICD-10-AM), 
10th edition codes (E101 to E109), using both primary and additional diagnoses. ICD-10-AM 





discharge. Children with neonatal diabetes and who had diabetes secondary to other causes 
were classified as not having T1D.   
4.2.4.3 Socioeconomic characteristics 
Information on socioeconomic characteristics was sourced from the South Australian 
Perinatal Statistics Collection, for all births in SA from 2002-2013, which we validated and 
supplemented with Births Registration data.256 The perinatal statistics collection at the time 
of birth (home and hospital) by midwives/neonatal nurses is mandatory for every birth in SA.  
Births registration data is collected as a part of the SA Births, Deaths and Marriages registry, 
and all births are legally required to be registered within 60 days of birth. Birth registration 
data includes parental and child demographic information and basic clinical birth data. 
Individual-level socioeconomic variables included parents’ employment status (both 
unemployed, one parent employed, both employed), type of hospital where child was born 
(public or private), and whether mother was a public patient or a private patient (with private 
health insurance) at time of delivery. Demographic and behavioural characteristics include 
maternal ethnicity (Caucasian, Aboriginal or Torres Strait Islander, Asian and other), and 
maternal smoking at first antenatal visit (yes/no), respectively. 
Area-level socioeconomic variables were derived using the mother’s postcode of residence 
at the child’s birth. Living in a remote or accessible area (major cities, inner regional, outer 
regional or remote) was coded using the Accessibility and Remoteness Index of Australia. 





neighbourhood-level summary measure of socioeconomic conditions. IRSAD was created 
by the Australian Bureau of Statistics (ABS) from Census information collected in 2001, 
2006 and 2011 (year of index applied depended on year of birth). The IRSAD score ranks 
geographic areas from most disadvantaged to most advantaged. The score has been 
categorized into quintiles for this study. Area-level variables used in the IRSAD include 
annual household income, education, employment status, occupation, home ownership, car 
ownership, internet connection, English language, child disability and one-parent 
households. 
4.2.4.4 Statistical analysis 
The age-specific T1D incidence was calculated as the number of cases per 100,000 
individuals, with the total number of children in each age-group as the denominator. The 
incidence rate per 100,000 person-years by socioeconomic characteristics was calculated 
using total person-time as the denominator.  
The proportion of children with missing data on each socioeconomic variable ranged from 
0.02-1.7% (Figure 4-1), with the exception of parental employment (12.0% missing), number 
of antenatal visits (7.4%) and father’s age (4.6%). Multiple imputation was conducted to 
maintain the validity of the association between socioeconomic characteristics and T1D, and 
to account for potential bias if the association differed for children with or without complete 
data.290 Multiple imputation by chained equation was performed to impute missing values, 





The outcome variable (T1D) was not imputed. Mother’s birth in Australia and type of 
antenatal care were included as auxiliary variables. Twenty datasets were generated, with 50 
iterations per imputed dataset.  
One cannot apply Rubin’s rules directly to our imputed data as the denominators (person-
time) change in every imputation, Due to the changing denominator (person-time) in each 
imputed dataset, we did not simply take the mean of incidence rates.  Instead we computed 
the average incidence rate as follows;   
                           𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑅𝑎𝑡𝑒 (?̅?) =
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑇1𝐷 𝑐𝑎𝑠𝑒𝑠 (?̅? ) 
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑝𝑒𝑟𝑠𝑜𝑛 𝑡𝑖𝑚𝑒
 × 100,000 
 And the 95% lower and upper bounds are computed as;312  






95% 𝑈𝑝𝑝𝑒𝑟 𝐶𝐼 = 𝜆̅ ∗ (
(?̅? + 1) 
?̅?
) ∗ (1 +
1.96  




Results from complete case and response sample are provided as supplementary material 
(Supplementary table 4-2 and 4-3).  Inferences from complete case, response sample and 
imputed data (main analysis presented below) are consistent. The estimates in our study are 







Among children born from 2002-2013, whose hospitalizations were followed from 2002-
2014, 333 (173 boys) were diagnosed with T1D.  The overall T1D incidence rate among ≤11-
year-olds was 23.0 per 100,000 person-years (95% CI: 20.7-25.7). There was no sex 
difference in the overall T1D incidence rate. However, age and sex specific incidence (Figure 
4-2) shows that peak age of diagnosis occurred earlier in boys (age 5) than girls (age 6).   
Table 4-1 depicts the socioeconomic characteristics of children with T1D. The T1D incidence 
rate was higher among children whose parents were both employed (26.0 per 100,000 [95% 
CI: 22.8-29.5]) compared to both unemployed (20.0 per 100,000 [95% CI: 12.3-30.6]).  
Children whose mother was a private patient had a higher T1D incidence (26.0 per 100,000 
[95% CI: 21.6-31.1]) than those whose mother was a public patient (21.6 per 100,000 [95% 
CI: 18.8-24.8]).  The T1D incidence rate was lower for children with a mother who identified 
as Aboriginal or Torres Strait Islander (7.5 per 100,000 [95% CI: 1.51-21.8]) compared to 
Caucasians (24.5 per 100,000 [95% CI: 21.9-27.4]). 
T1D incidence was lower in the most advantaged IRSAD quintile area (19.4 per 100,000 
[95% CI: 13.8-26.5]) compared to the most disadvantaged area (23.5 per 100,000 [95% CI: 
18.9-28.9]), but there was no clear gradient in the association between IRSAD and T1D 
incidence. T1D incidence was highest in the fourth IRSAD quintile (26.5 per 100, 000 [95% 
CI: 20.9-33.1]). There was no clear parental age patterning of T1D. Children whose mother 






In this population-based study, we found inconsistent evidence of the association between 
individual and area-level socioeconomic and demographic characteristics and T1D 
incidence. Individual-level measures of socioeconomic disadvantaged were consistently 
associated with lower T1D incidence.  
In this study, when socioeconomic position was measured by individual characteristics, T1D 
incidence was higher among advantaged children, whose parents were both employed and 
whose mothers were private patients. These results are consistent with the US population-
based study that reported low T1D risk in disadvantaged children.32 Higher T1D incidence 
in advantaged children could possibly be due to differences in lifestyle and health behaviour 
such as living in less crowded homes, caesarean-section, and breast-feeding/weaning 
practices not measured in this study. Caesarean-sections have been linked to T1D potentially 
via the microbiome and perinatal stress, although evidence is mixed.314 Household crowding 
has been associated with lower T1D incidence95, perhaps due to more microbial contact 
resulting in immune stimulations. Other studies link increasing T1D incidence to reduced 
herd-immunity to enterovirus infections, because early enterovirus and other viral infections 
have been associated with high T1D risk.106 This is supported by findings of a reduction in 
maternal enterovirus antibody levels over 20 years in Finland and Sweden while T1D 
incidence has increased in these countries during this period, possibly reflecting a lower 
immunity for fetal/infant enterovirus infections.109 Additionally, families with both parents 
employed may eat more processed and ready-to-eat food due to time scarcity. Children of 





can be linked with the accelerator or beta-cell-stress hypothesis, where environmental factors 
leading to fast growth/overweight can exhaust pancreatic beta-cells, which eventually fail 
due to a secondary autoimmune reaction.106  
The area-level measure of socioeconomic conditions (IRSAD) used in this study showed 
lower T1D incidence in the most advantaged areas compared to the most disadvantaged areas 
of SA, however, there was no dose-response pattern across the five IRSAD quintiles (most 
disadvantaged to most advantaged). Similar to our findings, low T1D incidence was observed 
in the most advantaged areas in Germany.304 Contrary to our area-level findings many 
previous studies 73, 95, 105 reported high T1D incidence in affluent areas. However, they have 
used different measures of area-level socioeconomic position, ranging from a few separate 
variables to combinations of different variables to create an index, such as the Townsend 
deprivation index in the UK151 and the Index of Relative Socioeconomic Disadvantage 
(IRSD) in WA.73 Both the Townsend deprivation index (unweighted sum of employment, 
car ownership, home ownership, overcrowding) and IRSD (weighted sum of socioeconomic 
variables representing disadvantage) are measures of disadvantage, and are slightly different 
measures than the IRSAD (which takes in to account area-level indicators of advantage and 
disadvantage). There have also been two studies from England using the Townsend 
deprivation index that have reported inconsistent findings even with the same index.99, 151 
Similarly, two Western Australian studies (200673, 2007152) reported inconsistent results 





birth or diagnosis. Together, these results suggest that small area-level socioeconomic 
measures may not be a consistent indicator of T1D risk.  
The area-level variation in T1D incidence observed in our study could be due to differences 
in individual characteristics. Individual characteristics not measured in this study that might 
have an effect on T1D incidence include genetic make-up, the pre-and-postnatal nutritional 
environment and other factors affecting parental health behaviour, such as income. It is 
possible these play a more crucial role than the small area environment. In the context of the 
hygiene hypothesis, country-level affluence and determinants of overall health such as 
hygiene, sewerage systems, and clean water supply may help explain the wide range of global 
T1D incidence, and increasing T1D incidence corresponding to country level socioeconomic 
improvements.54, 105 Area-level socioeconomic differences within a high income country like 
Australia do not necessarily reflect a large difference in hygiene, sewerage or clean water 
accessibility. Therefore, the hygiene hypothesis might not be relevant in countries like 
Australia where baseline levels of hygiene are high. This is supported by a Swedish study 
that used multilevel analysis and demonstrated that administrative areas (counties, 
municipalities) have minor relevance for individual risk of T1D in Sweden316, because 
differences disappeared after adjusting for individual-level factors.  Moreover, national 
reports show individual socioeconomic variation within each IRSAD deciles, suggesting 





We found that children born to Aboriginal or Torres Strait Islander mothers have lower T1D 
incidence compared to Caucasians and others, consistent with national reports.62 A higher 
proportion of Aboriginal or Torres Strait Islander people experience socioeconomic 
disadvantage, and are more likely to live in overcrowded households compared to non-
Aboriginal Australians.317 Both household crowding and socioeconomic disadvantage have 
been associated with lower T1D incidence.32, 95, 96 Ethnic disparities in T1D incidence have 
also been reported in the US (higher incidence in white-Americans than other ethnicities).32  
T1D incidence was lower among children whose mothers smoked during pregnancy. Least 
advantaged mothers are more likely to smoke during pregnancy, and disadvantage has been 
linked with lower T1D incidence.96 
This large whole-of-population study brings together multiple data sources to enable 
investigation of area and individual-level characteristics among children with T1D. As the 
study only includes data from public hospitals, it is possible that children who are diagnosed 
and treated for T1D in a private setting may be misclassified, however there are a number of 
reasons why case ascertainment is high. The incidence in this study (23 per 100,000 person-
years among children aged ≤11-year-olds) is consistent with a report of national diabetes 
register data (24 per 100,000 population for 0-14-year-olds).62 In a similar study in WA, 
99.6% of T1D cases in a national diabetes register were ascertained by capture-recapture 
method in hospital  data.73 In SA, children with incident T1D diagnosis will normally be 





hospital with a paediatric endocrinology and diabetes service for children, which is included 
in these data. Furthermore, children are included in the case definition even when they are 
admitted for reasons other than T1D (e.g. injury), as T1D is included in their additional 
diagnosis codes.  
4.2.7 Conclusion 
In this large population study, area and individual-level measures of socioeconomic 
condition were not consistently associated with T1D in SA. There was no clear area-level 
socioeconomic patterning of T1D. However, individual-level socioeconomic indicators 






























T1D, Type 1 diabetes; IRSAD, Index of Relative Socioeconomic Advantage and 
Disadvantage 
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Figure 4-2: Age-specific incidence of T1D per 100,000 population in South Australia, born 












































Table 4-1: Characteristics of children with type 1 diabetes in South Australia born 2002-
2013 with hospitalizations until 2014 (N=231,685: 231,352 Non T1D; 333 T1D) 
  Person time T1D, n IR    (95% CI) 
Mother's age (years)      
<25  288982.4 66 22.9 (17.7-29.1) 
25-29  408222.5 88 21.5 (17.2-26.5) 
30-34  465326.9 112 24.1 (19.9-29.1) 
≥35  281224.4 67 23.8 (18.4-30.2) 
Father's age (years)      
<25  162754.8 39 24.1 (17.1-32.9) 
25-29  322821.6 69 21.2 (16.5-26.9) 
30-34  468428.1 103 21.9 (17.9-26.6) 
≥35  489751.6 122 25.0 (20.8-29.9) 
Parents' employment       
Both unemployed 1 04902.7 21 20.0 (12.3-30.6) 
One parent employed  425959.3 75 17.6 (13.8-22.0) 
Both employed  912894.2 237 26.0 (22.8-29.5) 
Mother’s healthcare status      
Private  470721.7 122 26.0 (21.6-31.1) 
Public  973034.5 211 21.6 (18.8-24.8) 
Hospital category      
Private  384961.7 94 24.4 (19.7-29.9) 
Public 1058794.0 239 22.6 (19.8-25.6) 
Antenatal visits      
<7 visits   118222.0 20 17.3 (10.6-26.6) 
7-14 visits 1157203.0 270 23.3 (20.6-26.3) 
>14 visits   168331.3 43 25.2 (18.2-34.1) 
Maternal smoking       
No smoking  1180970.0 282 23.8 (21.1-26.8) 
Smoking   262785.8 51 19.6 (14.6-25.7) 
Mother's Ethnicity      
Caucasian  1272363.0 312 24.5 (21.9-27.4) 
Aboriginal or Torres Strait Islander ** ** 7.5 (1.5-21.8) 
Asian and other ** ** 13.8 (8.1-21.9) 
IRSAD quintile      
Most disadvantaged (1)  381984.0 90 23.5 (18.9-28.9) 
2nd quintile  320913.1 62 19.4 (14.9-24.9) 
3rd quintile  249842.7 65 26.1 (20.1-33.2) 
4th quintile  288934.4 77 26.5 (20.9-33.1) 
Most advantaged (5)  202082.1 39 19.4 (13.8-26.5) 
Remoteness      
Major cities 1044753.0 239 22.9 (20.1-26.0) 
Inner regional   138163.5 36 25.8 (18.0-35.8) 
Outer regional/remote    260839.7 58 22.4 (17.0-29.0) 
T1D, Type 1 diabetes; IR, Incidence rate per 100,000 person-years; IRSAD, Index of Relative Socioeconomic Advantage 





Table 4-2: (Supplementary Table) Response Sample: Characteristics of children with type 
1 diabetes 
    NON-T1D T1D cases       
  N % N %  IR (95% CI) 
Mother's age (years) 231352   277     
<25 45013 19. 5 56 20.2  19.4 (14.9-25.2) 
25-29 66011  28.5 72 25.9 17.6 (14.0-22.2) 
30-34 73945 32.0 94 33.9 20.2 (16.5-24.7) 
≥35 46383 20.1 55 19.9 19.6 (15.0-25.5) 
Father's age (years) 220742  268 
    
<25 22800 10.3 31 11.6 21.1 (14.9-30.1) 
25-29 48784 22.1 53 19.8 17.6 (13.4-23.0) 
30-34 71422 32.4 83 31.0 18.4 (14.8-22.8) 
≥35 77736 35.2 101 37.7 21.2 (17.5-25.8) 
Parents' employment  203622  243  
   
Both unemployed 14709 7.2 13 5.4 14.2 (8.3-24.5) 
One parent employed 59065 29.0 51 21.0 13.7 (10.4-18.0) 
Both employed 129848 63.8 179 73.7 22.3 (19.3-25.8) 
Mother’s healthcare status 230692  277 
    
Private 72690 31.5 99 35.7 21.1 (17.3-25.7) 
Public 158002 68.5 178 64.3 18.4 (15.8-21.3) 
Hospital category 230691  277     
Private 59558 25.8 80 28.9 20.8 (16.7-25.9) 
Public 171133 74.2 197 71.1 18.7 (16.2-21.5) 
Antenatal visits 214345  257 
    
<7 visits 17639 8.2 15 5.8 14.3 (8.6-23.7) 
7-14 visits 172479 80.5 209 81.3 19.7 (17.2-22.5) 
>14 visits 24227 11.3 33 12.8 21.3 (15.1-29.9) 
Maternal  smoking  227410  274 
 
   
No smoking  190108 83.6 230 83.9 19.8 (17.4-22.6) 
Smoking 37302 16.4 44 16.1 17.0 (12.7-22.9) 
IRSAD quintile 231193  277  
   
Most disadvantaged (1) 65389 28.3 78 28.2 20.5 (16.4-25.5) 
2nd quintile 52714 22.8 51 18.4 15.9 (12.1-20.9) 
3rd quintile 38783 16.8 54 19.5 21.6 (16.6-28.3) 
4th quintile 44805 19.4 64 23.1 22.2 (17.4-28.3 
Most advantaged (5) 29502 12.8 30 10.8 14.9 (10.4-21.2) 
Remoteness 231251  277     
Major cities  168673 72.9 199 71.8 19.1 (16.6-21.9) 
Inner regional  22050 9.5 29 10.5 21.0 (14.6-30.2) 






Table 4-3: (Supplementary Table) Complete cases (N=186174, Non-T1D n=185950, T1D 
cases n=224) Characteristics of children with type 1 diabetes 
  NON-T1D T1D cases       
  N % N % IR (95% CI) 
Mother's age (years)   
     
<25 32901 17.7 35 15.6 16.8 (12.1-23.5) 
25-29 54227 29.2 62 27.7 18.7 (14.6-24.0) 
30-34 61360 33.0 80 35.7 20.9 (16.8-26.1) 
≥35 37462 20.2 47 21.0 20.9 (15.7-27.8) 
Father's age (years)     
   
<25 18458 9.9 24 10.7 20.5 (13.8-30.6) 
25-29 41472 22.3 44 19.6 17.3 (12.9-23.3) 
30-34 60944 32.8 70 31.3 18.3 (14.5-23.2) 
≥35 65076 35.0 86 38.4 21.9 (17.7-27.0) 
Parents' employment      
   
Both unemployed 12285 6.6 11 4.9 14.6 (8.1-26.4) 
One parent employed 53522 28.8 47 21.0 14.0 (10.5-18.7) 
Both employed 120143 64.6 166 74.1 22.6 (19.4-26.3) 
Mother’s healthcare status    
   
 
Private 60874 32.7 85 38.0 21.8 (17.6-26.9) 
Public 125076 67.3 139 62.1 18.4 (15.6-21.7) 
Hospital category        
Private 52851 28.4 73 32.6 21.4 (17.0-26.9) 
Public 133099 71.6 151 67.4 18.8 (16.0-22.0) 
Antenatal visits   
     
<7 visits 11828 6.4 7 3.1 10.3 (4.9-21.5) 
7-14 visits 152681 82.1 186 83.0 19.8 (17.1-22.9) 
>14 visits 21441 11.5 31 13.8 22.5 (15.8-32.0) 
Maternal smoking      
  
 
No smoking  159543 85.8 188 83.9 19.5 (16.9-22.5) 
Smoking 26407 14.2 36 16.1 19.7 (14.2-27.3) 
IRSAD     
   
Most disadvantaged (1) 50663 27.3 51 22.8 17.6 (13.3-23.1) 
2nd quintile  42389 22.8 43 19.2 16.9 (12.5-22.8) 
3rd quintile 31607 17.0 50 22.3 24.8 (18.8-32.8) 
4th quintile 37211 20.0 56 25.0 23.7 (18.2-30.7) 
Most advantaged (5) 24080 13.0 24 10.7 14.7  (9.9-22.0) 
Remoteness        
Major Cities  137012 73.7 158 70.5 18.9 (16.1-22.1) 
Inner Regional  17765 9.6 26 11.6 23.4 (15.9-34.4) 






CHAPTER 5 CAESAREAN SECTION AND RISK OF TYPE 
1 DIABETES: WHOLE-OF-POPULATION STUDY   
 
5.1  Preface  
This Chapter contains the second paper contributing to this thesis. This paper has been 
published in Diabetic Medicine.  
This paper addresses the second questions of this doctoral thesis.  
What is the effect of caesarean birth on childhood type 1 diabetes? Does the risk of 
type 1 diabetes differ by prelabour and intrapartum caesarean? 
As mentioned in Chapter 2 that socioeconomic condition is major determinant of health, 
many risk factors of type 1 diabetes are socioeconomically patterned. For example, caesarean 
birth is more common among socioeconomically advantaged women. After studying the 
socioeconomic characteristics of children with type 1 diabetes in the first descriptive study, 
in study 2 (Chapter 5), I studied the association between caesarean birth and type 1 diabetes, 
using the SA ECDP data. First reason to explore this question was the rising incidence of 
type 1 diabetes and the parallel increasing rates of caesarean birth at national level in 
Australia.  Secondly, keeping the microbiome theory in mind, I wanted to explore the effect 
of caesarean birth occurring before and after the onset of labour because that may effect 





caesarean types (emergency and elective caesarean) on childhood type 1 diabetes. However, 
elective and emergency caesarean do not differentiate whether caesarean occurred before or 
after the onset of labour and after the rupture of membranes. Therefore, In Chapter 5, I 
explored the question whether type 1 diabetes risk differed for prelabour or intrapartum 

















The effect of caesarean birth on childhood type 1 diabetes is negligible. Similarly, for the 
effect of intrapartum caesarean on type 1 diabetes. Together this suggests that the differences 
in the neonatal microbiota as a result of caesarean birth is unlikely to impact on type 1 






5.2 PUBLICATION 2:  Caesarean section and risk of type 1 diabetes: 
whole-of-population study   





















What is New? 
 
• Evidence about caesarean section and childhood type 1 diabetes risk is mixed. Only 
one study reported whether type 1 diabetes risk differs by prelabour or intrapartum 
caesarean. 
 
• A potential link between type 1 diabetes and caesarean section is lack of exposure to 
the vaginal microbiota. Prelabour caesarean births are not exposed to the vaginal 
microbiota, whereas intrapartum caesareans presumably have some exposure. 
 
• We found a negligible risk of type 1 diabetes for children who had intrapartum or 
prelabour caesarean, and the 95% CI were wide and included the null suggesting that 






5.2.2 Abstract    
 
Background  
A hypothesized mechanism for increased type 1 diabetes risk among caesarean births is lack 
of exposure to the vaginal microbiota. Children born by prelabour caesarean are not exposed 
to the vaginal microbiota, while caesarean births during labour (intrapartum) may be 
exposed. The aim of this study was to estimate type 1 diabetes risk among children born by 
caesarean compared with normal vaginal delivery. 
Methods 
This whole-of-population study linked routinely-collected, de-identified administrative data 
from the South Australian Early Childhood Data Project for all births from 1999-2013. Type 
1 diabetes cases were identified using inpatient hospitalisations from 2001-2014 (ICD-10-
AM codes E10-E109). Type 1 diabetes risk for caesarean was assessed by Cox regression 
using two models: 1) caesarean versus vaginal, 2) prelabour or intrapartum caesarean versus 
vaginal. Analyses were adjusted for confounding and multiple imputation was used to 
address missing data.  
Results 
A total of 286,058 children born 1999-2013 contributed to 2,200,252 person-years, of which 





were prelabour and 46.9% intrapartum caesarean. Compared with vaginal delivery, the 
adjusted hazard ratio for type 1 diabetes was 1.05 (95% confidence interval (CI) 0.86-1.28) 
for caesarean, 1.02 (95% CI 0.79-1.32) for prelabour caesarean, and 1.08 (95% CI 0.82-1.41) 
for intrapartum caesarean.  
Conclusion   
There may be a small increased type 1 diabetes risk following caesarean, but confidence 
intervals included the null. The lower estimate for prelabour compared with intrapartum 
caesarean, and the potential for unmeasured confounding suggest that neonatal vaginal 
microbiota might not be involved in type 1 diabetes.  
Keywords: Caesarean section, intrapartum and prelabour caesarean, type 1 diabetes, record 






5.2.3 Introduction  
 
Type 1 diabetes is an autoimmune disorder, characterized by destruction of insulin producing 
pancreatic beta-cells. The increasing incidence of childhood type 1 diabetes has been linked 
with environmental risk factors interacting with genetic predisposition. The rise in caesarean 
births in parallel with increasing type 1 diabetes incidence is one reason caesarean births have 
been suggested as a risk factor for type 1 diabetes. For example, the average global annual 
increase in caesarean births was 4.4% from 1990 to 201418, and from 1990-1999 the Diamond 
project6 reported a 2.8% annual global increase in type 1 diabetes incidence.  However, not 
all countries with higher caesarean rates have high type 1 diabetes incidence. Brazil161 and 
China162 have caesarean rates of 77% and 46% respectively, but relatively low type 1 diabetes 
incidence (12.8 and 1.01 per 100,000 person-years, respectively).8, 150 Australia has high 
childhood type 1 diabetes incidence (24.4 per 100,000 population, aged <15 years)175, as well 
as caesarean rates (33% in 2015)318 more than double the World Health Organization 
recommendation of 10-15%.319   
It has been hypothesized the neonatal gut microbiota is a link between caesarean births and 
type 1 diabetes, as early microbial contact may influence the development of the immune 
system.133 During a normal vaginal delivery, the neonate is exposed to the vaginal and 
gastrointestinal microbiota of the mother.320 Children born by caesarean, particularly 
prelabor caesarean, are not exposed to vaginal microbiota and their gut microbial 





bacterial colonisation patterns differ among neonates born by emergency caesarean, elective 
caesarean and natural birth.156  
There are inconsistent findings about the association between caesarean birth and type 1 
diabetes risk. Multiple studies of varying designs (case-control, meta-analysis) have reported 
20-30% increased type 1 diabetes risk for caesarean birth.25 However, larger population-
based cohort studies with better control of confounding, found null or small associations 
between caesarean birth and type 1 diabetes.20-22 A Norwegian cohort study 22 and a Swedish 
case-control study 23 reported a 6% and 2% increased type 1 diabetes risk for caesarean birth, 
respectively. A Swedish sibling-design study reported a small relative risk for type 1 diabetes 
of 1.06 for elective and emergency caesarean compared with vaginal birth.20 A Danish cohort 
study distinguished whether caesarean occurred before or during labour and demonstrated no 
type 1 diabetes risk for intrapartum (during labour) and a small risk for prelabor caesarean. 
21 Therefore, for the present study, we separated prelabor and intrapartum caesarean births 
under the assumption children born by prelabor caesarean are not exposed to the maternal 
vaginal microbiota, whereas births by intrapartum caesarean have some exposure if the 
membranes have ruptured. The objective of this study was to estimate the association 
between caesarean birth and type 1 diabetes risk, and to see whether the risk differed by 







5.2.4 Materials and methods 
 
5.2.4.1 Study design and population 
Routinely collected, de-identified government administrative linked data from the South 
Australian Early Childhood Data Project (1999-2013)256 was used in this whole-of-
population study (Figure 5-1). The characteristics of the South Australian population are 
reflective of the Australian population.318   
Datasets were linked by SA NT Datalink, an independent agency, using a probabilistic 
linkage algorithm to match children across datasets using demographic information such as 
name, sex, date of birth, and address. Data custodians provide de-identified data to the 
researchers following data linkage. Australian data linkage systems typically estimate around 
0.1% false linkage rates.271   
5.2.4.2 Type 1 diabetes 
Type 1 diabetes information was sourced from hospitalisation data (2001-2014) from all 
South Australian public hospitals. Children with type 1 diabetes were identified from their 
first type 1 diabetes related hospitalisation, using International Classification of Disease, 10th 
edition, Australian Modification (ICD-10-AM) codes (E10, ranging E101 to E109) for 
primary and secondary diagnoses.264 Trained staff use these ICD-10-AM codes as reporting 





5.2.4.3 Method of delivery 
Information on delivery method (normal spontaneous and instrumental vaginal deliveries, 
elective and emergency caesarean) and onset of labour (spontaneous, no labour and 
induction) was obtained from South Australian Perinatal Statistics Collection259 for all 
children in South Australia, born from 1999-2013. This is a mandatory collection of perinatal 
information of all births at hospital or home. This information collected by neonatal 
nurses/midwives, when validated against an audit of medical records, was highly accurate in 
capturing perinatal information.261 Perinatal data was validated and supplemented with Births 
Registration data. Prelabour caesarean included all caesareans in the absence of spontaneous 
or induced labour, and intrapartum caesarean included all elective and emergency caesareans 
performed after spontaneous or induced labour.  
5.2.4.4 Confounding 
Based on previous studies and literature, potential confounding was identified a priori using 
a directed acyclic graph (Figure 5-2, Supplementary). Confounding factors were sourced 
from the South Australian Perinatal Statistics Collection259, and supplemented by Births 
Registration data. Parental characteristics included parents’ age, maternal pre-existing (type 
1 and  type 2 diabetes) or gestational diabetes (yes/no), hypertension (yes/no), smoking at 
first antenatal visit (smoker, quit before first visit, non-smoker), maternal birth region 
(Oceania, Europe, and Africa, Asia, America), mother’s ethnicity (White European ancestry, 





public or private hospital of birth, and number of antenatal visits (continuous variable). 
Parents’ highest occupation (four categories; I) Managers, administrators and professionals, 
II) Para-professionals, tradespersons, clerks, salespersons, and personal service, III) Plant, 
machine operators, drivers and labourers, IV) Students, pensioner, home duties and 
unemployed) was also included. Other child-related factors included are birth order (1st, 2nd, 
3rd, ≥4th child), birthweight for gestational age z-score (calculated using Australian 
birthweight standards321), area-level socioeconomic disadvantage (Index of Relative 
Socioeconomic Advantage and Disadvantage, IRSAD 305), and remoteness (measured using 
the Australian Remoteness Index for Areas, ARIA).322 Maternal body mass index (BMI) at 
first antenatal visit (BMI<25, 25-<30, ≥30 kg/m2) was only included in the sensitivity 
analyses, due to high proportion of missing data as it was not routinely collected until 2007. 
5.2.4.5 Statistical analysis 
Crude and adjusted hazard ratios (HR) for the risk of type 1 diabetes for children born by 
caesarean section was assessed by Cox regression using two models: 1) caesarean versus 
vaginal delivery, 2) prelabour or intrapartum caesarean versus vaginal delivery. Cox 
proportional hazard regression was used to account for differences in observation time. For 
instance, children born in 1999 were observed for 15 years and 2013 births were observed 
for one year, and the mean observation time was eight years. Children were followed from 





proportional hazard assumption was checked by the Schoenfeld residual test, and it 
demonstrated non-violation of the proportional hazard assumption.  
Five sensitivity analyses were performed to check if the association between caesarean and 
type 1 diabetes was similar to the main findings. The first sensitivity analysis was adjusted 
for maternal BMI in addition to other confounders. Maternal BMI was collected from 2007 
onwards and was not included in the main analyses. The second sensitivity analysis was 
restricted to singleton births, to make our study comparable with previous studies, which 
were conducted on singleton births.21 The third sensitivity analysis was restricted to children 
born from July 2001 to December, 2013 (similar starting point for hospital and births data), 
as hospital data was only available from July 2001 and any diagnosis of type 1 diabetes from 
1999 to mid-2001 may have been misclassified. The fourth sensitivity analysis was restricted 
to children born in South Australia, for whom we had more complete data. Lastly all the 
above reasons were combined, and analysis was restricted to singleton children who were 
born in South Australia from July 2001 to December 2013, with maternal BMI included in 
the model as a confounder.  
The exposure variable (delivery method) and confounding factors mentioned in Table 5-1 
had missing data ranging from 0.03% to 1.9%, except father’s age (4.6%), number of 
antenatal visits (8.7%) and maternal BMI (66.6%). Maternal BMI had a high proportion of 






Multiple imputation was performed to account for potential bias if the association was 
different for children with or without complete data.323 Multiple imputation by chained 
equation was performed, and 20 datasets were created with 50 iterations. All variables 
included in the adjusted and sensitivity analyses were included in the imputation model. 
Estimates were combined from the 20 imputed datasets following Rubin’s rules. 
The results from imputed analyses are presented. Imputed results were consistent with the 
complete case results that are provided in supplementary material (Table 5-4 and Table 5-5). 
All analyses were performed using Stata SE version 15.0 (Stata Corp, College Station, Texas, 
USA). 
The estimates and confidence intervals in our study are interpreted based on the American 
Statistical Association’s Statement on p-values.324  
5.2.4.6 Ethics Approval 
Ethics approval was granted by the Human Research Ethics Committees of the South 
Australian Department of Health (HREC/13/SAH/106), and the Aboriginal Health Council 








5.2.5  Results  
 
A total of 286,058 children born 1999-2013, contributed to 2,200,252 person-years, during 
which 557 children were diagnosed with type 1 diabetes. The incidence rate of type 1 diabetes 
for children born from 1999-2013 (aged ≤15 years) was 25.3 per 100,000 person-years. 
Among 286,058 children born from 1999-2013, 31.7% had a caesarean birth and 68.3% had 
a vaginal birth. Among 90,546 children who had a caesarean birth, 53.1% were prelabour 
and 46.9% were intrapartum caesarean (Figure 5-1). Type 1 diabetes was diagnosed 
following hospitalisation from 2001 to 2014 in 557 cases, of which 381 (68.5%) were a 
normal vaginal delivery, 89 (16.0%) were prelabour caesarean and 87 (15.6%) were 
intrapartum caesarean. 
Table 5-1 shows the sociodemographic and perinatal characteristics of children born by 
caesarean and vaginal delivery. There were differences in the characteristics of children born 
by caesarean compared with vaginal delivery. For example, children who had caesarean 
births were more likely to be from advantaged areas, born in private hospitals, their mother 
was more likely to have had private healthcare, pre-existing diabetes, hypertension, or high 
BMI (≥30 kg/m2).   
Table 5-2 illustrates the association of caesarean with type 1 diabetes, compared with vaginal 





delivery (crude HR = 1.09, 95% CI 0.90-1.33), which was attenuated after adjustment for 
confounding (HR = 1.05, 95% CI 0.86-1.28).  
Table 5-3 shows the risk of type 1 diabetes for caesarean types. Adjusted estimates show 
little evidence of increased type 1 diabetes risk for prelabour (HR = 1.02, 95% CI 0.79-1.32) 
and slightly higher risk for intrapartum caesarean (HR = 1.08, 95% CI 0.82-1.41) compared 
with vaginal delivery, but confidence intervals were wide.   
The association between caesarean and type 1 diabetes was similar to the main analysis in 
the five sensitivity analyses (Table 5-6, Supplementary) when restricted to singleton infants, 
children born in South Australia with available perinatal and birth data, and 2001-2013 births 
with similar data commencement periods for births and hospitalisation. Inclusion of maternal 
BMI as a confounder did not change the findings. Finally, restricting the analysis to singleton 
children who were born in South Australia from 2001-2013, and including maternal BMI in 
the model, showed a similar pattern as the main findings and had wide confidence intervals.  
 
5.2.6 Discussion  
 
This study compared the risk of type 1 diabetes for children born by caesarean with children 
who had normal vaginal birth, in a population-based cohort born from 1999-2013 (aged ≤15 





compared to vaginal delivery, but 95% CIs were wide and included the null. Contrary to what 
we had hypothesized (higher type 1 diabetes risk for prelabour than intrapartum caesarean), 
the estimates showed a slightly higher type 1 diabetes risk for intrapartum caesarean (8%) 
than prelabour caesarean (2%). This reversal of expected risk, together with wide confidence 
intervals and the potential for unmeasured confounding suggest the small increased type 1 
diabetes risk for caesarean birth may be due to unmeasured confounding.   
Contrary to our findings of a small increased type 1 diabetes risk, a meta-analysis (including 
children aged 0-14 years in 18 out of 20 studies) reported around 20% increased type 1 
diabetes risk for caesarean births.25 The meta-analysis of 20 studies included 17 case-control 
studies with limited information on potential confounding, and notably only eight studies 
adjusted for maternal type 1 diabetes.25 Our findings of 5% increased type 1 diabetes risk for 
caesarean birth are consistent with large population-based studies in Sweden (odds ratio (OR) 
= 1.02, 95% CI 0.94-1.10)23, and Norway (rate ratio = 1.06, 95% CI 0.91-1.23)22 that adjusted 
for similar confounding factors, and included similar age ranges (0-19 years, 0-15 years). A 
Swedish population-based study (type 1 diabetes = 10,428, aged <15 years) reported 15% 
increased type 1 diabetes risk for elective caesareans (relative risk = 1.15, 95% CI 1.06-1.25), 
which attenuated to 6% (relative risk = 1.06, 95% CI 0.85-1.31) in the sibling-design analysis, 
with wide confidence intervals that include the null. This attenuation in the sibling study also 
suggests the potential for residual confounding. However, the 2% (relative risk = 1.02, 95% 
CI 0.95-1.11) increased type 1 diabetes risk for emergency caesarean changed to 6% (relative 





interpret.20 Also consistent with our findings, a Danish nationwide population-based study 
(type 1 diabetes ~ 4,000, aged <15 years) reported a small increased risk of type 1 diabetes 
for prelabour (HR = 1.1, 95% CI 0.95-1.2), and no risk for intrapartum (HR = 1.0, 95% CI 
0.89-1.1) caesarean births.21 
The speculated mechanism between caesarean and type 1 diabetes risk comes from studies 
demonstrating disparity in the gut microbiota of children who had caesarean section versus 
vaginal birth, which was thought to impact immune development.156 Gut microbiota 
composition of children with type 1 diabetes also differs from that of healthy children.142  
However, our study findings do not support the theory that exposure to the maternal vaginal 
microbiota during birth plays a role in type 1 diabetes risk, as the risk for prelabour would be 
higher if vaginal microbiota were involved. It is possible that previously reported neonatal 
disparities in gut microbiota composition related to delivery method could be temporary 
changes and may not induce long term type 1 diabetes risk. In support of this, a study found 
delivery method was associated with different gut bacterial colonisation at one week across 
caesarean and normal vaginal deliveries, but these differences became less prominent at one 
month and almost disappeared by one year of age.156 Additionally, apart from the islet-
autoantibodies acquired from mothers’ placenta, islet-autoantibodies rarely appear before age 
6-months,325 which could suggest there is no involvement of the neonatal microbiota 
inherited at the time of birth in the initiation of type 1 diabetes. Previously observed 
disparities in the gut microbiota of children with and without type 1 diabetes may not be due 





an intense phase of remodelling, and by age 3-years it transitions to an adult-like 
composition.133 Therefore, other potential risk factors such as breastfeeding, dietary 
practices, medications, or infections might play a more important role in altering the 
microbiota composition of children,133 who develop type 1 diabetes.  
In our whole-of-population study, linkage of perinatal and hospital data enabled us to account 
for a wide range of confounding factors. Furthermore, routine collection of perinatal data at 
birth using a standardized tool provided precise and well documented detail of the 
confounding factors, minimising recall-bias. However, as with all observational studies 
unmeasured confounding remains possible. Although we included a wide range of parental 
and child characteristics to reduce confounding, we did not have data on maternal 
autoimmune conditions, maternal infections, and father’s type 1 diabetes. Father’s type 1 
diabetes is strongly associated with childhood type 1 diabetes, and may potentially impact 
caesarean delivery through socioeconomic conditions. When Clausen et al.21 adjusted for 
father’s type 1 diabetes, it did not change their estimate, possibly because the link between 
father’s type 1 diabetes and caesarean is weak. As we have adjusted for a range of 
socioeconomic variables, we have attempted to block the potential confounding path from 
father’s type 1 diabetes to caesarean birth (Figure 5-2, Supplementary). In addition, our 
estimates for intrapartum caesarean may be confounded by indication as maternal infection 
(for example group B streptococcus, GBS) may cause prelabour rupture of membranes and 





mothers, or mothers with prolonged rupture of membranes, to GBS prophylactic antibiotics 
may also affect the neonatal microbiota and the child’s risk of type 1 diabetes.326 
Our study only included children attending public hospitals in South Australia, so we may 
have missed children that have never attended public hospitals. However, we believe that 
case ascertainment is high, because there is one paediatric public hospital in South Australia 
with a specialised endocrinology unit, where children are admitted for stabilization after 
diagnosis with type 1 diabetes. In addition, by using primary and secondary ICD-10-AM type 
1 diabetes diagnoses codes, we have identified children with type 1 diabetes admitted to 
hospital for other reasons (e.g. injury), as type 1 diabetes is included as their secondary 
diagnoses. High case ascertainment is substantiated after comparing the incidence reported 
here (25.3 per 100,000 person-years) with national registry data (24.4 per 100,000 
population) collected from 2000 to 2016.175   
In this whole-of-population study, results indicated there was a small increased risk of type 
1 diabetes for all caesarean births, but confidence intervals were wide and included a null 
effect. The small estimates, and lower type 1 diabetes risk for prelabour caesarean than 
intrapartum caesarean suggest our findings do not support the theory that birth method 







5.2.7 Tables and Figures 
 
Figure 5-1:  Flow chart of the study population. IRSAD (Index of Relative Socioeconomic 
Advantaged and Disadvantaged), BWGA (birthweight for gestational age), SA (South 







Figure 5-2: (Supplementary Figure) Directed acyclic graph (DAG) showing proposed 
confounding structure  
Exposure = Caesarean birth  
Outcome = Childhood type 1 diabetes   
Confounders = Adjusted for in our model    





Path showing unmeasured confounding =  
Link between maternal infection and childhood type 1 diabetes (not a confounder)   
• As shown in the DAG, adjusting for socioeconomic variables (parent’s 
employment, remoteness, and area-level index of socioeconomic advantage and 
disadvantage) potentially blocked the path from father’s type 1 diabetes to 
caesarean births.  
• Maternal infection, maternal autoimmune conditions, and birth complications 
remain possible causes of unmeasured confounding.  
• Birthweight and gestational age are not mediators and colliders, they are 
confounders and effect both the exposure (caesarean birth) and the outcome 






Table 5-1: Sociodemographic and perinatal characteristics of children/parents by delivery 
method (N = 286,058) 
Characteristics Vaginal Delivery Caesarean delivery 
  N = 195,512  (%) N = 90,546    (%) 
Type 1 diabetes      
    No 195,131 (99.8) 90,370 (99.8) 
    Yes 381 (0.2) 176 (0.2) 
Mother's age (years)* 28.96 ± 5.6 30.65 ± 5.5 
Father's age (years)* 32.31 ± 6.5 33.63 ± 6.5 
BWGAZ* -0.04 ± 0.9 0.07 ± 1.1 
Number of antenatal visits* 10.36 ± 2.9 10.60 ± 2.9 
Maternal diabetes (gestational or pre-
existing)     
    No 186,786 (96) 83,236 (92) 
    Yes 8,726 (4.5) 7,310 (8.1) 
Maternal hypertension     
    No 182,228 (93) 80,085 (88) 
    Yes 13,284 (6.8) 10,461 (12) 
Mother BMI     
    <25 kg/m2 (underweight and 
normal) 106,740 (55) 38,376 (42) 
     25 – <30 kg/m2 (overweight) 50,718 (26) 25,846 (29) 
     ≥30 kg/m2  (obese/severely obese) 38,054 (20) 26,324 (29) 
Maternal smoking     
    Smoker 36,438 (19) 13,973 (15) 
    Quit in pregnancy before first visit 7,753 (4.0) 3,716 (4.1) 
    Non-smoker 151,321 (77) 72,857 (81) 
Birth order     
    1st child 79,841 (41) 40,037 (44) 
    2nd child 67,879 (35) 32,175 (36) 
    3rd child 30,056 (15) 12,411 (14) 
    ≥4 child 17,736 (9.1) 5,923 (6.6) 
Parent's highest occupation      
    Managers and professionals 76,112 (39) 39,439 (44) 
    Para professionals, tradesperson  73,802 (38) 34,066 (38) 
    Machines operators, drivers, 
labourers 23,362 (12) 9,386 (10) 





Mother's birth region     
    Oceania and Antarctica 163,343 (84) 75,478 (83) 
    Europe 13,723 (7.1) 6,183 (6.8) 
    Africa, Asia, Americas 18,446 (9.4) 8,885 (9.8) 
Hospital category     
    Private 42,819 (22) 29,670 (33) 
    Public 152,693 (78) 60,876 (67) 
Healthcare of mother     
    Private 52,838 (27) 35,530 (39) 
    Public 142,674 (73) 55,016 (61) 
Remoteness     
    Major cities of South Australia 141,024 (72) 66,543 (74) 
    Inner regional South Australia 19,323 (9.9) 7,985 (8.8) 
    Remote and very remote South 
Australia 35,165 (18) 16,018 (18) 
IRSAD quintile     
     Most disadvantaged (1) 56,179 (29) 23,328 (26) 
     2nd quintile 43,731 (22) 19,966 (22) 
     3rd quintile 32,664 (17) 14,888 (16) 
     4th quintile 37,132 (19) 18,773 (21) 
     Most advantaged (5) 25,806 (13) 13,591 (15) 
Mother's ethnicity     
    White European ancestry 169,538 (87) 79,033 (87) 
    Aboriginal or Torres Strait Islander 5,817 (3.0) 2,548 (2.8) 
    Asian, other 20,157 (10) 8,965 (10) 
*Data presented are mean ± SD, all others are n (%) 
IRSAD (Index of Relative Socioeconomic Advantage and Disadvantage) 
BWGAZ (Birthweight for gestational age z-score) 








Table 5-2: Method of delivery and risk of type 1 diabetes (n = 286,058, type 1 diabetes = 
557) 
  Unadjusted  Adjusted  
  HR (95% CI) HR (95% CI) 
     
Vaginal delivery Ref  Ref  
All caesarean births 1.09 (0.90-1.33) 1.05 (0.86-1.28) 
 Adjusted for birthweight for gestational age z score, parental age, 
 parental occupation, maternal diabetes and hypertension,  
 maternal region of birth, maternal ethnicity, IRSAD, remoteness, 
 birth at public or private hospital, child’s birth order, private or  







Table 5-3: Caesarean type and risk of type 1 diabetes (n = 286,058, type 1 diabetes = 557) 
  Unadjusted  Adjusted  
  HR (95% CI) HR (95% CI) 
Vaginal delivery  Ref  Ref  
Intrapartum caesarean  1.12 (0.87-1.45) 1.08 (0.82-1.41) 
Prelabour caesarean 1.06 (0.83-1.36) 1.02 (0.79-1.32) 
Adjusted for birthweight for gestational age z score, parental age, 
parental occupation, maternal diabetes and hypertension, maternal 
region of birth, maternal ethnicity, IRSAD, remoteness, birth at 
public or private hospital, child’s birth order, private or public  






Table 5-4: (Supplementary Table) Complete case analysis: Sociodemographic and 
perinatal characteristics of children/parents by method of delivery  
Perinatal and socioeconomic 
characteristics 
        Vaginal Delivery  Caesarean Delivery 
             N                 (%)       N (%) 
Type 1 diabetes 194,861  90,196 
 
No 194,539 (99.8) 90,050 (99.8) 
Yes 322 (0.2) 146 (0.2) 
Mother's age (years)* 194,861  90,198 
 
 28.9 ± 5.6 30.6 ± 5.5 
Father's age (years)* 185,124  86,890  
 32.4 ± 6.5 33.7 ± 6.4 
Number of antenatal visits* 179,376  81,663  
 10.4 ± 3.0 10.6 ± 2.9 
BWGAZ*   193,830  90,184  
 -0.04 ± 1.0 0.07 ± 1.1 
Maternal diabetes  
(gestational and pre-existing) 194,861  90,198 
 
No 186,168 (96) 82,919 (92) 
Yes 8,693 (4.5) 7,279 (8.1) 
Maternal hypertension 194,861  90,198 
 
No 181,617 (93) 79,772 (88) 
Yes 13,244 (6.8) 10,426 (12) 
Maternal BMI 64,431  31,004  
<25 kg/m2 (underweight and normal) 34,264 (53) 12,668 (41) 
25 – <30 kg/m2 (overweight) 17,034 (26) 8,741 (28) 
≥30 kg/m2 (obese/severely obese) 13,133 (20) 9,595 (31) 
Maternal smoking 192,261  88,513  
Smoker 35874 (19) 13,686 (16) 
Quit in pregnancy before first visit 7,633 (3.9) 3,651 (4.1) 
Non-smoker 148,754 (77) 71,176 (80) 
Child’s birth order 194,861  90,198  
1st child 79,609 (41) 39,917 (44) 
2nd child 67,656 (35) 32,048 (36) 
3rd child 29,939 (15) 12,346 (14) 
≥4 child 17,657 (9.0) 5,887 (6.5) 






Managers and professionals 75,515 (39) 39,139 (44) 
Para professionals, tradesperson  73,397 (38) 33,897 (38) 
Machines operators, drivers , labours 23,228 (12) 9,332 (10) 
Students and pensioners and unemployed 22,078 (11.4) 7,590 (8.4) 
Mother's region of birth 194,826  90,184  
Oceania and Antarctica 162,807 (84) 75,195 (83) 
Europe 13,659 (7.0) 6,145 (6.8) 
Africa, Asia, Americas 18,360 (9.4) 8844 (9.8) 
Hospital category 194,860  90,198  
Private 42,620 (22) 29,514 (33) 
Public 152,240 (78) 60,684 (67) 
Healthcare of mother 194,861  90198  
Private 52,594 (27) 35,349 (39) 
Public 142,267 (73) 54,849 (61) 
Remoteness 194,779  90,149  
Major cities of South Australia 140,497 (72) 66,255 (75) 
Inner regional South Australia 19,218 (9.9) 7,935 (8.8) 
Remote & very remote South Australia 35,064 (18) 15,959 (18) 
IRSAD-quintile 194,693  90,124 
 
Most disadvantaged (1) 56,006 (29) 23,249 (26) 
2nd quintile  43,578 (22) 19,889 (22) 
3rd quintile 32,511 (17) 14,814 (16) 
4th quintile 36,954 (19) 18,673 (21) 
Most advantaged (5) 25,644 (13) 13,499 (15) 
Mother’s ethnicity  194,861  90,197  
White European ancestry 168,967 (87) 78,722 (87) 
Aboriginal and Torres Strait Islander 5,801 (3.0) 2,540 (2.8) 
Asians and others 20,093 (10) 8,935 (9.9) 
Data presented are mean ± SD, all others are n (%) 
IRSAD (Index of Relative Socioeconomic Advantage and Disadvantage) 








Table 5-5: (Supplementary Table) Complete case analysis: Caesarean birth, intrapartum 
and prelabor caesarean and risk of type 1 diabetes 
    
 (Unadjusted) (Adjusted) 
 (N = 285,057, T1D = 468) (N =  246,821, T1D =  410) 
        HR          (95% CI) HR (95% CI) 
Vaginal delivery  Ref  Ref  
All caesarean births 1.07          (0.88-1.31) 1.10    (0.89-1.37) 
     
Vaginal delivery  Ref  Ref  
Intrapartum caesarean  1.12         (0.87-1.44)  1.16     (0.89-1.54) 
Prelabor caesarean      1.04         (0.80-1.34) 1.04     (0.79-1.38) 
Adjusted for birthweight for gestational age Z score, parental age, parental occupation,  
maternal diabetes and hypertension, maternal region of birth, maternal ethnicity, IRSAD, 
remoteness, public or private hospital, child’s birth order,  private or public health care,  








Table 5-6: (Supplementary Table) Sensitivity analyses based on imputed data: Caesarean birth, intrapartum and prelabor caesarean 
and risk of type 1 diabetes 
  BMI included1  Singleton2 SA born3 2001-2013 births4 Combined5 
 (n = 286,058) (n =  277,215) (n =  285,969) (n = 240,646) (n = 233,145) 
  HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) 
       
    
Vaginal delivery Ref  Ref  Ref  Ref  Ref  
All caesarean births 1.05 (0.82-1.36) 1.08 (0.84-1.40) 1.06 (0.83-1.35) 1.08 (0.83-1.41)   1.17 (0.89-1.52) 
       
    
Vaginal delivery  Ref  Ref 
 Ref     Ref  Ref  
Intrapartum caesarean  1.08 (0.81-1.45) 1.09 (0.81-1.47) 1.10 (0.83-1.47) 1.07 (0.76-1.50) 1.15 (0.82-1.61) 
Prelabor caesarean 1.02 (0.74-1.41) 1.07 (0.77-1.49) 1.02 (0.75-1.38) 1.09 (0.78-1.51) 1.18 (0.85-1.65) 
1Adjusted for maternal BMI, along with others confounders mentioned in the main analysis (Table 2 and 3, Supplementary Table 2)  
2Restricted to singleton births, and adjusted for all confounders as model 1 
3Restricted to South Australian born children, and adjusted for all confounders as model 1 
4Only children born from July-2001 to December-2013 are included, and adjusted for all confounders as model 1 







CHAPTER 6 EFFECT OF MATERNAL SMOKING 
DURING PREGNANCY ON CHILDHOOD TYPE 1 





This Chapter contains the third study contributing to this thesis. This study was accepted for 
publication in Diabetologia at the time of thesis submission and published during 
examination.  And it addresses the third question of this doctoral thesis.  
 
What is the effect of maternal smoking in pregnancy on the risk of childhood type 1 
diabetes? What is the risk of bias due to residual confounding in the effect estimate? 
 
In Chapter 6, I studied the association between maternal smoking in pregnancy and risk of 
childhood type 1 diabetes, using a large (n=286,085) whole-of-population routinely-collected 
linked dataset from South Australia.  Similar to caesarean birth, maternal smoking is a 
potentially modifiable risk factor that has been linked with type 1 diabetes with inconsistent 
evidence.  Smoking during pregnancy has been linked with poorer health outcomes for the 





Some reports of epigenetic modifications among children as a results of maternal smoking 
during pregnancy, and role of nicotine as an immune suppressant and its transfer through 
placenta makes maternal smoking in pregnancy a potential candidate for childhood type 1 
diabetes pathogenesis.   
Australia has both high maternal smoking in pregnancy rates and type 1 diabetes incidence. 
However, maternal smoking in pregnancy is declining and type 1 diabetes incidence is rising. 
Understanding these somewhat paradoxical trends was one reason why I wanted to explore 
the relationship between maternal smoking in pregnancy and childhood type 1 diabetes 
incidence. In addition, previous studies had numerous methodological imitations, which 
could be explored using contemporary epidemiological methods to better understand the 







• Maternal smoking in pregnancy is suggested to be associated with a small reduced 
risk of childhood type 1 diabetes. 
 
• All studies in this area (including mine) face the issue of small numbers of children 
with type 1 diabetes exposed to maternal smoking in pregnancy, highlighting the 










6.2 PUBLICATION 3: Effect of maternal smoking during pregnancy on 
childhood type 1 diabetes: Whole-of-population study   






















What is already known about this subject?   
• Evidence is mixed about maternal smoking in pregnancy and risk of childhood type 
1 diabetes  
• Most case-control and population-based cohort studies reported reduced type 1 
diabetes risk for children exposed to maternal smoking in pregnancy 
What is the key question?   
• What is the effect of maternal smoking during pregnancy on risk of childhood type 1 
diabetes and what is the potential for bias in this effect due to unmeasured 
confounding?   
What are the new findings?  
• Maternal smoking in pregnancy was associated with 16% lower childhood type 1 
diabetes incidence 
• Our meta-analytic estimates demonstrated 28-29% reduced type 1 diabetes risk for 
children exposed to maternal smoking in pregnancy 
• The negative control analysis indicated that some of the observed effect of prenatal 
maternal smoking on childhood type 1 diabetes was due to residual confounding. The 





smoking and childhood type 1 diabetes with a HR of 1.67 could negate the observed 
effect.    
How might this impact on clinical practice in the foreseeable future? 
Maternal smoking in pregnancy is not recommended but the mechanism leading to 
















6.2.2 Abstract  
 
Aims/hypothesis 
Evidence of an association between maternal smoking during pregnancy (prenatal smoking) 
and childhood type 1 diabetes is mixed. Previous studies have been small and potentially 
biased due to unmeasured confounding. The objectives of this study were to estimate the 
association between prenatal smoking and childhood type 1 diabetes, assess residual 
confounding with a negative control design and an E-value analysis, and summarize 
published effect estimates from a meta-analysis.  
Method  
This whole-of-population study (births 1999-2013, aged ≤15-years) used de-identified linked 
administrative data from the South Australian Early Childhood Data Project. Type 1 diabetes 
was diagnosed in 557 children (ICD-10-AM codes, E10, E101-E109) during hospitalization 
(2001-2014). Families not given financial assistance for school fees was a negative control 
outcome. Adjusted Cox proportional hazard ratios (HR) were calculated. Analyses were 
conducted on complete-case (n = 264,542, type 1 diabetes = 442) and imputed (n = 286,058, 
type 1 diabetes = 557) data. A random-effects meta-analysis was used to summarize effects 
of prenatal smoking on type 1 diabetes.   





Compared with non-smokers, children exposed to maternal smoking only in the first or 
second-half of pregnancy had 6% higher type 1 diabetes incidence (adjusted-HR 1.06, 95% 
CI 0.73, 1.55). Type 1 diabetes incidence was 24% lower (adjusted-HR 0.76, 95% CI 0.58, 
0.99) among children exposed to consistent prenatal smoking, and 16% lower for exposure 
to any maternal smoking in pregnancy (adjusted-HR 0.84, 95% CI 0.67, 1.08), compared 
with unexposed group. Meta-analytic estimates showed 28-29% lower risk of type 1 diabetes 
among children exposed to prenatal smoking compared with those not exposed. The negative 
control outcome analysis indicated residual confounding in the prenatal smoking and type 1 
diabetes association. E-value analysis indicated that unmeasured confounding associated 
with prenatal smoking and childhood type 1 diabetes with a HR of 1.67 could negate the 
observed effect.    
Conclusions/interpretation 
Our best estimate from the study is that maternal smoking in pregnancy was associated 
with 16% lower childhood type 1 diabetes incidence, and some of this effect was due to 






6.2.3 Introduction  
 
Onset of type 1 diabetes can occur at any age, but many children who develop this condition 
have detectible autoantibodies targeting beta cell antigens within the first year of life45, 
suggesting that early exposures may have a role in the natural history of type 1 diabetes.145 
Increasing trends, country variation in global type 1 diabetes incidence (0.01 to 60 per 
100,000 per-year) and the type 1 diabetes discordance in monozygotic twins all suggest a 
role of non-genetic factors.3, 6, 11 An environmental exposure implicated in type 1 diabetes 
pathogenesis is maternal smoking during pregnancy. Mechanisms that link prenatal smoking 
and childhood type 1 diabetes are not understood but may be associated with altered gene 
expression or immune function. 87, 172  
Type 1 diabetes incidence has increased in many countries that are ranked in the top ten for 
type 1 diabetes incidence including Finland, Sweden, USA and UK3, 54 while prenatal 
smoking rates have declined or become stable in these countries in the last decade.19 In 
Australia, type 1 diabetes incidence among 0-14 year olds has increased from 21.5 per 
100,000 population in 2000, to 24.7 per 100,000 population in 2015 175, whilst prevalence of 
smoking during late pregnancy reduced from 17.3% in 2006 176 to 9.9% in 2016. 177 Previous 
studies of prenatal smoking and childhood type 1 diabetes reported mixed findings, 
demonstrating increased 26, decreased 29-31, and null type 1 diabetes risk.34 A Swedish HLA-





children exposed to prenatal smoking26, and a UK record-linkage study did not find any 
difference in the type 1 diabetes incidence between children exposed and unexposed to 
prenatal smoking.34 Conversely, large population-based cohort studies have demonstrated 
25-35% lower type 1 diabetes risk for children exposed to prenatal smoking.29, 30 These mixed 
findings of an association between prenatal smoking and childhood type 1 diabetes could be 
due to differences in confounding adjustments. Many population-based studies have adjusted 
for confounders such as maternal age26, 29-31, maternal deprivation or socioeconomic position, 
30, 31 birth order or parity,26, 29, 30 maternal education, pre-pregnancy BMI and diabetes, and 
some have adjusted for mediators.26, 30, 31 Some studies have not adjusted for father’s age, 
pre-pregnancy diabetes or hypertension, ethnicity or socioeconomic indicators, and one study 
excluded children whose mothers had pre-existing diabetes.26, 30, 31  Most studies on smoking 
during pregnancy and type 1 diabetes risk have small numbers of children exposed to 
smoking during pregnancy, ranging from 5 to 78 in population-based cohort studies 27, 29, 30 
and 29 to 258 in case-control studies.26, 31, 32, 309, 310, 327  Small sample sizes could be another 
reason for variable findings in previous studies, therefore, one way to obtain a more precise 
effect estimate of the prenatal smoking and type 1 diabetes association is to combine these 
estimates in a meta-analysis. 
The objectives of this study were: firstly to estimate the association between prenatal 
maternal smoking and childhood type 1 diabetes incidence with adjustment for a range of 
confounding factors defined a priori; secondly, to measure the potential for bias due to 










6.2.4.1 Study population and design  
We used data from the South Australian Early Childhood Data Project, which consists of 
routinely collected, de-identified, linked government administrative datasets.256 Datasets 
were linked by an independent agency (SA NT Datalink).269 Children were linked across 
datasets using a probabilistic algorithm that included demographic information such as name, 
date of birth, sex and address. A 0.5% false linkage rate has been reported in Australia.269 
This study used inpatient hospitalization data from July 2001 to June 2014, and perinatal and 
birth registration data from 1999-2013 (Figure 6-1).   
6.2.4.2 Type 1 diabetes 
Individuals with Type 1 diabetes (aged <15 years) were identified from inpatient 
hospitalization data from all public hospitals in South Australia (SA). Children with index 
type 1 diabetes hospitalizations were identified using International Classification of Disease, 





including both principal and additional diagnoses.264 Diagnoses codes were assigned to each 
hospitalisation episode by trained hospital staff.   
6.2.4.3 Maternal smoking during pregnancy 
Data on prenatal smoking was obtained from the South Australian Perinatal Statistics 
Collection 259 from 1999-2013. It is mandatory for perinatal statistics to be collected for every 
child born in South Australia. Data are collected by midwives or nurses using a standard data 
collection form. The perinatal data have been collected by the South Australian government 
since 1981 to track mother and child health indicators.177, 259 The data collection form has 
been validated against an audit of medical records.261    
Maternal smoking data were collected at the first antenatal visit (≤20 weeks gestation) and 
in the second-half of pregnancy (≥20 weeks gestation).259 Most women (74.3%) had their 
first antenatal visit before 14 weeks gestation.259 For the primary analysis smoking was 
categorized into non-smokers, smokers only in first or second half of pregnancy, and 
consistent smokers. For women who smoked only in the first or second half of pregnancy, 
no information is available on when they started or stopped smoking, therefore the duration 
of smoking is unclear. Due to small numbers of offspring with type 1 diabetes among women 
who smoked, smoking in pregnancy was dichotomized into non-smokers or smokers 






Confounders of the association between maternal smoking during pregnancy and type 1 
diabetes risk were identified a priori based on literature and by using a directed acyclic graph 
(Figure 6-2, Supplementary). Information on confounders was obtained from the South 
Australian Perinatal Statistics Collection.259 Parental characteristics included mother’s and 
father’s age (continuous variables), and parental highest occupation in four categories: (1) 
Managers, administrators and professionals;(2) Para-professionals, tradespersons, clerks, 
salespersons, and personal service; (3) Plant and machine operators, drivers and labourers; 
(4) Students, pensioner, home duties and unemployed. Maternal and child characteristics 
were maternal birth region (Oceania, Europe, or Africa, Asia or America), mother’s ethnicity 
(European decent; Aboriginal or Torres Strait Islander; Asian and other), whether mother 
was a private or public hospital patient, type of hospital where child was born 
(private/public), maternal pre-pregnancy hypertension (yes/no), pre-pregnancy diabetes 
(yes/no), parity (1st, 2nd, 3rd, and ≥4th) and the child’s year of birth. Area-level measures of 
socioeconomic conditions (Index of Relative Socioeconomic Advantage and Disadvantage, 
IRSAD), and remoteness and accessibility (Australian Remoteness Index for Areas) were 
based on mother’s postcode at the time of birth. Maternal BMI at the first antenatal visit (<25; 
25 to <30; ≥30 kg/m2) was included as a confounder only in sensitivity analysis as maternal 





6.2.4.5 Statistical Analysis  
The crude and adjusted association between prenatal smoking and childhood type 1 diabetes 
for both primary and secondary analyses was estimated by Cox proportional hazard 
regression, to account for differences in observation time across successive birth years. These 
analyses were conducted on both complete-case (Table 6-5, Supplementary) and imputed 
data (Table 6-2). Schoenfeld residual tests demonstrated non-violation of the proportional 
hazard assumption. Children were followed from birth until the diagnosis of type 1 diabetes 
or the end of follow-up (June 2014). The observation time ranged from one year (for 2013 
births) to 15 years (for 1999 births), with a mean follow-up of eight years.  
A negative control outcome analysis was used to investigate whether any association between 
maternal smoking in pregnancy and type 1 diabetes could be due to unmeasured confounding. 
285 Cox proportional hazard regression analysis estimated the association between maternal 
smoking during pregnancy and the family not having a school card for financial assistance 
with school fees. An assumption about negative control outcomes is that the measured and 
unmeasured confounding pattern for the association between maternal smoking and type 1 
diabetes is the same as for the maternal smoking and no school card association (called ‘U-
comparable’).285 There is no plausible reason for prenatal maternal smoking to directly cause 
a child to get a school card. If there is any association between maternal smoking in 
pregnancy and child not having a school card, it must be through confounders (e.g. 





(Figure 3-5 is given in Chapter 3). School card data was sourced from the school enrolment 
census and was provided by the Department of Education, South Australia.  Data were only 
available for children who had started school (complete-case analysis: n=277,370 [ no school 
card , n=84531]; imputed data: n=184,663[no school card, n= 149,670]).  
The E-value was calculated to measure the potential for bias due to unmeasured confounding 
in the prenatal smoking and type 1 diabetes association. The E-value quantifies the minimum 
strength of an association that an unmeasured confounder would need to have with the 
exposure and outcome to negate the observed association between prenatal smoking and type 
1 diabetes, given the measured confounders.288 The E-value for the CI quantifies the strength 
of an association that unmeasured confounding would need to have with prenatal smoking 
and the childhood type 1 diabetes, above and beyond the measured confounders, to change 
the CI to include the null.288 
Five sensitivity analyses were performed to see if the association between prenatal smoking 
and childhood type 1 diabetes was similar to the main findings. In the first sensitivity 
analysis, we examined whether adjusting for pre-pregnancy BMI (in addition to all other 
confounders) influenced the association between prenatal smoking and type 1 diabetes. 
Maternal BMI was only collected from 2007 onwards and therefore could not be included in 
the main analyses. The second sensitivity analysis was restricted to births from July-2001 to 
December-2013, as hospital data was only available from July-2001 and any diagnosis of 





only collected for South Australian born children, the third sensitivity analysis was restricted 
to children born in South Australia, for whom more complete data were available. The fourth 
sensitivity analysis was restricted to singleton births, to make our study comparable with 
previous studies that were conducted only on singleton births.29, 30 Finally, all the above were 
combined, and the analysis was restricted to singleton children born in South Australia from 
July-2001 to December-2013. All the sensitivity analyses were adjusted for maternal BMI 
along with all other confounders.   
The amount of missing information on the exposure and confounders in Table 6-1 ranged 
from 0.03% to 0.35%, except prenatal maternal smoking (3.0%), father’s age (4.6%), and 
maternal BMI (66.6%; not included in primary analysis). Multiple imputation by chained 
equations was conducted to maintain the association between prenatal smoking and 
childhood type 1 diabetes, and to account for potential bias if the association differs between 
children with and without complete data.290 The outcome variable (type 1 diabetes) was not 
imputed. The outcome variable, all variables in Table 6-1 and the sensitivity analyses, and 
the Nelson-Aalen estimator of the cumulative hazard were included in the imputation 
models.328 Summary statistics (Table 6-1) and estimates in Table 6-2 and 6-3 were derived 
by combining the 20 imputed datasets, using Rubin’s rules. Analysis from complete-case 






Even the largest studies investigating the effect of prenatal maternal smoking on type 1 
diabetes only included relatively small numbers of children with type 1 diabetes who were 
born to mothers who smoked during pregnancy (number ranging from 42 to 78 in population-
based cohort studies).29, 30 Therefore, estimates from individual studies are imprecise. To 
compute a more precise estimate, a meta-analysis of the current results with previous studies 
that reported an association between prenatal smoking and childhood type 1 diabetes was 
conducted in January 2019. PubMed, Web of Science, and EMBASE databases were 
systematically searched for studies on type 1 diabetes, maternal smoking during diabetes and 
related terms, without limiting year of publication. Population-based studies written in 
English that reported maternal smoking during pregnancy as the exposure, and overt or 
clinical type 1 diabetes in childhood (<19 years) as an outcome were included. Studies that 
reported beta cell autoimmunity (preclinical type 1 diabetes) as an outcome were excluded. 
Only population-based studies with some attempt to adjust for confounding were included in 
the analysis.   
Separate random-effects model were performed for the meta-analyses of population-based 
cohort and case-control studies. The meta-analysis of population-based studies pooled the 
HRs and the meta-analysis of the case-control studies pooled the odds ratios.  All population-
based-cohort studies reported HRs and all the case-control studies reported odds ratios. We 





Analyses were conducted in Stata SE version 15.0 (Stata Corp, College Station, Texas, USA).  
6.2.4.7 Ethics Approval  
Ethics approval was granted by the Human Research Ethics Committees of the South 
Australian Department of Health (HREC/13/SAH/106), and the Aboriginal Health Council 




A total of 286,058 children (aged ≤15 years) born from 1999-2013, contributed to 2,200,252 
person-years of data. During follow up 557 children were diagnosed with type 1 diabetes: an 
incidence of 25.3 per 100,000 person-years. Among 286,058 children, 62,216 were born to 
mothers who smoked during pregnancy.  
Of the 557 children diagnosed with type 1 diabetes from 2001 to 2014, 118 were exposed to 
maternal smoking during pregnancy, with 80 exposed to consistent smoking in both the first 
and second half of pregnancy. The crude type 1 diabetes incidence was 26.3 per 100,000 
person-years for children not exposed, and 22.2 per 100,000 person-years for children 





The numbers in Table 6-1 shows that overall, socioeconomically disadvantaged women, who 
were from low income occupations, living in most disadvantaged areas, younger at the child’s 
birth, and delivered in a public hospitals had higher prevalence of smoking during pregnancy. 
The distributions of these characteristics were similar in both the complete-case and imputed 
analyses (Table 6-1). There were numerically more socioeconomically disadvantaged 
women in the group that consistently smoked throughout pregnancy (Table 6-4, 
Supplementary).  
6.2.5.1 Primary and Secondary Analyses  
In the primary analysis (Table 6-2), following adjustment for confounding, type 1 diabetes 
incidence was 6% higher for children whose mothers smoked only in first-half or second-
half of pregnancy (HR 1.06, 95% CI 0.73,1.55), and 24% lower incidence for children 
exposed to consistent prenatal maternal smoking (HR 0.76, 95% CI 0.58, 0.99), compared 
with unexposed children. For smoking in the first or second-half of pregnancy, CIs were 
wide, ranged from 27% reduced to 55% increased type 1 diabetes incidence. For consistent 
smoking, CIs ranged from 42% reduced to almost no difference in type 1 diabetes incidence 
between children exposed and unexposed to maternal smoking.   
In secondary adjusted analysis, when the exposure included any smoking (first or second half 
of pregnancy, and consistent smoking), childhood type 1 diabetes incidence was 16% lower 





compared with those unexposed. Again, the confidence intervals were wide. Complete-case 
analyses showed similar associations (Table 6-5, Supplementary).  
6.2.5.2 Potential for unmeasured confounding  
The negative control outcome analysis (Table 6-3) demonstrated 15% reduced incidence of 
not having a school card (HR 0.85, 95% CI 0.83, 0.87) for children exposed to consistent 
prenatal maternal smoking, and 14% reduced incidence of not having a school card (HR 0.86, 
95% CI 0.85, 0.88) related to exposure to any maternal smoking in pregnancy after 
adjustment for confounding. Complete-case analysis showed similar pattern (Table 6-6, 
Supplementary). 
The E-value for the observed point-estimate (HR 0.84, 95% CI 0.67, 1.08) of prenatal 
smoking and childhood type 1 diabetes was 1.67. The observed 16% reduced incidence of 
type 1 diabetes for children exposed to prenatal smoking could be explained away by 
unmeasured confounding that was associated with prenatal smoking and the childhood type 
1 diabetes by an HR of 1.67 each, above and beyond the measured confounders. The observed 
95% CI already included the null value (95% CI 0.67, 1.08), therefore the E-value for the CI 
was 1, suggesting that no unmeasured confounding would be needed to move the CI to 
include the null. For example in our study,  type 1 diabetes in the father  is a potential 
unmeasured confounder and a strong predictor of type 1 diabetes in the offspring (paternal 
type 1 diabetes vs. no paternal type 1 diabetes OR 9.19, 95% CI 3.8, 22.0),310 which could 





As the E-value indicated the “unmeasured confounder and outcome association”, and the 
“unmeasured confounder and exposure association”, each would need to be equal to a HR of 
1.67 to negate the observed effect.  Although type 1 diabetes in the father is a strong predictor 
of type 1 diabetes in the offspring, we do not know the strength of the association between  
type 1 diabetes in the father and maternal smoking in pregnancy. In addition, the low 
prevalence of type 1 diabetes in the father (<1%) also reduces the potential to confound the 
maternal smoking and childhood type 1 diabetes association. Therefore, type 1 diabetes in 
the father may not be a strong enough unmeasured confounder to negate the observed effect 
of maternal smoking in pregnancy on childhood type 1 diabetes in this study.  
6.2.5.3 Sensitivity Analyses 
The sensitivity analyses (Table 6-7, Supplementary) were consistent with the main findings.  
6.2.5.4 Meta-analysis 
In addition to the current study, there were four previous population-based studies describing 
an association between prenatal smoking and type 1 diabetes available for meta-analysis 
(Figure 6-3). The meta-analysis showed 28% lower type 1 diabetes incidence for children 
exposed to prenatal smoking (HR 0.72, 95% CI 0.62, 0.82) compared with unexposed 
children. Similarly, the meta-analysis of six case-control studies (Figure 6-4, Supplementary) 
demonstrated 29% reduced type 1 diabetes risk for children whose mothers smoked during 
pregnancy (OR 0.71, 95% CI 0.55, 0.86) compared with those children whose mothers had 






6.2.6 Discussion  
 
In this large whole-of-population study, type 1 diabetes incidence was lower for children 
exposed to maternal smoking in pregnancy compared with children unexposed, after 
adjusting for a wide range of confounders. Similar to studies in this area, small numbers of 
type 1 diabetes cases among children exposed to prenatal smoking has impacted on the 
precision of the effect estimates. The CIs around the adjusted effect estimates in our primary 
and secondary analyses were wide, but on balance, provided some evidence to suggest a 
lower incidence of type 1 diabetes (consistent smokers HR 0.76, 95% CI 0.58, 0.99). The 
crude absolute risk reduction was small, with 4 fewer type 1 diabetes cases per 100,000 
person-years among children exposed to maternal smoking in pregnancy versus unexposed 
children The 6% increased type 1 diabetes incidence for children whose mothers smoked 
only in the first or second half of pregnancy is difficult to interpret, again because of the very 
wide confidence intervals (95% CI 0.73,1.55), and the small number of type 1 diabetes cases 
associated with mothers who smoked (n=38) in the first or second half of pregnancy.  In 
addition, 69% of the 38 women who smoked only in the first or second half of pregnancy 
and had a child with type 1 diabetes reported quitting before or at their first antenatal visit. 
This suggests that the exposure to smoking during pregnancy among this group is mostly 





and despite the negative control outcome analysis indicating the likelihood of a small amount 
of unmeasured confounding, the evidence suggests a lower type 1 diabetes incidence for 
children exposed to maternal smoking during pregnancy as compared with unexposed 
children.  However, because of the unmeasured confounding, the effect of smoking on type 
1 diabetes is likely to be smaller than the point estimates suggest. As indicated by the E-
value, unmeasured confounding associated with prenatal smoking and childhood type 1 
diabetes with an HR of 1.67 could negate the observed effect.   
Smoking will never be recommended as an intervention for type 1 diabetes due to the 
significant harm it causes to both the mother and the foetus. The consequences of prenatal 
smoking have been well researched and include increased risk of miscarriage, preterm 
delivery, low birthweight, childhood obesity, respiratory problems, neurodevelopment and 
behavioural consequences. 329, 330 It is not known which component of tobacco, nicotine or 
other combustible chemicals, may be an active  factor associated with reduced type 1 diabetes 
risk. Our findings suggest the mechanism of the effect of maternal smoking during pregnancy 
on type 1 diabetes (e.g. immune suppression by nicotine exposure, or alterations in gene 
expression) needs further investigation.   
The prevalence of smoking in first half of pregnancy (23.8% in 1999, 11.2% in 2013) in our 
study is similar to reports of smoking in early pregnancy from Australia (11.3% in 2013),331 
and Scandinavia in 2009 (Denmark 12.5%, Norway 16.5%, Finland 15% ).332 Of the women 





antenatal visit or only smoked in first half of pregnancy, consistent with Australian national 
reports.177 Consistent smoking in both first and second half of pregnancy in our study (20.7% 
in 1999, 9.7% in 2013) is similar to Scandinavian estimates (~10% in Finland and Denmark 
in 2009).332  
Our findings of a lower type 1 diabetes incidence following exposure to prenatal smoking 
were similar to findings of previous case-control and population-based cohort studies, 
however, the effect sizes in our study (16-24%) were smaller than previously reported 
estimates (25-35%).29-31, 33, 310 In our study, adjusting for a range of confounders did not 
considerably attenuate the effect estimate of maternal smoking on childhood type 1 diabetes. 
The number of children with type 1 diabetes exposed to prenatal smoking is small across 
previous studies, ranging from 42 to 72 in other population-based studies from Australia and 
Norway.29, 30 This is similar to our study, with 118 out of 557 children with type 1 diabetes 
exposed to maternal smoking in pregnancy. A meta-analysis was undertaken in our study to 
address the small samples and indicated that there was a 28% reduced risk of type 1 diabetes 
using data from population-based studies 27, 29, 30 and 29% reduced risk using data from case-
control studies.26, 31-33, 309, 310 These results involve six countries (Norway, Denmark, Sweden, 
UK, US, and Australia), and 9,872 children with type 1 diabetes of which 16% were exposed 
to prenatal smoking. Our meta-analytic estimates are consistent with a recent meta-
analysis.186 However, our results are inconsistent with the HLA-matched case-control study 
that reported increased type 1 diabetes risk for children exposed to prenatal smoking.26 Whilst 





it is plausible that other genetic risk variants contributing to susceptibility75 may be more or 
less prevalent in the type 1 diabetes cases compared with controls in the HLA-matched study.  
Many studies such as the Australian-based Environmental Determinants of Islet 
Autoimmunity ENDIA study333 have been established in at-risk populations to elucidate 
mechanisms that lead to type 1 diabetes, and current thinking is that there are likely to be 
multiple mechanisms that link prenatal smoking with type 1 diabetes.165 Epigenetic 
modifications induced by prenatal smoking, such as DNA methylation, may lead to changes 
in gene expression. Differences in DNA methylation have been reported among children 
exposed and unexposed to prenatal smoking,87 and among children with type 1 diabetes and 
their type 1 diabetes-discordant twins.170 In addition, nicotine, a known immune suppressant 
reported to effect both the innate and adaptive immune responses, can pass through the 
placenta to foetal circulation.172 The suppressive impact of smoking on immunity increases 
the risk of many chronic diseases, but there is some suggestion it could be protective for an 
autoimmune disease like type 1 diabetes. Smoking during pregnancy has been associated 
with reduced risks of other diseases with immune elements such as pre-eclampsia, 
Parkinson’s disease, ulcerative colitis, and sarcoidosis.334-337 The presence of autoantibodies 
in preeclampsia suggests that it may be a pregnancy-induced autoimmune disease.338 High 
risk HLA genotypes for type 1 diabetes are also reported to be involved in ulcerative colitis, 
339 suggesting there may be a similar underlying mechanism of smoking in modifying the 





This study included children attending all public hospitals in South Australia, therefore 
children with type 1 diabetes who never attended any public hospital might have been missed. 
However, we believe that case ascertainment is high in this study, because, both primary and 
secondary diagnoses codes were used, and thus even children who are hospitalized for other 
reasons were included if type 1 diabetes was noted as their secondary diagnosis. In addition, 
the South Australia paediatric hospital with specialized endocrinology unit and where 
children are admitted for stabilization after diabetes diagnosis, was included in this study. In 
a similar setting in Western Australia, 99.8% of type 1 diabetes cases on the state diabetes 
register were ascertained in public hospital data.267 Although social desirability bias in 
collecting maternal smoking is a common issue in observational studies, a Swedish validation 
study demonstrated that of the women who reported no smoking in pregnancy, 95% were 
classified as non-smokers based on serum cotinine concentration.171  In our study, there could 
be some measurement error in maternal smoking during pregnancy. However, we do not have 
information about the extent of mismeasurement in the exposure to smoking as the data are 
not available. Furthermore, the capture of perinatal data is via a form validated against 
medical records. There may be misclassification of mother’s tobacco exposure, because we 
do not have data on father’s smoking, which can affect the foetus through maternal passive 
smoking. Another limitation is the lack of information on dose or number of cigarette smoked 
daily, in pregnancy. We used the E-value and negative control outcome to indicate the 
potential for bias due to unmeasured confounding. The E-value is dependent on the validity 





We have tried to improve the internal validity by adjusting for a range of potential 
confounders, using routinely collected data (reduced risk of recall-bias), and conducting 
multiple imputation to account for bias due to loss of information. In addition, the negative 
control outcome analysis is assumed to have exact same set of measured and unmeasured 
confounders (perfectly U-comparable), as the maternal smoking and childhood type 1 
diabetes association. It is rare to have a perfectly U-comparable negative control outcome, 
and it is most likely to only be approximately U-comparable.285 However, because of non-
perfect U-comparability, the negative control outcomes suggests that the association between 




Our best estimate from this study is there is 16% reduced incidence of type 1 diabetes for 
children exposed to any maternal smoking in pregnancy as compared to unexposed children, 
but some of this effect is likely due to residual confounding. With the current analyses we 
cannot rule out an effect of maternal smoking during pregnancy on childhood type 1 diabetes. 
However, the absolute reduction in type 1 diabetes cases among children exposed to smoking 
was small (4 cases per 100,000 person-years). This study along with the results of similar 
population-based studies, suggests that the mechanism leading to the maternal smoking and 










6.2.8 Tables and Figures  
 
 






Figure 6-2: (Supplementary Figure) Directed acyclic graph showing proposed confounding 
structure 
Exposure = Maternal smoking in pregnancy  
Outcome = Childhood type 1 diabetes   
Confounders = Adjusted for in our model    
Confounders = Not measured, and not adjusted for in our model   




















Table 6-1: Characteristics of children by maternal smoking during pregnancy (N=286,058) 
 Imputed analysis 
 N = 286,058a 
Complete-case analysis 









Type 1 diabetes     
   No 223403 (99.8) 62098 (99.8) 212064 (99.8) 52036 (99.8) 
   Yes 439 (0.2) 118 (0.2) 350 (0.2) 92 (0.2) 
Mother's age (years) (Mean ± 
SD) 
30.1 ± 5.4 27.4 ± 6.1  30.1 ± 5.3 27.6 ± 6.0 
Father's age (years)  (Mean ± 
SD) 




   No  222591 (99.4) 61759 (99.3) 211283 (99.5) 51774 (99.3) 




   No  221030 (98.7) 61475 (98.8) 209763 (98.8) 51524 (98.8) 
   Yes 2812 (1.3) 741 (1.2) 2651 (1.2) 604 (1.2) 




   Private 67304 (30.1) 5191 (8.3) 65446 (30.8) 4830 (9.3) 
   Public 156538 (69.9) 57025 (91.7) 146968 (69.2) 47298 (90.7) 




   Private 81670 (36.5) 6704 (10.8) 78018 (36.7) 6014 (11.5) 




   1st child 95457 (42.6) 24419 (39.2) 90323 (42.5) 20622 (39.6) 
   2nd child 81299 (36.3) 18754 (30.1) 77871 (36.7) 16098 (30.9) 
   3rd child 32074 (14.3) 10392 (16.7) 30440 (14.3) 8696 (16.7) 
   ≥ 4th child 15011 (6.7) 8650 (13.9) 13780 (6.5) 6712 (12.9) 
Parents’ highest occupation 
  
  
   Managers, administrators 103424 (46.2) 12088 (19.4) 99549 (46.9) 10994 (21.1) 
   Para-professional, 
tradespersons 
83595 (37.3) 24295 (39) 80009 (37.7) 21578 (41.4) 
   Plant machine operators 20554 (9.2) 12203 (19.6) 19459 (9.2) 10598 (20.3) 
   Students, pensioners 16269 (7.3) 13630 (21.9) 13397 (6.3) 8958 (17.2) 
Mother's birth region 
  
  
   Oceania  180678 (80.7) 58150 (93.5) 171221 (80.6) 48533 (93.1) 
   Europe 17029 (7.6) 2869 (4.6) 16268 (7.7) 2528 (4.8) 
   Africa, Asia, Americas 26135 (11.7) 1197 (1.9) 24925 (11.7) 1067 (2.0) 
Mother's ethnicity  
  
  
   Caucasian 192995 (86.2) 55577 (89.3) 183646 (86.5) 47587 (91.3) 
   Aboriginal or Torres Strait  
   Islander 









   Major cities  166731 (74.5) 40835 (65.6) 158572 (74.7) 34628 (66.4) 
   Inner regional  21161 (9.5) 6147 (9.9) 20054 (9.4) 5165 (9.9) 




   Most disadvantaged (1) 54062 (24.2) 25441 (40.9) 50598 (23.8) 20661 (39.6) 
   2nd quintile  48338 (21.6) 15359 (24.7) 45861 (21.6) 12888 (24.7) 
   3rd quintile  38442 (17.2) 9111 (14.6) 36669 (17.3) 7827 (15.0) 
   4th quintile 47752 (21.3) 8152 (13.1) 45731 (21.5) 7154 (13.7) 




   <25 kg/m2 
(Underweight/normal) 
114211 (51) 29006 (46.6) 38046 (50.4) 6715 (44.5) 
   25 to <30 kg/m2 
(Overweight) 
59981 (26.8) 17167 (27.6) 20500 (27.1) 4044 (26.8) 
   ≥30 kg/m2 (Obese/severely 
obese) 
49649 (22.2) 16042 (25.8) 17005 (22.5) 4327 (28.7) 
Data are presented as mean ± SD or n(%) 
aFor the imputed analysis, the n values of the subgroups of the following do not equate to the total 
due to rounding: parity (both groups), mother’s 
ethnicity (smoking), remoteness (smoking), IRSAD (no smoking), maternal BMI (both groups) 
bFor IRSAD, first quintile is most disadvantaged, fifth quintile is most advantaged 
cMissing data: complete-case analysis/no smoking, n=136,863; complete-case analysis/smoking, 
n=37,042 






Table 6-2: Maternal smoking during pregnancy and risk of childhood type 1 diabetes 
(T1D)  (Total n = 286,058, type 1 diabetes n = 557)  
   Unadjusted  Adjustedc 
 T1D n HRa (95%CIb) HR (95%CI) 
Maternal smoking in pregnancy      
Non smoking 439 Ref  Ref  












Consistent smoking 80 0.72 (0.56, 0.93) 0.76 (0.58, 0.99) 
Maternal smoking in pregnancy      
Non smoking 439 Ref  Ref  
Smokingd (any smoking in 
pregnancy) 
118 0.80 (0.64, 1.01) 0.84 (0.67, 1.08) 
aHR (hazard ratio)  
bCI (confidence interval) 
cAdjusted for parents’ age, parents’ occupation, mother’s birth region, maternal ethnicity, 
remoteness, IRSAD (Index of Relative Socio-economic Advantage and Disadvantage), 
mother type of patient, hospital category, parity, pre-pregnancy hypertension, pre-
pregnancy diabetes, and child’s year of birth 












Table 6-3: Negative control outcome analysis: Association between maternal smoking 
during pregnancy and child not having a school card (Total n = 184,663, No school card n 
= 149,670) 




HRa (95%CIb) HR (95%CI) 






Non smoking 119,843     
Smoked only in first or second 









Consistent smoking 21,208 0.80 (0.78, 0. 81) 0.85 (0.83, 0.87) 
Maternal smoking in 
pregnancy 
 
    
Non smoking 119,843 Ref  Ref  
Smokingd (any smoking in 
pregnancy) 
29,827 0.82 (0.81, 0.84) 0.86 (0.85, 0.88) 
aHR (hazard ratio)  
bCI (confidence interval) 
cAdjusted for parents’ age, parents’ occupation, mother’s birth region, maternal ethnicity, 
remoteness, IRSAD (Index of Relative Socio-economic Advantage and Disadvantage), 
mother type of patient, hospital category, parity, pre-pregnancy hypertension, and pre-
pregnancy diabetes 















Table 6-4: (Supplementary Table) Complete-case analysis: Characteristics of children by 
maternal smoking during pregnancy (N=264,542) 
 No smoking 
Smoking only in 1st 




 n=212,414  n=14,315 n=37,813 
Type 1 diabetes    
   No 212064 (99.8) 14286 (99.8) 37750 (99.8) 
   Yes 350 (0.2) 29 (0.2) 63 (0.2) 
Mother's age (years) (Mean 
± SDa) 30.1 ± 5.3 28.0 ± 5.8 27.5 (6.0) 
Father's age (years)  (Mean 
± SD) 33.3 ± 6.3 31.1 ± 6.5 31.1 (7.0) 
Pre-pregnancy diabetes    
   No  211283 (99.5) 14245 (99.5) 37529 (99.2) 
   Yes 1131 (0.5) 70 (0.5) 284 (0.8) 
Pre-pregnancy hypertension    
   No  209763 (98.8) 14141 (98.8) 37383 (98.9) 
   Yes 2651 (1.2) 174 (1.2) 430 (1.1) 
Hospital category (for child 
birth)    
   Private 65446 (30.8) 2739 (19.1) 2091 (5.5) 
   Public 146968 (69.2) 11576 (80.9) 35722 (94.5) 
Mother type of patient 
(Healthcare)    
   Private 78018 (36.7) 3204 (22.4) 2810 (7.4) 
   Public 134396 (63.3) 11111 (77.6) 35003 (92.6) 
Parity    
   1st child 90323 (42.5) 7859 (54.9) 12763 (33.8) 
   2nd child 77871 (36.7) 4055 (28.3) 12043 (31.8) 
   3rd child 30440 (14.3) 1621 (11.3) 7075 (18.7) 
   ≥ 4th child 13780 (6.5) 780 (5.4) 5932 (15.7) 
Parents’ highest occupation    
   Managers, administrators 99549 (46.9) 4697 (32.8) 6297 (16.7) 
   Para-professional, 
tradespersons 80009 (37.7) 6551 (45.8) 15027 (39.7) 





   Students, pensioners 13397 (6.3) 1199 (8.4) 7759 (20.5) 
Mother's birth region    
   Oceania  171221 (80.6) 12894 (90.1) 35639 (94.3) 
   Europe 16268 (7.7) 872 (6.1) 1656 (4.4) 
   Africa, Asia, Americas 24925 (11.7) 549 (3.8) 518 (1.4) 
Mother's ethnicity     
   Caucasian 183646 (86.5) 13366 (93.4) 34221 (90.5) 
   Aboriginal or Torres Strait 
Islander 2543 (1.2) 375 (2.6) 2816 (7.4) 
   Asians and others 26225 (12.3) 574 (4.0) 776 (2.1) 
Remoteness    
   Major cities  158572 (74.7) 10083 (70.4) 24545 (64.9) 
   Inner regional  20054 (9.4) 1474 (10.3) 3691 (9.8) 
   Outer regional/remote 33788 (15.9) 2758 (19.3) 9577 (25.3) 
IRSADb    
   Most disadvantaged (1) 50598 (23.8) 4311 (30.1) 16350 (43.2) 
   2nd quintile  45861 (21.6) 3283 (22.9) 9605 (25.4) 
   3rd quintile  36669 (17.3) 2430 (17.0) 5397 (14.3) 
   4th quintile 45731 (21.5) 2637 (18.4) 4517 (11.9) 
   Most advantaged (5) 33555 (15.8) 1654 (11.6) 1944 (5.1) 
Maternal BMIc    
   <25 kg/m2 (Underweight 
& normal) 38046 (50.4) 2071 (43.4) 4644 (45.0) 
   25 to <30 kg/m2 
(Overweight) 20500 (27.1) 1375 (28.8) 2669 (25.9) 
   ≥30 kg/m2 
(Obese/severely obese) 17005 (22.5) 1330 (27.8) 2997 (29.1) 
aSD (standard deviation)  
bIRSAD (Index of Relative Socio Economic Advantage and Disadvantage) 










Table 6-5: (Supplementary Table) Complete-case analysis: Maternal smoking during 
pregnancy and risk of childhood type 1 diabetes (T1D)   
   Unadjusted Adjustedc 
 
 (N = 264,542) 
(T1D n = 442) 
(N =  264,542) 
(T1D n  = 442) 
 T1D, n HRa (95%CIb) HR (95%CI) 
Maternal smoking in pregnancy       
Non smoking 350  Ref  Ref  
Smoked only in first or second 
half of pregnancy 
     
29 1.07 (0.73, 1.56) 1.06 (0.72, 1.55) 
Consistent smoking 63 0.82 (0.63, 1.08) 0.82 (0.61, 1.09) 
Maternal smoking in pregnancy      
Non smoking 350  Ref  Ref  
Smokingd 92 0.89 (0.71, 1.12) 0.89 (0.69, 1.13) 
aHR (hazard ratio)  
bCI (confidence interval) 
cAdjusted for parent’s age, parent’s occupation, mother’s birth region, maternal ethnicity, 
remoteness, IRSAD (Index of Relative Socio-economic Advantage and Disadvantage),  
mother type of patient, hospital category, parity, pre-pregnancy hypertension,  
pre-pregnancy diabetes and child’s year of birth 







Table 6-6: (Supplementary Table) Negative control outcome complete case-analysis 
 Association between maternal smoking during pregnancy and child not having a school 
card (Total n = 277,370, No school card n = 84,531)  
   Unadjusted  Adjustedc 
 No school 
card 
HRa (95%CIb) HR (95%CI) 
Maternal smoking in pregnancy  Ref  Ref  
Non smoking 65,983     










Consistent smoking 13,480 0.79 (0.77, 0. 80) 0.84 (0.82, 0.85) 
Maternal smoking in pregnancy      
Non smoking 65,983 Ref  Ref  
Smokingd (any smoking in pregnancy) 18,548 0.81 (0.80, 0.83) 0.85 (0.83, 0.87) 
aHR (hazard ratio)  
bCI (confidence interval) 
cAdjusted for parents’ age, parents’ occupation, mother’s birth region, maternal ethnicity, 
remoteness, IRSAD (Index of Relative Socio-economic Advantage and Disadvantage), 
mother type of patient, hospital category, parity, pre-pregnancy hypertension, and pre-
pregnancy diabetes 











Table 6-7: (Supplementary Table) Sensitivity analyses based on imputed data 
Maternal smoking during pregnancy and risk of childhood type 1 diabetes 
  With BMI1 
2001-2013 
births2 
SA born3 Singleton4 Combined5 
 n = 286,058 n = 240,646 n = 285,969 n = 276,207 n = 232,271 
  HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) 
Maternal smoking in pregnancy      
     
 
Non smoking  Ref  Ref 
 Ref  Ref  Ref  
Smoked only in first or second half 
of pregnancy 
          
1.07 (0.74, 1.55) 1.20 (0.77, 1.89) 1.11 (0.77, 1.60) 1.06 (0.73, 1.55) 1.21 (0.77, 1.91) 
Consistent smoking 0.75 (0.57, 0.99) 0.80 (0.57, 1.13) 0.78 (0.59, 1.03) 0.75 (0.57, 0.99) 0.80 (0.56, 1.14) 
Maternal smoking in pregnancy           
Non smoking  Ref  Ref  Ref 
 Ref  Ref  
Smoking (any smoking) 0.84 (0.66, 1.07) 0.91 (0.68, 1.23) 0.86 (0.69, 1.10) 0.83 (0.65, 1.06) 0.91 (0.69, 1.23) 
 
1With BMI (Model 1) : Adjusted for maternal BMI, along with parent’s age, parent’s occupation, mothers’ birth region, maternal 
ethnicity, remoteness, IRSAD (Index of Relative Socio-economic Advantage and Disadvantage), mother type of patient, hospital 
category, parity, pre-pregnancy hypertension, pre-pregnancy diabetes and child’s year of birth 
2Restricted to children born from July-2001 to December-2013, and adjusted for all confounders as model 1  
3Restricted to South Australian born children, and adjusted for all confounders as model 1 
4Restricited to singleton births, and adjusted for all confounders as model 1 
5Restricted to singleton children, born in South Australia form July-2001 to December-2013, and adjusted for all confounders as 
model-1 




CHAPTER 7 EDUCATIONAL OUTCOMES AMONG 
CHILDREN WITH TYPE 1 DIABETES: WHOLE-OF-
POPULATION LINKED-DATA STUDY 
 
7.1 Preface 
This Chapter contains the fourth study contributing to this doctoral thesis. (This study was 
under review in Paediatric Diabetes when the thesis was submitted for examination and was 
subsequently accepted and published in that journal during thesis examination). 
In this paper, I have studied the impact of childhood type 1 diabetes on educational outcomes 
of South Australian children in grade 5 (~10 years of age). In this paper I used the potential 
outcomes theory in designing the analysis and estimated the average treatment effect of type 
1 diabetes on children’s educational outcomes. 
 
 This paper addresses the fourth research question planned to be studied in this doctoral 
project. “What is the impact of type 1 diabetes on children’s educational outcomes?”  
 
  






• South Australian children with type 1 diabetes are not disadvantaged in terms of 
educational outcomes, compared to children without type 1 diabetes. 
 
• This paper compares the educational outcomes of children with and without type 1 
diabetes at age 10 when we assume there is considerable parental involvement in type 
1 diabetes management.  
 
  




7.2 PUBLICATION 4: Educational outcomes among children with type 
1 diabetes: whole-of-population linked-data study 
7.2.1 Statement of Authorship  
 
 


























What’s known on This Subject? 
 Evidence about type 1 diabetes and educational outcomes is inconsistent. Cross-sectional 
and population-based studies showed poorer cognitive and educational outcomes for 
children with type 1 diabetes. However, two recent studies demonstrated no effect of type 1 
diabetes on educational outcomes. 
What This Study Adds?  
Our whole-of-population study using doubly-robust analytical methods demonstrated little 
difference in year 5 literacy and numeracy skills of children with and without type 1 
diabetes. These literacy and numeracy skills are important for progression through school, 
higher education and employment.  
  




7.2.2 Abstract  
Background 
Challenges with type 1 diabetes (T1D) blood glucose management and illness-related school 
absences potentially influence children’s educational outcomes. However, evidence about 
the impact of T1D on children’s education is mixed. The objectives were to estimate the 
effects of T1D on children’s educational outcomes, and compare time since T1D diagnosis 
(recent diagnosis (≤2 years) and 3-10 years long exposure) on educational outcomes.  
Methods 
This whole-of-population study used de-identified, administrative linked-data from the South 
Australian Early Childhood Data Project. T1D was identified from hospital ICD-10-AM 
diagnosis codes (E10, ranging E101 to E109), from 2001 to 2014. Educational outcomes 
were measured in grade 5 by the National Assessment Program-Literacy and Numeracy 
(NAPLAN, 2008-2015) for children born from 1999-2005. Analyses were conducted using 
augmented inverse probability of treatment weighting. Multiple imputation was used to 
impute missing data.  
Results 
Among 61,445 children born in South Australia who had undertaken NAPLAN assessments, 
162 had T1D. There were negligible differences in the educational outcomes of children with 
and without T1D, and between recently diagnosed and those with longer exposure. For 
example, the mean reading score was 482.8±78.9 for children with T1D and 475.5±74.3 for 
other children. The average treatment effect of 6.8 (95% CI -6.3–19.9) reflected one-tenth of 
a standard deviation difference in the mean reading score of children with and without T1D.   
Conclusion  




Children with T1D performed similarly on literacy and numeracy in grade 5 (age ~10-
years) compared to children without type 1 diabetes. This could be due to effective type 1 
diabetes management. 
Key words: Childhood, Type 1 diabetes, Educational outcomes, Augmented inverse 
probability weighting, Linked-data  
 




7.2.3 Introduction  
Children with Type 1 diabetes (T1D) are dependent on exogenous insulin their entire lives 
due to the immune-mediated destruction of their insulin-producing pancreatic beta cells. In 
the last few decades, advances in clinical care and intensive insulin treatment regimens for 
children with T1D have reduced the risk and severity of long-term complications such as 
vision loss, renal failure, cardiovascular disease, and T1D specific mortality.3, 222-224 
However, achieving optimum glucose control is challenging in the pediatric population with 
T1D,  and the associated risk of hypo- or hyperglycaemia may have consequences for 
children’s cognitive function and learning outcomes.237, 340 
Daily glycaemic variations, severe hypo-or hyperglycaemic episodes and other T1D related 
challenges may impact classroom learning and academic attainments of children in many 
ways. Firstly, glycaemic variations during school day even without overt hypo-or-
hyperglycaemia can affect cerebral glucose transport,341 and may have implications for 
children’s concentration and memory processes. Secondly, clinically significant severe 
hypoglycaemia243, 342, 343 and hyperglycaemia or diabetic ketoacidosis (DKA),240 can impact 
brain and cognitive functions during and in the aftermath of the event. Thirdly, early onset 
of T1D has been associated with changes in brain volumes and altered neural pathways, and 
may exert chronic effects on children’s cognition and presumably academic performance.344 
Children with T1D have shown lower executive functioning including planning, working-
memory, processing, attention, problem solving capacity, and visual motor integration.340, 345 




In addition, compared to children without T1D, children with T1D are reported to have 3% 
lower school attendance per-year13, three times more hospital days per person-year,12 and 
19% higher mental health referral rates.14 Collectively, reduced concentration and focus in 
classroom during transient glycaemic excursion, decreased cognitive and brain function 
during overt hypo- or hyperglycaemic episodes, psychological challenges, repeated 
hospitalization and school absenteeism put children with T1D at risk for poor educational 
outcomes. Although in the last 10 years there have been advances in T1D therapy, it is 
unknown to what extent these improvements have helped children in South Australia to reach 
their full potential in learning and educational achievement.    
While there are plausible biological pathways linking T1D with educational outcomes, 
studies have mixed results that range from poorer outcomes35, 36, 346 to null association.13, 37 
It is possible these differing results relate to differences in recent improvements in T1D care, 
such as the use of insulin pumps, better diabetes education programs and training school staff 
for managing T1D.347 For example, two Swedish studies used school data from 1988-2003 
during a period when use of insulin pumps was lower, and reported negative effects of T1D 
on educational outcomes.35, 36 Since that time, insulin pump use has increased, and has been 
linked with lower risks of severe hypoglycaemia and diabetic ketoacidosis.348 However, these 
Swedish studies 35, 36 as well as other study from Western Australia13 did not adjust for some 
important confounders including socioeconomic position,13, 35 ethnicity,13, 35 maternal 
diabetes,13, 35, 36 mother’s birth-region,13, 35 maternal smoking,13, 35, 36 and child’s 
birthweight.13, 35, 36 We used recent whole-of-population linked-data, with a wide range of 




potential confounders, to compute the average treatment effect (ATE) of T1D on children’s 
educational outcomes using augmented inverse probability weighting (AIPW). AIPW is a 
doubly robust procedure using which one can obtain results that have similar interpretation 
as the results obtained from a randomised trial in the absence of unmeasured confounding. 
AIPW handles observed confounding by creating a pseudo population where every child 
appears both as exposed (T1D) and unexposed (non- T1D).250, 283, 284 
 
 
7.2.4 Methods  
 
7.2.4.1 Study design and data source 
This study used whole-of-population, de-identified, administrative linked data from the 
South Australian Early Childhood Data Project (SA ECDP).256 Data linkage was conducted 
by an independent linkage agency (SA NT Datalink).269 Children appearing in different 
administrative datasets were linked using a probabilistic linkage algorithm that matched 
children using basic demographic information, such as name, sex, address and date of birth. 
A very small false linkage rate (0.1-0.5%) has been reported in Australian data linkage 
systems.269, 271 The data custodians provided de-identified data with a project linkage key to 
the researchers for analysis.  




The impact of T1D on educational outcomes was estimated by linking routinely collected 
perinatal and births registration data from 1999 to 2005, inpatient hospitalization data from 
2001 to 2014, and school assessment data of year 5 children (age ~10 years) from South 
Australia collected from 2008 to 2015.259, 268 
 
7.2.4.2 Type 1 diabetes 
 
Children with T1D were identified from inpatient hospitalization data from all public 
hospitals in South Australia, using the International Classification of Disease, 10th edition, 
Australian Modification (ICD-10-AM) codes (E10, ranging E101 to E109), including both 
primary and secondary diagnoses.264 These diagnoses codes are assigned by trained hospital 
staff following discharge from each hospitalisation episode. The age at first T1D code in 
hospitalization data was taken as age at diagnosis.  
 
7.2.4.3 Educational outcome 
De-identified individual-level educational data for all public schools in South Australia were 
provided by the South Australian Department for Education. These data were collected 
through the National Assessment Program-Literacy and Numeracy (NAPLAN), a 
standardized assessment of literacy and numeracy that commenced in 2008, and is 
administered annually to students in year/grade 3 (age ~8 years), 5 (~10 years), 7 (~12 years) 




and 9 (~14 years), in all schools in Australia.268  NAPLAN assessment was paper-based for 
all students from 2008-2015. We used year 5 NAPLAN scores as outcomes because year 5 
children were the oldest cohort in our dataset with sufficient numbers of children diagnosed 
with T1D prior to their NAPLAN assessment.    
Raw NAPLAN scores are converted to scaled scores ranging from 0-1000. Results are 
reported using five scales, one for each domain of numeracy, reading, writing, spelling and 
grammar. The Australian national average scale score for year 5 children is approximately in 
the high 400s to 500, and the score increases with advancing grade.268  
 
7.2.4.4 Confounding 
Potential confounders were identified a priori based on content knowledge, previous studies 
and directed acyclic graphs. These confounders were sourced from the Perinatal Statistics 
Collection,259 a mandatory data collection on every child born in South Australia collected at 
the time of birth, using a standardized tool. Parental characteristics included as confounders 
were parental age and parents’ highest occupation (Managers, administrators and 
professionals; Para-professionals, tradespersons, clerks, salespersons, and personal service; 
Plant, machine operators, drivers and labourers; Students, pensioner, home duties and 
unemployed). Maternal characteristics included pre-pregnancy or gestational diabetes 
(yes/no), pre-pregnancy or gestational hypertension (yes/no), ethnicity (Caucasian, 
Aboriginal or Torres Strait Islander, Asian and others), mother’s birth region (Oceania, 




Europe, and Asia, Africa, America), smoking during pregnancy (yes/no), number of antenatal 
visits (continuous variable), whether mother was a private or public patient, and whether the 
child was delivered in a private or public hospital. Child’s birthweight for gestational age z-
score321 was also included. Area-level socioeconomic indicator (Index of Relative 
Socioeconomic Advantage and Disadvantage, IRSAD305), and living in an accessible or 
remote area (measured by the Australian Remoteness Index for Areas, ARIA322), were based 
on mother’s residential postcode at the time of child birth. Parents’ highest education level 
(school only; certificate/diploma; bachelor degree or above) was obtained from school 
enrolment data. If parental education information was missing, then parental education of the 
child’s biological sibling was transposed.   
 
7.2.4.5 Statistical analysis 
In the primary analysis, we estimated the average treatment effect (ATE) of T1D on the five 
educational domains (reading, writing, spelling, grammar and numeracy scale scores), using 
AIPW.250, 349 In this case the “treatment” is being exposed to T1D. In AIPW analysis, two 
models were specified, and all the above-mentioned confounders were included in the 
outcome model (linear), and also in the treatment model (logistic). The treatment (exposure) 
model computes the probability of having T1D given the observed confounders, and the 
reciprocal of this probability is then used as the weight in the outcome regression. AIPW is 
known as a doubly robust model, and produces unbiased estimates if at least one of the 




models (the outcome or treatment model) is correctly specified.250 The ATE in our study is 
the marginal difference in NAPLAN scale scores of children with and without T1D.  
For the secondary analysis, AIPW for multivalued exposures was used to estimate the ATE 
of recently diagnosed T1D (≤2 years since diagnosis) and those exposed to T1D for 3-10 
years before the time of NAPLAN assessment, compared with no T1D.350 Recently 
diagnosed children might have more difficulty in adjusting and managing T1D, which could 
impact their assessment. There were only 24 children diagnosed with T1D, 6-12 months prior 
NAPLAN assessment, therefore, we used ≤2 years since T1D as recent diagnosis.  
 
7.2.4.6 Missing data  
The amount of missing data on the five educational domains ranged from 5.8-6.3%. The 
missing data for confounding factors was low (ranging from 0.3-1.7%), except father’s age 
(4.8%), number of antenatal visits (11.6%) and parents’ highest education (31.1%) (Figure 
7-1). Multiple imputation by chained equation was conducted to impute missing data on 
confounders and the outcome.323 Twenty datasets were generated. Multiple imputation was 
conducted to maintain the association between childhood type 1 diabetes and educational 
outcomes, and to account for the potential bias if the association differs between children 
with and without complete data. All the variables mentioned in Table 7-1 were included in 
the imputation model. In addition, birth plurality, year of birth, sex, school-card (financial 
assistance with school fees), and year in which NAPLAN was conducted were included as 




auxiliary variables to inform the imputation model, but were not part of the main analysis. 
We applied Rubin’s rules298 to compute the mean ATE, within imputation variance and 
between imputation variance, and to combine the estimates from the imputed datasets 
(Supplementary File 7-3). 
Analyses based on imputed datasets are presented in the paper. Complete-case analyses are 
presented in Supplementary Table 7-4 and 7-5.  All analyses were conducted in Stata SE 
(version 15.1). 
 
7.2.4.7 Ethics Approval  
Ethics approval for this project was granted by the Human Research Ethics Committees of 
the South Australian Department of Health (HREC/13/SAH/106), and the Aboriginal Health 
Council of South Australia (04-13-538).  
 
7.2.5 Results  
Among 61,445 children born in South Australia from 1999-2005 with year 5 NAPLAN 
assessment from 2008-2015, 162 had T1D (Figure 7-1).    
Table 7-1 shows some differences in the sociodemographic and perinatal characteristics of 
children with and without T1D. For example, children with T1D were less likely to be born 
to mothers who smoked, and were more likely to have highly educated parents. Children with 




T1D were more likely to have mothers who had hypertension or diabetes. Complete-case 
analysis showed similar patterns (Supplementary Table 7-4). 
Table 7-2 presents the crude mean, standard deviation (SD), and the ATE (computed by 
AIPW) of T1D, for the five educational domains. There was negligible difference in the mean 
reading, writing, spelling, grammar, and numeracy scores of children with and without T1D. 
For example, the mean reading score±SD was 482.8±78.9 for children with T1D and 
475.5±74.3 for children without T1D. The reading scale score ATE, or the difference in 
potential outcome means of the reading scale scores of children with and without T1D was 
6.8 (95% CI -6.3–19.9). This effect represents a difference of around one-tenth of the 
standard deviation, and at an assessment level it is a difference of less than one mark.351 
Complete-case analysis showed similar findings (Supplementary Table 7-5).  
Table 7-3 presents the associations according to the time since T1D diagnosis (≤2 years or 
3-10 years) versus no T1D. There were negligible differences in the mean reading, writing, 
spelling, grammar and numeracy scores according to time since diagnosis. For example the 
mean reading score±SD was 475.5±81.5 for children without T1D, 488.2±83.0 for recently 
diagnosed (≤2 years since T1D), and 480.2±75.4 for 3-10 years exposure to T1D. Compared 
to children without diabetes, the reading scale score ATE was 6.3 (95% CI -29.8–42.3) for 
the recently diagnosed children (≤2 year since T1D), and 2.6 (95% CI -10.9–16.2) for 3-10 
years exposure to T1D. This estimate reflects a difference of one-twelfth of the SD for 
recently diagnosed children and one twenty-fifth of the SD for 3-10 years exposure to T1D 




compared to children without diabetes. Once again, these effects reflect a difference of less 
than one mark in the raw reading score.351   
7.2.6 Discussion  
In this whole-of-population study a diagnosis of T1D had little impact on educational 
outcomes of children completing the educational assessment (NAPLAN) in year 5. This was 
consistent across all NAPLAN domains of reading, writing, spelling, grammar and 
numeracy. Differences in mean literacy and numeracy scale scores for children with and 
without T1D were very small, around one tenth of a standard deviation, or equivalent to less 
than one mark in the raw assessment. In addition, the estimate (ATE) for recently diagnosed 
children (≤2 years since diagnosis) and those exposed to T1D for 3-10 years, compared to 
children without T1D reflected a difference equivalent to less than one mark in the raw scores 
of the five domains of educational outcomes in year 5. 
Our findings are in contrast to small cross-sectional studies244, 245 two large Swedish 
population-based studies35, 36 and a recent record linkage study from Scotland346 that have 
demonstrated differences in educational or cognitive outcomes between children with and 
without T1D. The small cross-sectional studies used cognitive tests that measured verbal, 
performance and overall intelligence quotient such as the Wechsler Intelligence Scale244, 245 
Whereas educational assessments, such as NAPLAN used in our study, measure literacy and 
numeracy skills required for children to progress through school, and has implications for 
access to higher education,247 employment248 and income in adulthood.249 The two large 




Swedish nationwide population-based studies that demonstrated poor educational outcomes 
for children with T1D at the end of compulsory schooling (<15 years) and upper secondary 
school level (<19 years), used data from children born during the 1970s to 1980s (1972-1978; 
T1D n=2,485,36 1973-1986; T1D n=5,15935) with school results from 1988 to 2003.35 Our 
study used more recent educational outcomes (2008-2015) and hospital data (2001-2014), 
during a period of improved T1D treatment, which may help explain why we found little 
association between T1D and educational outcomes. Similar to our findings, no difference in 
educational outcomes of children with and without T1D was reported in two recent studies 
from Western Australia (2008-2011) and Denmark (2011-2015) that used nationally 
administered standardized school tests as their outcome.13, 37 The Western Australian study13 
did not adjust for parents’ socioeconomic position, ethnicity, and maternal characteristics 
(diabetes, birth-region, smoking), and the Danish37 study adjusted for similar confounders as 
in our study.  
Improvements in T1D management, diabetes education programs for school staff, and 
perhaps increasing use of insulin pumps due to government subsidy233-235 in recent years may 
have helped children in achieving better glycaemic control.233, 235, 347, 352 In Australia, 43% of 
children with T1D aged 0-14 years used a pump to administer insulin in 2013.53 The risk of 
severe hypoglycaemia has shown to be lower among insulin pump users compared with 
injection users.348, 353 Improvements in glycaemic control could also be attributed to the fact 
that T1D is a recognized medical condition by the Australian Government, Department of 
Social Service354, and it is a legal obligation for schools to make reasonable adjustments to 




encourage participation for children with T1D at school.352 Thus, children with T1D may reach 
their optimum capabilities and achieve similar educational outcomes as children without 
T1D, as demonstrated in our study.  
One potential reason for no discernible differences in the educational outcomes of children 
with and without T1D could be the younger age (9-10 years) of children in our study. Studies 
have shown that younger children are more likely to have better glycaemic control than older 
children.355, 356 It is possible that children with severe T1D and poor glycaemic control were 
absent on the day of the NAPLAN assessments. Therefore, the impact of T1D on educational 
outcomes may have been underestimated. However, consistency in the effect estimate 
between complete-case and imputed analyses suggest similarity in the characteristics of 
children who took the test or were absent on the test day. NAPLAN assesses the learned 
literacy and numeracy skills, it does not capture day-to-day difficulties children have with 
learning and other aspects of cognitive and psychosocial development. NAPLAN may not 
measure higher level reasoning or problem-solving skills or the capacity to analyse complex 
and lengthy text where success is heavily dependent on intact working memory skills. 
Therefore, the impact of T1D and its related events on children’s overall wellbeing and 
development cannot be ruled out.    
 The use of AIPW, an analysis that is  robust to model misspecification,250 is a strength of 
this study as it provides unbiased results if either the outcome model or the treatment model 
is correctly specified. The linkage of school data with the perinatal data enabled us to use a 
range of socioeconomic and perinatal characteristics to account for potential confounding, as 




some of them were not adjusted for in previous studies.13, 35, 36 Our study only included 
children attending public hospitals, therefore, we may have missed children who never 
appeared in any public hospital. However, we believe that case-ascertainment is high in our 
study because firstly, we have used both primary and secondary diagnoses codes, even 
capturing children hospitalised for other reasons, if T1D is coded as their additional 
diagnosis. Secondly, the one paediatric public hospital in South Australia with a specialized 
endocrinology unit, where children get admitted for stabilization after diabetes diagnosis is 
included in our study. Thirdly, T1D incidence in our study is consistent with Australian 
national reports.62 Still, our study has small number of children with T1D (n=162), because 
not all children with T1D were diagnosed before year 5 NAPLAN assessments or were old 
enough to sit the NAPLAN. In addition, private schools do not release individual-level 
NAPLAN data, therefore, were not included in this study. Educational outcomes of children 
in private and public schools have shown to be similar after adjusting for socioeconomic 
composition.357 It is not the school-sector, rather socioeconomic composition that confounds 
the association between T1D and educational outcomes, therefore having no data on private 
schools is unlikely to bias our estimate.  
7.2.7 Conclusion 
This whole-of-population study demonstrated that South Australian children with T1D are 
not disadvantaged on educational outcomes in year 5 compared to children without T1D. 




This supports the idea that the negative effects of T1D on educational outcomes may have 
equalized possibly through improved T1D management in children.    
  

























aSA (South Australia) 
bNAPLAN (National Assessment Program-Literacy and Numeracy) 
cIRSAD (Index of Relative Socioeconomic Advantage and Disadvanatge) 
 
  






Missing data on confounding (n) 
Mother’s age (23) 
Father’s age (2,927) 
Number of antenatal visit (7,141) 
Parents’ occupation (166) 
Parents’ education (19,088) 
Maternal smoking (1,050) 
Maternal birth region (244) 
Maternal ethnicity (241) 
Hospital category (241) 
Mother type of patient (241) 
Maternal hypertension (241) 








Children born in SAa (1999-2005) 
with least one NAPLANb (2008-
2015)     n = 61,445 
No type 1 diabetes  n = 61,283 
Type 1 diabetes  n = 162 
 
 
Complete case n = 33,648 
No type 1 diabetes n = 33,580 
Type 1 diabetes  n = 67 
 
Imputed dataset n = 61,445 
No type 1 diabetes n = 61,283 
Type 1 diabetes  n = 162 
 
Figure 7-1: Flow chart of the study population 




Table 7-1: Characteristics of children with and without type 1 diabetes (N = 61,445) 
  
No Type 1 
diabetes 
n = 61,283 
Type 1 diabetes 
n =162 
  n  %     n  % 
Mother’s age (years), mean (SD)a 28.6  (5.9) 28.6  (6.0) 
Father’s age (years), mean (SD) 31.9  (6.7) 31.6  (7.7) 
Number of antenatal visits, mean (SD) 10.6  (3.2) 10.6  (2.8) 
BWGAZb, mean (SD) 0.03  (1.1) 0.12  (1.0) 
Maternal diabetes      
   No  58,758 95.9 150 92.3 
   Yes 2,525 4.1 12 7.7 
Hypertension      
   No 55,475 90.5 138 84.9 
   Yes 5,808 9.5 24 15.1 
Parents’ highest occupation     
   Managers, administrators 19,160 31.3 54 33.1 
   Para-Professional, tradespersons 24,858 40.6 75 46.2 
   Plant machine operators 9,342 15.2 16 9.8 
   Students, pensioners 7,923 12.9 18 10.9 
Parents’ highest education      
   School only 21,275 34.7 55 33.8 
   Certificate/diploma 27,081 44.2 64 39.5 
   Bachelor degree or above 12,928 21.1 43 26.7 
Health care of mother     
   Private 13,754 22.4 45 27.7 
   Public 47,529 77.6 117 72.3 
Hospital category     
   Private 11,027 18.0 34 21.0 
   Public 50,256 82.0 128 79.0 
Mother's birth region     
   Oceania and Antarctica 54,519 89.0 143 88.4 
   Europe 4,149 6.8 ** ** 
   Africa, Asia, Americas 2,615 4.3 ** ** 
Mother's ethnicity     
   Caucasian 56,609 92.4 157 96.8 
   Aboriginal or Torres Strait Islander 1,934 3.2 ** ** 
   Asian or other 2,739 4.5 ** ** 




Maternal smoking during pregnancy     
   No  44,248 72.2 138 85.3 
   Yes 17,035 27.8 24 14.7 
IRSADc     
   Most disadvantaged (1) 17,346 28.3 45 27.8 
   2nd quintile  13,701 22.4 34 20.8 
   3rd quintile  10,077 16.4 30 18.3 
   4th quintile 11,385 18.6 32 19.8 
   Most advantaged (5) 8774 14.3 21 13.3 
Remoteness     
   Major cities  41666 68.0 119 73.7 
   Inner regional  5985 9.8 9 5.8 
   Outer regional/remote 13631 22.2 33 20.5 
aSD (Standard Deviation) 
bBWGAZ (birthweight for gestational age z-score) 
cIRSAD (Index of Relative Socioeconomic Advantage and Disadvantage) 
**Cells with n<5 and adjacent cells have been retracted as per ethics requirements  
  




Table 7-2:  Crude mean (SD) NAPLANa scale scores and average treatment effect (ATE) 
of type 1 diabetes on educational outcomes in year 5 (N = 61,445)  
  
Type 1 diabetes 
n = 162  
No type 1 diabetes 
n = 61,283  
 
  
  Crude mean SDb Crude Mean  SD 
Difference  in 
crude mean 
ATE (95% CI)c 
Reading 482.8 78.9 475.5 74.3 7.3 6.8 (-6.3–19.9) 
Writing  458.8 75.1 455.6 74.3 3.2 1.9 (-11.0–14.8) 
Spelling 478.3 73.8 472.8 74.3 5.5 3.8 (-9.5–17.0) 
Grammar 481.9 87.8 475.1 99.0 6.8 0.7 (-13.5–15.1) 
Numeracy 463.2 67.5 463.6 74.3 -0.4 -5.4 (-14.9–4.0) 
aNAPLAN (National Assessment Program-Literacy and Numeracy) 
bSD (Standard Deviation) 





Table 7-3: Crude mean (SD) NAPLANd scale scores and average treatment effect (ATE) of recent diagnosis  
(≤2 years since diagnosis) and 3-10 years exposure to type 1 diabetes (N = 61,445)  
 
No type 1 diabetes 
   n = 61,283  
cType 1 diabetes       
(≤2 years) 
n = 52 
dType 1 diabetes 
(3-10 years) 
n = 110 
Type 1 diabetes  
(≤2 years) 
Vs no T1D 
Type 1 diabetes  
(3-10 years)  
Vs no T1D 
  Meana SDb Mean SD Mean  SD ATEe 95%CIf ATE 95%CI 
Reading 475.5 81.5 488.2 83.0 480.2 75.4 6.3 (-29.8–42.3) 2.6 (-10.9–16.2) 
Writing  455.6 75.5 462.1 81.6 457.3 71.1 -0.2 (-33.2–32.9) 2.3 (-12.4–17.0) 
Spelling 472.8 76.9 488.4 73.7 473.5 73.5 9.1 (-17.2–35.4) -0.2 (-15.3–14.9) 
Grammar 475.1 87.2 492.1 103.5 477.0 78.5 9.6 (-26.2–45.4) -3.7 (-18.8–11.4) 
Numeracy 463.6 68.7 464.3 69.3 462.7 67.9 -10.2 (-29.3–8.9) -6.0 (-18.3–6.4) 
aCrude mean (scale scores) 
bSD (Standard Deviation) 
c≤2 years since T1D diagnosis at the time of year 5 NAPLAN  
d3-10 years since T1D diagnosis at the time of year 5 NAPLAN 
eATE (Average treatment effect) 
fCI (Confidence interval)  




Supplementary Tables  
Table 7-4: (Supplementary Table) Characteristics of children with and without type 1 
diabetes (complete-case analysis) 
 No type 1 diabetes Type 1 diabetes  
  N % N % 
Mother’s age (years)  61,277  145  
Mean (SD)a 28.6   (5.8) 28.6  (6.3) 
Father’s age (years) 58,379  139  
Mean (SD) 32.0   (6.5) 31.9   (7.4) 
Number of antenatal visits 54,175  129  
Mean (SD) 10.6   (3.1) 10.7   (2.6) 
BWGAZb 61,059  145  
Mean (SD) -0.02   (1.0) 0.12    (1.1) 
Maternal diabetes  61,059  145 
 
No  58,547 95.9 134 92.4 
Yes 2,512 4.1 11 7.6 
Hypertension  61,059  145  
No 55,271 90.5 123 84.8 
Yes 5,788 9.5 22 15.2 
Parents’ highest occupation 61,134  145 
 
Managers, administrators 19,130 31.3 46 31.7 
Para-Professional, tradespersons 24,806 40.6 69 47.6 
Plant machine operators 9,313 15.2 14 9.7 
Students, pensioners 7,885 12.9 16 11.0 
Parents’ highest education  42,250  107  
School only 14,400 34.1 38 35.5 
Certificate/Diploma 18,757 44.4 40 37.4 
Bachelor degree or above 9,093 21.5 29 27.1 
Health care of mother 61,059  145  
Private 13,674 22.4 38 26.2 
Public 47,385 77.6 107 73.8 
Hospital category 61,059  145  
Private 10,961 18.0 29 20.0 
Public 50,098 82.1 116 80.0 
Mother's birth region 61,056  145  
Oceania and Antarctica 54,332 89.0 129 89.0 
Europe 4,124 6.8 ** ** 




Africa, Asia, Americas 2,600 4.3 ** ** 
Mother's ethnicity 61,059  145  
Caucasian 56,405 92.4 ** ** 
Aboriginal or Torres Strait Islander 1,928 3.2 ** ** 
Asian or other 2,726 4.5 ** ** 
Maternal smoking during 
pregnancy 
60,252 
 143  
No  43,485 72.2 122 85.3 
Yes 16,767 27.8 21 14.7 
IRSADc 61,183  145  
Most disadvantaged (1) 17,310 28.3 41 28.3 
2nd quintile  13,677 22.4 31 21.4 
3rd quintile  10,060 16.4 27 18.6 
4th quintile 11,370 18.6 29 20.0 
Most advantaged (5) 8,766 14.3 17 11.7 
Remoteness 61,263  145  
Major cities  41,653 68.0 107 73.8 
Inner regional  5,983 9.8 ** ** 
Outer regional/remote 13,627 22.2 ** ** 
aSD (Standard Deviation) 
bBWGAZ (birthweight for gestational age z-score) 
cIRSAD (Index of Relative Socioeconomic Advantage and Disadvantage) 






Table 7-5: (Supplementary Table) Average treatment effect (ATE) of type 1 diabetes on 
NAPLANf scale scores in year 5 (complete case analysis) 
  Type 1 diabetes No type 1 diabetes    
  N Meana SDb N Mean SD ATEc 95% CId N 
Reading 151 483.0 74.3 57744 476.7 78.6 2.90 (-10.67–16.48) 33,692 
Writing  151 458.9 71.1 57657 457.0 73.2 -2.19 (-23.59–19.21) 33,648 
Spelling 150 479.4 68.1 57851 473.8 74.0 0.33 (-16.33–17.00) 33,734 
Grammar 150 483.0 82.2 57851 476.4 85.4 -3.48 (-19.37–12.40) 33,734 
Numeracy 144 466.2 62.7 57433 464.7 66.5 -0.93 (-12.43–10.58) 33,495 
aCrude mean 
bSD (Standard Deviation) 
cATE (Average treatment effect) 
dCI (Confidence interval)  
fNAPLAN (National Assessment Program-Literacy and Numeracy) 
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Supplementary File 7-6. Stata Syntax for computing augmented inverse probability 




 qui mi xeq `j' : teffects aipw (Outcome-variable  confounders, linear) /// 




matrix TEmat [`j',1]=coeffv[1,1] 
*within imputed data variance 














matrix colnames final= TEmat1bar lci uci 












CHAPTER 8 DISCUSSION  
 
My doctoral thesis has brought together descriptive epidemiology on the incidence of type 1 
diabetes in South Australia, with an examination of potential risk factors (caesarean birth and 
maternal smoking in pregnancy), and an exploration of the sequelae of type 1 diabetes in 
terms of children’s educational outcomes in year 5. This project has utilised a wide range of 
information on all children in South Australia born from 1999-2013, sourced from multiple 
linked administrative datasets. The SA ECDP256 used in this thesis has been recognized 
federally as an innovative data platform for improving children’s wellbeing, with the 
principle of using public data for public good.258 In this thesis, rigorous methodological 
approaches were deployed to address the systematic biases that are commonly seen in 
observational studies. To estimate the risk of bias due to unmeasured confounding negative-
control outcome designs and E-value analyses were employed,285, 288 to reduce risk of bias 
due to missing data multiple imputation was used,290 and to improve causal inference doubly 
robust methods were used.250, 276 By using multiple linked administrative datasets that hold 
different information, I was able to adjust for a wide range of potentially confounding 
variables. Both primary and 25 additional ICD-10-AM diagnoses codes from hospital 
admissions records were used to identify children with type 1 diabetes, which helped 
increased case ascertainment. Furthermore, being a population-wide data source, inclusion 
of children in the study was independent of the exposure and the outcome, thereby reducing 
the risk of selection bias. In this final chapter I interpret the key findings, describe the 




contribution of this dissertation to the field, discuss issues of variability in the effect 
estimates, limitations of this body of work, and potential areas for future research.  
 
8.1  Key findings: interpretation and contribution 
 
Type 1 diabetes is estimated to affect ~0.3%  of the Australian population aged <20 years.41 
Despite the low prevalence, it has large individual (e.g. low life expectancy,15 psychosocial 
challenges14) and economic implications (e.g. high healthcare and hospitalization costs, poor 
educational outcomes).12, 36, 358 As the incidence of type 1 diabetes has doubled in the last 
four decades in many countries,7, 175, 267 a major research effort has formed to understand the 
aetiology, but many divergent findings have been described.20-22, 25, 29, 30, 36, 37 The research in 
this thesis uses many progressive epidemiological methods to minimise possible sources of 
bias and better understand these divergent findings. 
The first descriptive study (Chapter 4) confirmed that type 1 diabetes incidence in South 
Australian data varied depending on the measure of socioeconomic position used. Individual-
level socioeconomic indicators demonstrated higher type 1 diabetes incidence among more 
advantaged children, however, there was no clear area-level socioeconomic patterning of 
type 1 diabetes incidence. This postulates that area and individual socioeconomic measures 
have different associations with type 1 diabetes.154 The area-level measure of socioeconomic 
position is the principal component of multiple items including income, education, 




occupation, and housing of the area. Each socioeconomic variable included in the IRSAD 
score has a different loading on the principal component and it is the sum of these that make 
up the final score. Each variable in the area-level score (IRSAD) might have a different 
association with type 1 diabetes. If we consider this in the context of the hygiene hypothesis, 
there may be a negligible association between education and type 1 diabetes when the basic 
level of hygiene is the same. However, housing may have a greater impact, as household 
crowding has been associated with lower risk of type 1 diabetes. Area-level measures of 
socioeconomic position73, 95, 149 may also misclassify an individual’s socioeconomic 
position.154, 359 Studying socioeconomic inequalities in type 1 diabetes incidence is important 
for understanding why type 1 diabetes is increasing. The countries with the top ten highest 
published childhood type 1 diabetes incidence are developed countries, including 
Australia.54, 175 This suggests a role of lifestyle changes driven by economic development for 
type 1 diabetes pathogenesis. One such lifestyle change could be involvement of both parents 
in the workforce, leading to time constraints for making healthy meals and reliance on ready-
to-eat or processed foods.360, 361  Parental employment has been linked with higher risk of 
childhood obesity315, 361, which is a risk factor of type 1 diabetes362 according to the 
accelerator or beta-cell stress  hypothesis.106 Some upper-middle income countries (Brazil, 
China) have reported low type 1 diabetes incidence.8, 150 However, there is a dearth of type 1 
diabetes data from lower-middle and low-income countries,54 as they do not have diabetes 
registers, or routine record collection systems. This makes it more difficult to draw inferences 
about the association between socioeconomic position and type 1 diabetes incidence globally. 




Socioeconomic position is a major determinant of health behaviour and healthcare choices, 
as socioeconomic patterning has been seen in both type 1 diabetes incidence and in its risk 
factors. For example, socioeconomically advantaged women are more likely to have 
caesarean births and less likely to smoke during pregnancy.253   
Caesarean birth and maternal smoking in pregnancy are two potential causes of type 1 
diabetes that are controversial and debated. Study 2 (Chapter 5) demonstrated negligible (5%) 
increased type 1 diabetes incidence for children born by caesarean, compared with normal 
vaginal delivery, with wide confidence intervals including the null. Contrary to the study 
hypothesis, intrapartum caesarean birth, where the foetus may have some exposure to vaginal 
microbiota was not associated with a lower type 1 diabetes incidence. This suggested that 
caesarean-induced changes in neonatal microbiota composition probably do not effect type 
1 diabetes risk. In Australia, 35% of births were by caesarean in 2017,253 and WHO has 
indicated that globally 6.2 million caesarean births are performed each year without medical 
indication,308, 363 suggesting an overuse of this medical intervention. Caesarean birth has been 
linked with many other adverse childhood health outcomes such as asthma and obesity,363, 
364 although its long terms implications on child health have not been rigorously 
investigated.363 However, the large majority of studies on caesarean have reported short term 
positive neonatal and child health outcomes.363, 365, 366 On balance, the findings of previous 
large population-based studies,21-23 and this thesis suggest that caesarean birth is not a risk 
factor for childhood type 1 diabetes.  




Study 3 (Chapter 6) demonstrated that maternal smoking in pregnancy was associated with 
lower childhood type 1 diabetes incidence compared with unexposed children, which was 
also supported by the meta-analytic estimates. The negative control outcome and E-value 
analyses indicated the potential for some unmeasured confounding. This suggests that 
previous studies that did not adjust for important confounders might have overestimated the 
protective effect of maternal smoking in pregnancy for childhood type 1 diabetes. In this 
doctoral thesis, even without adjusting for father’s type 1 diabetes, the observed effect of 
maternal smoking in pregnancy on childhood type 1 diabetes was smaller (16-24% lower 
risk) than previously reported estimates (25-60% reduced risk).29, 30, 32, 33, 310 This may be 
related to adjustment for a more comprehensive set of confounders. Maternal smoking in 
pregnancy has many short and long term consequences for the child,329, 330, 367-369 however, it 
has been linked with reduced risk of some diseases with an immune component, such as 
preeclampsia, ulcerative colitis and Parkinson’s disease.334, 336, 338, 370-372 Further studies 
among smokers might be helpful to understand the epigenetics or immune suppression 
mechanisms linking maternal smoking with childhood type 1 diabetes. In addition, smoking 
cessation data could be linked with the broader SA ECDP, to study whether children born to 
women who quit smoking had the same type 1 diabetes risk as those who continuously smoke 
throughout pregnancy. Furthermore, it could be used to study whether the association 
between smoking and type 1 diabetes is causal, or not. 
One of the encouraging results from this thesis is that children with type 1 diabetes are not 
disadvantaged in terms of their educational outcomes compared to children without type 1 




diabetes in South Australia (Chapter 7). This implies that the efforts taken in Australia for 
children with type 1 diabetes including insulin and insulin-pump subsidization, and 
involvement of schools in type 1 diabetes management, among other things, have been 
beneficial in helping children reach their full potential for learning.233, 352, 354  Perhaps, due to 
improved type 1 diabetes management in Australia13 and Denmark37 children with type 1 
diabetes are achieving the same educational outcomes as children without type 1 diabetes. 
This is not observed globally as a recent Swedish study reported a negative effect of type 1 
diabetes on high school outcomes measured from 1998-2010.246 This is surprising given that 
Sweden has a universal health care system but suggests that inequalities in educational 
outcomes for children with type 1 diabetes may remain in some settings even when there are 
advancements in care that could ameliorate such inequalities. The finding that there were no 
discernible differences in educational outcomes of children with and without type 1 diabetes 
are especially reassuring for patients and their families to know that children can reach their 
learning capability if high quality care is provided and accessible. Education outcomes are 
key to human capital. Studies like this could be used to advocate for type 1 diabetes care in 
settings where children with type 1 diabetes have poorer educational outcomes than their 
non-type 1 diabetes peers.   
 
 




8.2  Variability in effect estimates  
 
One of the curious observations from my thesis is that the estimates of the effect of caesarean 
birth (Chapter 5) and maternal smoking on childhood type 1 diabetes (Chapter 6) and 
educational outcomes of children with and without type 1 diabetes (Chapter 7) were smaller 
than previously reported findings. In the following sub-sections, detail about small effect 
estimates in my findings and previous studies will be discussed; including adjusting for a 
wide range of potential confounders, larger numbers of children with type 1 diabetes than 
many previous studies, and use of recent whole-of-population data instead of data in high 
risk populations.   
 
8.2.1 Differences in confounding adjustment 
 
Exchangeability is a term used in modern causal inference corresponding to comparability 
between the treated and untreated group,276 and is one of the important criteria for obtaining 
unbiased effect estimates. However, in observational studies the exposed and unexposed are 
not generally exchangeable, and this lack of comparability gives rise to confounding bias.373 
Confounding is a major threat to the internal validity of the observed effect of the exposure 
on the outcome.  In this thesis, efforts were made to make the exposed and unexposed 
exchangeable by conditioning on the measured confounders, in order to achieve conditional 




exchangeability.276 Analytical methods can only successfully control confounding to the 
extent that confounders are accurately measured (i.e. little to no error in the measurement of 
confounders) and are included in the analysis.275, 373 However, as mentioned in Chapters 5, 
6, and 7, many previous studies did not adjust for some important confounders making them 
at risk of bias due to residual confounding and potentially produced biased estimates. 
Adjusting for a wide range of confounders could be one reason for the smaller and closer to 
the null findings reported in this thesis than other studies.25 30 
 
8.2.2  Small number of children with type 1 diabetes 
 
Type 1 diabetes is a rare disease, therefore, having a sufficient number of children with type 
1 diabetes who are exposed to the risk factors under investigation has always been an issue 
for research. Even the largest nationwide studies can have small numbers of exposed cases ( 
for some exposures). Many population-based cohort studies conducted in at high risk 
populations had a relatively small number of children with type 1 diabetes exposed to 
caesarean birth and maternal smoking in pregnancy.27, 29, 30 Studies with small numbers of 
children with type 1 diabetes (who are exposed to the risk factor under study) may have lower 
reproducibility, reduced statistical power, a lower chance of detecting a true effect, and are 
less likely to yield reliable or precise effect estimates.291, 374, 375 The use of multiple linked 
population-wide administrative datasets and follow up of children in successive birth years 




for 15 years, enabled this study to have a large number of children (n = 286,058). However, 
even having larger numbers of children compared to most previous studies, the confidence 
intervals in this study were wide, due to the small number of exposed cases. Although 
Australia is in the top ten countries for published type 1 diabetes incidence, the absolute 
numbers in the South Australian population are still quite small. One option to overcome 
small exposed samples in research might be to combine data from multiple studies in meta-
analyses, as attempted in study 3 of this doctoral thesis (Chapter 7). South Australia is a 
relatively small state and including data from other states would have increased the number 
of children with type 1 diabetes and improved precision. However, data linkage across 
Australian jurisdictions is highly complex due to jurisdictional laws and ethics approvals 
required for accessing the data. Furthermore, not all jurisdictions have established data 
linkage systems. Thus, data linkage including multiple jurisdictions in Australia at this point 
is challenging. Other possibilities to have big studies with a sufficient number of children 
with type 1 diabetes could be global consortia where researchers from different jurisdictions 
in Australia and other countries could pool data (for meta-analysis) or combine analysed data. 
Large multicentre cohort studies focusing on at risk participants are potential areas to get 
sufficient numbers of children with type 1 diabetes such as ENDIA and TEDDY,212, 333 again 
these studies have their own challenges in terms of recruitment and follow up which is 
discussed further below (8.2.3).  
 




8.2.3  Variability in study design, data sources and follow-up time  
 
In this section I will explain potential reasons for small estimates in my thesis compared to 
previous studies, given the use of different data sources and years of follow up.  Population-
based cohort studies conducted in high risk populations (having a first degree relative with 
type 1 diabetes,  or HLA genotype) such as ENDIA, DAISY and TEDDY27, 333, 376, 377 have 
been investigating risk factors of type 1 diabetes. These cohort studies prospectively collect 
data; and may be at lower risk of confounding if all potential confounders are properly 
measured and used. However, cohort studies are costly and can take a long time to detect the 
outcome, with loss to follow-up potentially leading to attrition and selection bias.378 In 
addition, other cohort studies followed children for a short time, reported preclinical type 1 
diabetes as their outcome, and had a very small number of children with clinical type 1 
diabetes which impacted their precision.291, 374  This depicts the challenges faced by the whole 
field of studying type 1 diabetes or other conditions that are rare. One way to deal with the 
issue of small numbers is the setup of multicentre cohort studies in at risk populations to 
investigate the aetiology of type 1 diabetes. Linkage of routinely collected administrative 
datasets of children born in successive birth years may be less costly, and is an efficient way 
of exploring the risk factors and outcomes of children with type 1 diabetes, and are less prone 
to have selection bias, power and precision problems. However, population-wide linked data 
can have issues of unmeasured confounding, because these data are not collected with a 
particular research question in mind.    




Most previous studies that investigated the risk factors of type 1 diabetes were case-control 
studies and some of them did not adjust for individual-level socioeconomic information and 
important confounders.31, 33, 310  This may explain why the case-control studies, and the meta-
analyses consisting of mostly case-control studies may have high risk of confounding.25, 31, 
33, 310  In addition, some matched case-control studies did not adjust for the matching 
variables,26 which may introduce bias.  
 
8.3  Limitations and suggestions for future research 
 
In Chapter 5, 6, 7 the limitations of each individual study have been discussed.  The thesis 
limitations and future research directions are discussion in this section.   
In study 4 (Chapter 7) I looked at the educational outcomes of children in year 5 (age ~ 10 
years), but I could not look at the educational outcomes at 10-14 years (due to small 
numbers), during which the highest incidence of type 1 diabetes has been reported in most 
countries, including Sweden,59 Norway,66 US,70 Northern Ireland,71 and Australia.57, 63, 64 In 
addition, older children and young adults take their own responsibility for managing blood 
glucose, it may only be at older ages when inequalities become evident.355, 356, 379  Studies 
have shown better glycaemic control among younger children compared with adolescents.355, 
356 When the transition occurs from more parental involvement to self-management of type 
1 diabetes, deteriorating adherence to treatment resulting in poor glycaemic control during 




adolescence is often reported.380 This highlights the importance of continuous surveillance 
and the routine collection of data to investigate long term implications of type 1 diabetes to 
inform policy decisions.  
I will discuss disparities in accessing healthcare that could impact children’s access to insulin, 
insulin pumps and consumables and can have implications for their type 1 diabetes 
management and metabolic control, which further increases the risk of complications and 
poorer educational outcomes. There is a lack of universal healthcare coverage in many 
countries, and insulin costs have tripled in the last decade,381, 382 making it even more 
unaffordable for disadvantaged people, and those without health insurance.383-385  High 
insulin costs have impacted access to insulin all over the world,381, 382, 385-387 with about 2.8% 
of households in high-income and 63% of households in low-income countries unable to 
afford insulin.386 In the US the cost of insulin is around 23 times more than in Australia.388 
The inequalities in affordability and accessibility of insulin in high, middle and low income 
countries could have lasting health, educational, and socioeconomic consequences for people 
with type 1 diabetes.382  It was recently reported that the high insulin cost has been 
catastrophic for young adults in the US leading to insulin under-dosing; 25% of young adults 
reported underusing insulin, jeopardizing their health and survival.379 In addition, in the US 
11% people had no health insurance in 2018,384 and HbA1c levels were higher for people 
without health insurance (HbA1c level 8.6%) than people with insurance (HbA1c level 
7.5%).383 This depicts a large socioeconomic disparity in glycaemic control for people with 
and without health insurance.383 Such circumstances across the globe not only have 




implications for maintaining glycaemic control, but can also have consequences for health, 
educational outcomes and even for the survival of people with type 1 diabetes. Therefore, 
future studies could look at the long-term health and educational outcomes of people with 
type 1 diabetes with and without access to health insurance, or in settings where people have 
to pay out-of-pocket for insulin. According to the WHO, every year 100 million people are 
pushed to extreme poverty because of out-of-pocket spending on health.389  
Studies have suggested an increasing role of the environment for type 1 diabetes 
pathogenies.82 Despite this, a genetic risk score has been developed to predict the risk of type 
1 diabetes.82, 86 The utility of an environmental risk score could be investigated to explore the 
impact of the pre-and-postnatal environmental factors on the risk of type 1 diabetes.  
In my thesis paternal information on age, education, employment and occupation were 
available but there was no information on other paternal characteristics. In research more 
generally there has been a call for greater information on fathers390 as this has been a long-
overlooked contributor to children’s health. For data linkage, it is unlikely that such 
information will be introduced to perinatal data collections in the near future because of the 
cost of data collection and the fact that it is unlikely to be needed by government. However, 
birth cohorts are making headway on collecting information from fathers, such as TEDDY.212 
Information from such studies could have been applied to my effect estimates in a 
quantitative bias analysis, however it was beyond the scope of the project. This might be a 




way forward to get better quality evidence, to combine numbers from large linkage studies, 
with the rich data from cohort studies.  
Next, I reflect on what I learned from my doctoral studies and consider possible next steps 
for research.  My research on caesarean section and childhood type 1 diabetes, as well as 
other similar studies has shown that birth method induced variation in the neonatal 
microbiome is unlikely to be involved in type 1 diabetes pathogenesis. Therefore, clinical 
studies should focus on other areas for exploration of the potential causes of type 1 diabetes 
rather than the neonatal microbiome. The maternal smoking and type 1 diabetes study 
suggests that the prenatal environment might a have a role in type 1 diabetes pathogenesis. 
Epidemiological data has the limitation of not having detailed clinical information, therefore, 
clinical studies are needed to explore the mechanisms involved. A powerful way to make 
such progress in research would be for clinical and epidemiological experts to combine skills 
and resources as I believe there is a need for more epidemiologically rigorous research to 
inform clinical work, and vice versa. Additionally, further inroads might be made if diabetes 
register data was freely available for linkage with other administrative datasets following 
ethics approval. Currently the Australian Diabetes Register data, particularly unit-record 
level data, is only available to researchers after going through ethics approval and relevant 
data custodian agreement in all states and territories, which makes the process costly and 
time consuming.  Even there is a cost to access the register data for research.  In addition, 
clinical trials should routinely seek consent from participants for linkage with administrative 
and registry data, to be able to explore more complex questions and longer-term outcomes 




by bringing together the strengths of both clinical and epidemiological data.  As demonstrated 
in my maternal smoking and type 1 diabetes study, residual confounding is a common 
problem in observational studies and has been highlighted previously. The linkage of 
information from clinical trials and birth cohorts (when detailed clinical information is 
carefully observed) with administrative datasets and registries can help produce higher-




During this doctoral candidature my epidemiological expertise has matured from the use of 
descriptive epidemiology to causal thinking using directed acyclic graphs, gradually applying 
more sophisticated thinking and methods about causality, and then moving beyond 
conventional regression to a potential outcomes approach. This whole-of-population 
routinely collected administrative linked data study of children in South Australia, born from 
1999-2013, demonstrated that type 1 diabetes incidence varied for individual and area-level 
socioeconomic position, and that the hygiene hypothesis was only supported by individual 
level socioeconomic patterning of type 1 diabetes incidence in South Australia. The 
involvement of birth method induced variation in neonatal microbiota in type 1 diabetes was 
not supported by the caesarean and childhood type 1 diabetes study. The negative control and 
E-value analyses indicated residual confounding in the estimate of maternal smoking in 




pregnancy on childhood type 1 diabetes, suggesting that previously reported large protective 
effects were probably confounded. However, triangulation of the evidence suggested a small 
reduced risk of type 1 diabetes for children exposed to maternal smoking in pregnancy, 
highlighting the need to explore the mechanisms involved; such as the effect of smoking 
cessation on DNA methylation or transfer of nicotine to the foetus. My findings of similar 
education outcomes for children with and without type 1 diabetes are heartening and 
highlight the importance of improvement in type 1 diabetes management.  
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